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ABSTRACT 
            Lyme disease is a multisystem disorder caused by the tick vector Borrelia burgdorferi. 
During its life cycle between the tick vector and the mammalian host, Borrelia up- and down-
regulates the expression of its surface lipoproteins. Of its many surface lipoproteins, the Outer 
surface protein C (OspC) is crucial for initial mammalian infection. OspC has a common role 
shared with other lipoproteins of protection against host innate defences and a unique function in 
facilitating the dissemination of B. burgdorferi in the murine host.  
            The structure of OspC was solved in 2001 and the lipoprotein was found to be 
predominantly alpha-helical with 5 alpha helices and 2 beta sheets interconnected by 6 loops, 
and an N- and C-terminus. Not much is known as to how the OspC structure relates to the 
function of the lipoprotein and/or possible regulation. The up-and down-regulation of OspC is 
achieved by the rpoS alternative sigma factor and by an unidentified repressor, respectively.  
            Several truncated versions of OspC were tested in an OspC-deficient background to 
better understand the role of the amino acid sequences deleted. Structural deletions of 5 to 8-AA 
made within the OspC core, resulted in loss of infectivity. Longer deletions of 10- and 13 AA 
towards the N- and C-terminus of OspC, respectively, also resulted in loss of infectivity. 
Interestingly, a deletion of only 5-AA of the N-terminus of OspC did not affect the role of OspC 
in evasion but caused inefficient dissemination of B. burgdorferi in SCID mice.  
            Interestingly, whereas the deletion of N-terminus 5-AA of OspC resulted in upregulation, 
a deletion of 6- and 9-AA of the C-terminus of OspC resulted in downregulation of ospC mRNA 
in joints, indicating that OspC may be involved in self-regulation. This hypothesis was 
confirmed by the use of monoclonal antibody treatment. Deletion of 6-AA of the C-terminus of 
OspC resulted in lower spirochete burdens in heart and joint, whereas deletion of 9-AA resulted 
in higher spirochete burden in skin, indicating the tissue-dependent effects resulting from the 
xiv 
 
deletion of the C-terminal sequence. Taken together, these results indicate that OspC is involved 
in the pathogenesis of B. burgdorferi. 
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CHAPTER 1 
 
INTRODUCTION AND LITERATURE REVIEW 
INTRODUCTION 
            Borrelia burgdorferi, the agent of Lyme disease, differentially expresses several 
lipoproteins during its transmission cycle between a tick vector and a mammalian host 
(Burgdorfer et al., 1982). Timely expression of the outer surface protein C (OspC) is crucial for 
the pathogenic strategy of B. burgdorferi. The pathogen expresses OspC abundantly during early 
infection of a mammal, when the antigen is required (Liang et al., 2002a, Liang et al., 2002b). 
However, OspC being a protective antigen, its continued presence poses a threat to the pathogen, 
once anti-OspC humoral response has developed. If the pathogen does not down-regulate OspC 
or undergo escape mutations on the ospC gene, infection would be cleared (Xu et al., 2006).  
            When the crystal structure of OspC was resolved, OspC was shown to be predominantly 
alpha-helical in structure (Eicken et al., 2001, Kumaran et al., 2001). The molecule forms dimers 
in solution. Each subunit is made up of five alpha helices, two beta strands, six loops that 
connect the alpha helices and the beta strands and an amino (N-) and a carboxy (C-) terminus.  
Although the solution of the crystal structure did not shed much light to the function of OspC, 
through genetic and molecular methodologies, recent studies have shown that OspC has dual 
roles in early protection and in facilitation of dissemination of B. burgdorferi (Tilly et al., 2007, 
Xu et al., 2008).  
            In terms of regulation, the ospC gene is under the control of the sigma factor RpoS. 
Several virulent genes have an RpoS-dependent promoter (Yang et al., 2000, Yang et al., 2003a). 
In mice, RpoS appears to be constitutively expressed. The down-regulation of OspC when under  
immune pressure is thus dependent on an as-yet unidentified repressor that negatively regulates 
the gene via a specific interaction with the ospC operator (Xu et al., 2007). 
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            In this research project, we explored the crystal structure of OspC and made several types 
of strategic deletion mutants and analyzed the same for their effects on the functions of OspC 
and the regulation of the lipoprotein. The results show that deletion of the beta strands 1, 2 and 
alpha helix 4, 13-AA of the C-terminus and 10-AA of the N-terminus of OspC (βs1, βs2, αH4, 
Ct13-AA and Nt10-AA) leads to non-infectious spirochete phenotypes, thus abrogating the role 
of OspC in early evasion of B. burgdorferi from host innate defences; that 5-AA sequence of the 
N-terminus of OspC is able to dissect the role of OspC in early immune evasion from that of 
dissemination, because the mutant is infectious but unable to disseminate efficiently in SCID 
mice; that the same 5-AA N-terminus sequence and along with the C-terminus of OspC are 
involved in self-regulation of ospC. Collectively, this study showed a correlation between the 
structure of OspC and its function in innate immune evasion, dissemination and self-regulation.   
                                                         LITERATURE REVIEW  
            Discovery of Lyme Disease. Lyme disease was first recognized in 1975 as a distinct 
clinical disorder by Dr. Allen Steere. The disease derives its name from the small town of Lyme, 
Connecticut, USA (Steere et al., 1977b). Awareness of the disease began when a cluster of 
children with an initial diagnosis of “juvenile rheumatoid arthritis” on one small street in Old 
Lyme, CT was reported by their parents to the State Health Department.  Investigation of this 
unexplained arthritis in three contiguous Connecticut communities led to the description of Lyme 
arthritis. The geographical clustering of the patients in heavily wooded areas along with the peak 
occurrences in summer months suggested an infectious etiology and transmission of the 
infectious agent by an arthropod vector (Steere et al., 1977a, Steere et al., 1977b). However, the 
serendipitous discovery of the spirochetal etiology of Lyme disease was closely linked with 
studies on the natural history of spotted fever rickettsiae on Long Island, New York, where 
during 1971-1975, a total of 124 cases of spotted fever with eight deaths occurred.  A scientist by 
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the name Dr. Willy Burgdorfer along with another scientist, Dr. Jorge Benach from the New 
York State Health Department were primarily interested in obtaining a virulent strain of 
Rickettsia rickettsii from Dermacentor variabilis ticks collected near the homes of spotted fever 
patients on Long Island, New York. Instead, they found R. montana, a rickettsia non-pathogenic 
for humans. This then led them to speculate that possibly other tick species, such as the black-
legged deer tick Ixodes dammini (now, I. scapularis), might play a role in the ecology of spotted 
fever group. In the fall of 1981, Dr. Benach supplied Dr. Burgdorfer with additional ticks from 
Shelter Island, NY. None of the ticks examined contained Rickettsia but Dr. Burgdorfer found 
several microfilarias in the hemolymph of two female ticks, and to determine if this nematode 
was present in other tissues, he dissected and prepared smears of all other tissues, including the 
midgut. Surprisingly, instead of additional microfilaria, he found poorly shaped, long, irregularly 
coiled spirochetes. Dark-field microscopy confirmed the nature of the organism. Thus, the 
previously unidentified spirochete was named Borrelia burgdorferi, after the scientist Willy 
Burgdorfer (Burgdorfer et al., 1982, Glaser, 2006). The antigenic relationship between the I. 
scapularis spirochete and Lyme disease was established by indirect immunofluorescence and by 
Western Blot of sera from patients recovered from Lyme disease (Burgdorfer et al., 1982). The 
discovery of this spirochete as the long-sought etiologic agent of Lyme disease was hailed as an 
important breakthrough that led to an exploration of research on other spirochetal diseases.             
           Clinical Manifestations of Lyme Disease. Lyme disease generally occurs in stages, 
with different clinical manifestations at each stage. Although the initial classification of Lyme 
disease was as simple as erythema migrans (stage 1), meningitis or Bell’s palsy (stage 2) and 
arthritis (stage 3) (Steere et al., 1983), due to the overlap of the clinical manifestations at the 
different stages, the disease was re-classified in a system similar to that used to classify Syphilis 
(Asbrink and Hovmark, 1988). Thus, Lyme disease was essentially divided into early and late 
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infection. Early infection consists of stage 1 (early localized), followed within days or weeks by 
stage 2 (early disseminated) and within weeks or months by intermittent symptoms. Late or 
persistent infection (stage 3) usually begins a year or more after the onset of the disease 
(Nadelman and Wormser, 1998, Steere, 1989, Yoshinari et al., 1989).  
            The initial most common and clinical hallmark of the early localized stage of Lyme 
disease is a skin rash known as erythema chronicum migrans (Figure 1.1). The rash is recognized 
in about 90% of patients with objective evidence of B. burgdorferi infection (Gerber et al., 
1996). Erythema chronicum migrans typically develops at the site of the bite, within 7 to 10 days 
after the bite, as a small red annular macule or papule. As the redness around the center grows 
larger, the lesion tends to have red outer borders with partial central clearing that may expand to 
a diameter of up to 50 cm (Behera et al., 2005, Steere et al., 1978), for which reason the rash is 
also known as a “bull’s eye rash”. The lesion  is usually asymptomatic but may be pruritic or 
painful and it may be accompanied by constitutional symptoms such as low-grade fever, fatigue,  
malaise, arthralgias, headaches, cough, stiff neck and regional lymphadenopathy (Steere et al., 
1983). 
            The most common manifestation of the early disseminated stage is multiple erythema 
migrans. These secondary skin lesions appear 3 to 5 weeks after the tick bite and consist of 
multiple annular erythematous lesions similar to, but usually smaller than the primary lesion. 
Other manifestations of this stage include cranial nerve palsy, especially facial nerve palsy 
(Bell’s palsy), and meningitis. Unilateral or bilateral facial palsy is the most common cranial 
neuropathy, and it may be the only neurologic abnormality (Clark et al., 1985).  Rarely, carditis, 
manifested by various degrees of atrio-ventricular (A-V) block, may also occur at this stage 
(Steere et al., 1980). 
5 
 
 
Figure 1.1. Erythema chronicum migrans. (Courtesy of Dori F Zaleznik, MD). The rash is 
often seen in the early stage of Lyme disease. It is not an allergic reaction to the tick bite but an 
actual skin infection by Borrelia burgdorferi. Because of its reddish outer borders and central 
clearing, it is commonly referred to as “Bull’s eye rash”.  
                        In the United States, the most common manifestation of late Lyme disease is arthritis. 
Arthritis occurs weeks to months after the initial infection; it is usually monoarticular or 
oligoarticular (Steere et al., 1977b) and affects the large joints, particularly the knee (Figure 1.2). 
Although the joint is swollen and tender, the intense pain associated with a septic arthritis is 
usually not present. At this stage, about 10% of adults and 5% of children are refractory to 
antimicrobial treatment. 
            Other manifestations highly indicative of Lyme disease are lymphocytoma, 
meningoradiculoneuritis (Garin-Bujadoux-Bannwarth syndrome), and acrodermatitis chronic 
atrophicans.  Borrelial lymphocytoma, is a solitary bluish-red swelling with a diameter of up to 
few centimeters that appears most commonly on the ear lobe or nipple of the breast (Asbrink and 
Hovmark, 1988, Maraspin et al., 2002, Strle et al., 1992). Patients with meningoradiculoneuritis 
tend to have severe pain, usually in the thoracic or abdominal region, often belt-like and most  
pronounced during night (Kristoferitsch, 1991, Pachner and Steere, 1985, Steere, 1989). 
Acrodermatitis chronica atrophicans is a skin lesion that begins insidiously with bluish-red 
discoloration and swollen skin on an extremity. The lesion’s inflammatory phase may persist for 
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Figure 1.2. Lyme arthritis. (Rahn and Evans, 1998). Lyme arthritis occurs during the late stage 
of Lyme disease. It tends to be mono or oligoarticular, usually affecting the large joints, 
particularly the knee joint. Although the area is typically swollen, the intensity of joint pain is not 
comparable to that of a septic arthritis.  
            many years and it gradually leads to atrophy of the skin  (Asbrink and Hovmark, 1988). It is 
most often located in the extensor sites of the hands and feet. It is frequent in patients older than 
40 years and is more frequent in women than in men (Asbrink and Hovmark, 1988, Asbrink et 
al., 1986, Steere, 1989).  
                        Lyme disease is caused by Borrelia burgdorferi sensu lato strains. The human infection 
is caused primarily by three pathogenic genospecies, Borrelia burgdorferi sensu strictu, B. 
garinii, and B. afzelii (Johnson et al., 1984). Whereas B. burgdorferi is the sole cause of 
infection in the United States, B. garinii and B. afzelii are the main causes of the disease in 
Europe and Asia (Baranton et al., 1992, Canica et al., 1993). The various clinical manifestations 
of chronic Lyme disease have been associated with different tissue tropisms of the three 
genospecies of Borrelia. Cutaneous and neurological manifestations such as acrodermatitis 
chronica atroficans and neuroborreliosis are often associated with B.afzelii and B.garinii  
infections, respectively, whereas Lyme arthritis is mainly a complication of B. burgdorferi sensu 
strictu infections (Balmelli and Piffaretti, 1995, van Dam et al., 1993). 
            Diagnosis and Treatment of Lyme Disease. According to the Center for Disease 
Control and Prevention (CDC, 2009), the diagnosis of Lyme disease is based on symptoms, 
objective physical signs (such as the typical erythema migrans, facial palsy, or arthritis), and a 
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history of possible exposure to infected ticks. Validated laboratory tests can be very helpful, but 
are generally not recommended when a patient has erythema migrans. The most recommended 
laboratory tests are serodiagnostic.  
            CDC recommends a two-step process when testing blood for evidence of Lyme disease. 
The first step uses an enzyme immunoassay such as Enzyme-Linked Immunosorbant Assay 
(ELISA) or Immunofluoresence Assay (IFA) tests. These tests are designed for screening and are 
very sensitive. The ELISA provides a quantitative estimate of the concentration of antibodies 
against B. burgdorferi. If the ELISA or IFA is positive or indeterminate (equivocal), a second 
step should be performed to confirm the results. The second step uses a Western blot test, for its 
high specificity. The immunoblot provides antibodies against specific protein antigens of 
Borrelia burgdorferi. Most authorities require the presence of antibodies against at least 2 (for 
IgM) or 5 (for IgG) specific protein antigens of B. burgdorferi for the immunoblot to be 
considered positive (CDC, 1995). CDC does not recommend testing blood by Western blot 
without first testing it by ELISA or IFA. Dressler et al., (Dressler et al., 1993) and Johnson, et 
al., (Johnson et al., 1996) showed that the use of Western blot is important in determining 
whether “intermediate” results by ELISA are true positive.  
                        Treatment of Lyme disease involves primarily antibiotic therapy. The recommended 
treatment for early localized or disseminated Lyme disease, in the absence of specific neurologic 
manifestations, involves oral administration of doxycycline, amoxicillin, or cefuroxime axetil for 
14 days. The intravenous use of ceftriaxone for 14 days in early Lyme disease is recommended  
            for adult patients with acute neurologic disease manifested by meningitis or radiculopathy 
(Wormser et al., 2006). 
            Lyme arthritis can usually be treated successfully with antimicrobials administered 
orally. Doxycycline, amoxicillin, or cefuroxime axetil for 28 days is recommended for adult 
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patients without clinical evidence of neurologic disease. Adult patients with arthritis and 
objective evidence of neurologic disease should receive ceftriaxone IV (intravenous) (Wormser 
et al., 2006). For persons who have persistent or recurrent joint swelling after a recommended 
course of oral antibiotic therapy, the panel formed by Wormser, GP and colleagues recommend 
re-treatment with another 4-week course of oral antibiotics or with 2-4- week course of 
ceftriaxone IV (Wormser et al., 2006).  
            The severity and the duration of Lyme arthritis are increased in patients with IgG 
antibodies against OspA (Kalish et al., 1993, Steere et al., 1994). Particular class II major 
histocompatibility molecule (MHC) genes can determine a host immune response to B. 
burgdorferi that results in chronic arthritis and lack of response to antibiotic therapy (Steere et 
al., 1990, Steere et al., 1994). Due to the increased frequency of certain MHC molecules such as 
HLA-DR3 and HLA-DR4 alleles (Nocton, 1994, Steere et al., 1988, Steere et al., 2006) and the 
identification of human leukocyte function-associated antigen-1 (hLFA-1) as a candidate 
autoantigen (Gross et al., 1998) in these patients, an autoimmune mechanism has been proposed. 
However, LFA-1 is unlikely a relevant autoantigen, instead, an OspA epitope may be critical in 
triggering an antibiotic treatment-resistant Lyme arthritis (Steere et al., 2003). Although the 
pathogenesis of this refractory arthritis is not well understood, future technologies may allow the 
identification of spirochetal components or a relevant autoantigen, or both in the joint synovia of 
these patients. Since most patients with treatment-resistant Lyme arthritis yield consistently 
negative PCR results after antibiotic treatment, it is possible that chronic synovitis is maintained 
in the absence of B. burgdorferi. 
                      Vaccine Development against Lyme Disease. Considerable morbidity is associated 
with Lyme disease and there are areas in the United States and Europe where up to 3% of the 
population is infected annually (Fahrer et al., 1991). Based on pharmaco-economic studies, there 
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is a clear need for a Lyme disease vaccine, particularly in populations where the annual risk 
exceeds 1% (Meltzer et al., 1999, Shadick et al., 2001). However, at the present time a human 
vaccine is not commercially available. The first human Lyme disease vaccine was an Outer 
surface protein A or OspA-based formulation named as LYMErix (GlaxoSmithKline); however, 
its tenure was short, and citing a drop in sales, it was voluntarily pulled from the market in 2002. 
The decline in sales could be traced to concerns, real or perceived, of possible adverse effects 
including a chronic inflammatory arthritis that could theoretically develop in HLA-DR4 positive 
patients suggesting a vaccine associated auto-immune arthritis (Kalish et al., 1993). While new 
OspA based vaccinogens are being developed to mitigate this potential complication (Koide et 
al., 2005, Willett et al., 2004), questions remain about the viability of an OspA-based vaccine. 
One concern is the frequency of boosts required to maintain long term protection. OspA is 
expressed in the tick midgut, is rapidly down-regulated upon tick feeding, and is not expressed in 
mammals. The inherent problems associated with OspA-based vaccines can be avoided by use of 
antigens that are expressed at high levels during early mammalian infection and that elicit 
bactericidal antibody, such as the outer surface protein C or OspC. 
            OspC has received considerable attention in Lyme disease vaccine development. Its 
expression is induced during tick feeding and maintained during early mammalian infection 
(Schwan, 2003). Anti-OspC antibodies have been demonstrated to protect against infection, but 
only against strains that are closely related in sequence to the vaccinogen (Bockenstedt et al., 
1997, Gilmore et al., 1996, Scheiblhofer et al., 2003). Analysis of OspC sequences has 
delineated 21 phyletic ospC clusters or types that are differentiated by letter designation (A-U) 
(Seinost et al., 1999, Wang et al., 1999). Although OspC exhibits diversity, it is genetically 
stable during infection (Hodzic et al., 2000, Stevenson et al., 1994). Identification of protective 
epitopes of each OspC type will allow for construction of, recombinant, polyvalent, chimeric 
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vaccines that will elicit broad protection. Thus, a tetravalent (Earnhart et al., 2007) and an 
octavalent (Earnhart and Marconi, 2007) vaccine based on OspC types have been developed and 
resulted in induction of  complement-dependent bactericidal activity. Interestingly, a DNA-
vaccine encoding ospC gene was also shown to be suitable for inducing protection against Lyme 
borreliosis (Scheiblhofer et al., 2003). 
EPIDEMIOLOGY AND TICK VECTOR LIFE CYCLE 
            According to the Center for Disease Control and Prevention, since 1985, Lyme disease 
has been the most prevalent vector-borne illness in the United States (CDC, 2000). In 2007, more 
than 27,000 new cases of Lyme disease were reported in the United States, yielding a national 
average of 9.1 cases per 100,000 persons (CDC, 2007). In 2008, State health departments 
reported 28,921 confirmed cases and 6,277 probable cases of Lyme disease to CDC (Figure 1.3).  
            The 2008 Case Definition for Lyme disease, for the purpose of surveillance, states a 
confirmed case as: 
a) a case of EM with a known exposure. Exposure is defined as having been (less than or equal 
to 30 days before onset of EM) in wooded, brushy, or grassy areas (i.e., potential tick habitats) in 
a county in which Lyme disease is endemic. A history of tick bite is not required;  
b) a case of EM with laboratory evidence of infection and without a known exposure; or  
c) a case with at least one late manifestation that has laboratory evidence of infection;  
and a probable case as: any other case of physician-diagnosed Lyme disease that has laboratory 
evidence of infection. For the purposes of surveillance, the definition of a qualified laboratory 
assay is  
(1) a positive culture for B. burgdorferi,  
(2) two-tier testing interpreted using established criteria (CDC, 1995), or  
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Figure 1.3. Reported cases of Lyme disease by year, United States, 1994-2008. (CDC-
Division of Vector-borne Infectious Diseases-last reviewed August 2009). 
http://www.cdc.gov/ncidod/dvbid/lyme/ld_UpClimbLymeDis.htm. State health departments 
reported 28,921 confirmed cases and 6,277 probable cases of Lyme disease to CDC in 2008. 
This represents a 5% increase in confirmed cases compared to 2007. The definition and reporting 
of probable cases was initiated in 2008 based on revisions to the national surveillance case 
definition.  
 
 
(3) single-tier IgG immunoblot seropositivity interpreted using established criteria (CDC, 2005, 
CDC, 1995, Dressler et al., 1993, Engstrom et al., 1995). 
            Lyme disease is endemic in several regions of the United States, particularly areas of the 
Northeast, upper Midwest, and northern California (CDC, 2004, CDC, 2000) (Figure 1.4). The 
ten states of the United States with the highest incidence rates are Connecticut, Delaware, New 
Hampshire, Massachusetts, Maryland, Maine, New Jersey, Pennsylvania, Minnesota, and 
Wisconsin.  
            Lyme disease is considered a zoonosis because Borrelia burgdorferi, the causative agent 
is maintained in a natural infectious cycle that does not include humans, who only inadvertently 
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become infected. Transmission of B. burgdorferi to humans occurs by the bite of an infected tick 
vector of the genus Ixodes, which is a hard-tick (Steere et al., 1978, Wallis et al., 1978). The tick 
vectors vary depending on the region of the United States. The main species involved are I. 
scapularis in northeastern and upper midwestern United States, I. pacificus in the far-western 
 
 
 
Figure 1.4. Average rate* of Lyme disease by County of Residence† –United States,  
1992-2006. (CDC 2008). During the 15-year study period, the number of cases reported 
increased 101%. The highest incidence rates were found in Northeastern and North-Central 
States. 
            United States, I. ricinus and I. persulcatus in Eurasia (Lane et al., 1991). In the southeastern and 
western United States, immature stages of the vector ticks feed primarily on lizards (Apperson et 
al., 1993, Durden et al., 2002, Wright et al., 1998). Lizards, however, rarely serve as competent 
reservoir hosts for the pathogenic Lyme disease spirochetes in the USA, probably because  
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proteins comprising the alternative complement pathway are responsible for the borreliacidal 
activity observed in the blood of certain species of lizards (Kuo et al., 2000).  
             Ixodes scapularis, also known as the blacklegged tick, was first described by Spielman et 
al., (Spielman et al., 1979) as a vector of Babesia microti infecting man in New England.  This 
tick vector can also transmit Anaplasma the agent of human granulocytic anaplasmosis (HGA) 
(Dumler et al., 2001). Ixodes scapularis Say is the same species as I. dammini (Cooley and 
Kohls, 1945) and thus has retained the older name (Oliver et al., 1993). I. scapularis, particularly 
the immature stages, has a broad host range (mainly small mammals and birds) (Anderson, 
1989a, Anderson, 1989b, Anderson, 1988) and the adult ticks feed on large mammals. However, 
two hosts stand-out as central to the survival of the tick I. scapularis and of the spirochete B. 
burgdorferi: the white-footed mouse, P. leucopus (Anderson and Magnarelli, 1980), which 
serves as the host for larval and nymphal ticks, and the white-tailed deer, Odocoileus virginianus 
(Bosler et al., 1984, Carey et al., 1980, Piesman et al., 1979, Wilson et al., 1990), which serves 
as the host for adult ticks.  
            The tick has a 2-year life cycle and has four life stages: the egg, and 3 developmental 
stages: larva, nymph and adult stages (Figure 1.5). Ixodes ticks feed once at each of the three 
developmental stages. The cycle begins with eggs being laid during the spring. The larvae hatch 
in the summer and are usually uninfected with B. burgdorferi. The uninfected larval tick feeds on 
an infectious vertebrate (during August, September), primarily the white footed mouse, 
Peromyscus leucopus which is the natural reservoir for B. burgdorferi. After feeding slowly for 3 
to 5 days, engorged larvae drop from the host to the ground where they overwinter. The 
following spring, the larvae molt into nymphs. In a similar manner, nymphs also feed for 3-5 
days on mammals (during May, June), detach and drop to the forest floor, where they molt into  
the adult stage during the fall. After mating, the females lay eggs on the ground the following  
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spring before they die and the 2-year life cycle begins again. (Burgdorfer et al., 1988b, Lane and 
Loye, 1991, Magnarelli and Anderson, 1988).  
            Transovarial transmission of B. burgdorferi does occur in ticks (Burgdorfer et al., 1983, 
Magnarelli et al., 1986, Piesman et al., 1986). However, it is rare and inadequate to maintain 
infected populations of either the tick vector or vertebrate hosts (Schulze et al., 1985). Adult 
ticks are infected through transtadial transmission of the spirochetes from immature stage ticks 
which had fed earlier in their life history on infected animals (Bosler et al., 1984). It is critical 
that the tick feeds on the same host species (particularly rodents and chipmunks) in both of its 
immature stages (larval and nymphal), because the life cycle of the spirochete depends on 
horizontal transmission (Steere et al., 2004). Studies using animals have shown that the infected 
nymphal ticks must remain attached for 36 to 48 hours or longer and infected adult ticks must 
remain attached for 48 to 72 hours or longer before the risk of transmission of B. burgdorferi 
becomes substantial (Falco et al., 1996, Piesman, 1993, Piesman et al., 1987, Piesman et al., 
1991). 
                        Although all stages have been observed to feed on humans (Main et al., 1981), the 
nymphal stage tick is the most likely to transmit the infection to humans. Presumably, because 
(1) the nymphs are smaller than the adult ticks, and thus are difficult to be identified and 
removed soon; (2) they become engorged quicker than the adults and engorgement is necessary 
before the bacteria can be transmitted; and (3) they are prevalent during spring and summer, 
when humans enter the habitats where ticks thrive. Interestingly, the seasonal questing (host-  
seeking  pattern) of nymphal I. scapularis precedes the peak of human disease cases (Lane et al., 
1991).  
            Thus, uninfected larval ticks generally acquire B. burgdorferi by feeding on infectious 
mammals and uninfected mammals acquire B. burgdorferi by feeding on infected nymphal ticks. 
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Figure 1.5. The 2 year enzootic life cycle of the Lyme disease vector. (CDC-Division of 
Vector-borne Infectious Diseases-last modified November 2007). 
http://www.cdc.gov/ncidod/dvbid/lyme/ld_transmission.htm. Ixodes scapularis ticks feed once at 
each of the three stages of their usual life cycle. Eggs are laid on the ground during the spring, 
larvae hatch from the eggs in the summer and take one blood meal on a small mammal or bird, 
molt to nymphs the following spring and feed once during late spring or early summer when the 
risk of human infection is greatest, and molt into adult stage during fall. After mating, the adult 
females feed once, usually on large mammals, and lay their eggs the following spring before they 
die.  
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            Larval feeding follows nymphal feeding and thus it increases the efficiency of the enzootic cycle 
of B. burgdorferi because it ensures that juvenile rodents become infected with spirochetes 
(May, June) before serving as hosts to larvae (August, September), thus perpetuating the 
infection from year to year (Spielman et al., 1985, Wilson and Spielman, 1985).  
MOUSE MODEL OF LYME DISEASE 
            In 1988, Schaible, et al., found that experimental inoculation of several inbred mouse 
strains with high-passage isolate of B. burgdorferi led to pathomorphological changes in several 
organs, comparable with those found in patients with Lyme disease (Schaible et al., 1988). The 
following year, Schaible, et al. reported that severe combined immunodeficiency (SCID) mice 
with severely impaired T and B cell functions develop multisystemic disease with a 
preponderance for polyarthritis and carditis after inoculation with tick isolate of B. burgdorferi 
(Schaible et al., 1989). Although natural rodent hosts and most laboratory mice can have 
persistent B. burgdorferi infections without signs of disease, some inbred mice develop joint and 
heart pathologies that resemble human infection of Lyme disease (Barthold et al., 1990). Thus, 
the mouse serves as a useful model for Lyme disease.   
                        In a mouse model of infection, B. burgdorferi initially establishes a localized infection at 
the site of the tick bite, transiently disseminates via the bloodstream to various tissues, including 
skin, joints, heart and bladder (Barthold et al., 1991). In addition to mice, other experimentally 
infected animals include rats, hamsters, gerbils, rabbits, dogs, and monkeys (Kornblatt et al., 
1984, Kornblatt et al., 1985, Mursic et al., 1990, Piesman et al., 1987). Significantly, infected 
primates can develop infection of the central nervous system (CNS) and neurological 
manifestations that are not common in infected rodents (Philipp and Johnson, 1994). In 2000, a 
study showed for the first time, evidence of induced infection in ponies by exposure to adult 
ticks infected with B. burgdorferi (Chang et al., 2000).   
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BORRELIA BURGDORFERI 
                     Taxonomy. Spirochetes are a phylogenetically ancient group of eubacteria (Paster et al., 
1984). The phylum Spirochetes is composed of a single class (Spirochetes) and order 
(Spirochetales). The order is divided into three families:  Brachyspiraceae, Leptospiraceae, 
Spirochaetaceae (Paster and Dewhirst, 2000). Within the family Spirochaetaceae is the genus 
Borrelia.  Of the 37 known Borrelia species, 12 can cause Lyme disease (LD) transmitted by 
ticks (Hengge et al., 2003) (Figure 1.6).  
        
Figure 1.6. Phylogeny of Spirochetes. (Rosa et al., 2005). Members of the phylum Spirochaetes 
are easily identified by their unique spiral morphology and periplasmic flagella. The phylum is 
composed of a single class and order, divided into three families. Spirochetes include the genera 
Leptospira, Treponema and Borrelia, which all contain species pathogenic for the human host. 
Borrelia is the only known member of the phylum that contains linear DNA molecules. 
                        Since Borrelia burgdorferi was first isolated in 1982 and identified as a new species of 
the genus Borrelia in 1984, hundreds of B. burgdorferi isolates have been cultured worldwide. 
Molecular analysis has indicated that these isolates are genetically and phenotypically divergent. 
A closely related cluster containing at least 10 tick-borne Borrelia species associated with Lyme 
Borreliosis has been defined (Baranton et al., 1992, Canica et al., 1993, Fukunaga et al., 1996, 
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Kawabata et al., 1993, Marconi et al., 1995, Postic et al., 1998, Wang et al., 1997). The term 
“Borrelia burgdorferi sensu lato” is now collectively used for all Borrelia isolates within this 
cluster and to distinguish it from the species “Borrelia burgdorferi sensu strictu” (strict sense of 
Borrelia burgdorferi) (Baranton et al., 1992). Hence, the Borrelia burgdorferi sensu lato 
complex includes species such as B. burgdorferi sensu strictu, B. afzelii, B. garinii, and B. 
japonica. 
            Biology of B. burgdorferi. Borreliae belong to the spirochete Family and as such have in 
common with other spirochetes the following structural characteristics: 1) helical shape and 
motile; 2) a double-membrane: an outer membrane, which surrounds the protoplasmic cylinder 
complex, consisting of the cytoplasm, the peptidoglycan complex, and the inner membrane; 3) 
flagella, located in the periplasmic space between the outer membrane and the protoplasmic 
cylinder (Barbour and Hayes, 1986, Holt, 1978, Johnson, 1977) (Figure 1.7).              
                        In terms of size, borreliae are 10-30 μm long and 0.2-.3μm wide; the 7 to 11 periplasmic 
flagella give the bacteria its spiral shape (Burgdorfer et al., 1982, Hovind-Hougen et al., 1986). 
Borreliae are extracellular, fastidious bacteria requiring a rich growth medium. Dr. Alan Barbour 
first grew B. burgdorferi (strain B31) in BSK (Barbour-Stoenner-Kelly) medium (Burgdorfer et 
al., 1982).  The spirochete is grown at temperatures between 30 and 37 °C in the laboratory in 
microaerophilic conditions (Kelly, 1971), hence, it is usually grown in capped tubes with limited  
air space. The generation time for Borrelia is 8 to 24 h and culture adapted strains achieve cell 
densities of about 10
8 
/ml (Barbour, 1984).   
            Although B. burgdorferi contains a double-membrane similar to enteric Gram-negative 
bacteria, it has several distinct features (Figure 1.8).These features include: an extraordinary 
abundance of membrane proteins covalently linked with lipids also known as lipoproteins 
(Bergstrom et al., 1989, Brandt et al., 1990); the absence of lipopolysaccharide (LPS) 
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Figure 1.7. Schematic representation of a spirochete. (Canale-Parola, 1977). The broken line 
indicates the outer membrane. The area delimited by the thick solid line represents the 
protoplasmic cylinder. The circles near the ends of the protoplasmic cylinder indicate the 
insertion points of the periplasmic flagella. The thin solid lines denote periplasmic flagella.  
 
             (Takayama et al., 1987) and phosphatidylethanolamine (Belisle et al., 1994); the presence of 
glycolipids other than LPS (Belisle et al., 1994, Eiffert et al., 1991) and an outer membrane 
which contains a relatively low density of transmembrane proteins (Radolf et al., 1994).  
            Genome. The genome of B. burgdorferi sensu strictu strain B31 was completed in 1997 
(Fraser et al., 1997). The genome size is relatively small, about 1.5 MB. One of the most striking 
features of B. burgdorferi is its unusual genome, which includes a linear chromosome of 
approximately 910 kilobases (kb) (Baril et al., 1989, Davidson et al., 1992), and 12 linear and 9 
circular plasmids that total 610kb (Figure 1.9). The linear plasmids (lp) and circular plasmids 
(cp) are numbered according to their sizes in kilo base pairs. The isolate B31 contains the 
following linear plasmids: lp5, lp17, lp21, lp25, four different homologous plasmids of 28 kbp 
(lp28-1, lp28-2, lp28-3, and lp28-4), lp36, lp38, lp54, and lp56; and the following circular 
plasmids: cp9, cp26 and six or seven homologous plasmids of 32 kbp (cp32-1, cp32-3, cp32-4, 
cp32-6, cp32-7, cp32-8 and cp32-9) (Fraser et al., 1997). Comparisons with other B31 cultures 
suggest that this isolate may have lost one linear plasmid (lp21) and one or two 32 kbp circular 
plasmids during growth in culture since its original isolation (Barbour, 1988, Barbour and Garon, 
1987, Norris et al., 1995). Eight plasmids: lp5, lp21, lp28-1, lp28-2, lp28-4, lp56, cp9 and cp32-
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Figure 1.8. Membrane structure of spirochetes compared to that of Gram-negative and 
Gram-positive bacteria. (Courtesy of Dr. Fang-ting Liang). All three types of bacteria contain 
an inner membrane. Whereas Gram-positive bacteria do not contain an outer membrane and 
instead contain an abundance of peptidoglycans, both Gram-negative bacteria and spirochetes 
contain an inner and an outer membrane. The difference between the last two is the presence of 
lipopolysaccharides on the outer surface of Gram-negative bacteria and the absence thereof in 
spirochetes. Instead, spirochetes have an abundance of lipoproteins.  
            3, tend to be spontaneously lost during in vitro propagation (Purser and Norris, 2000).  The 
overall G+C contents of the B31 plasmids vary from 20.7% to 31.6% (Casjens, 2000).      
            Some of the most unusual aspects of the Borrelia genome are the presence of (1) linear 
replicons; (2) more than 20 replicons in a single bacterium; and (3) large tracts of directly 
repeated short DNA sequences. Approximately 5% of B. burgdorferi chromosomal genes and    
5% of plasmid genes are de voted to encoding more than 130 lipoproteins (Casjens, 2000). 
These percentages are larger than any for lipoproteins encoded in a sequenced bacterial genome 
(Templeton, 2004). 
            Lipoproteins. Most of the outer surface proteins (osps) that have been characterized in 
Borrelia are lipoproteins (Rosa, 1997). Orthologues of the genes encoding the essential 
components of the bacterial secretory machinery and homologues of the three enzymes required 
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            Figure 1.9. The segmented genome of B.burgdorferi. Borrelia is a unique bacterium that 
contains one linear chromosome and up to 21 extrachromosomal elements. (Stewart et al., 
2005). Linear plasmids are abbreviated lp and circular plasmids cp, the number represents the 
approximate size of the plasmid in kilobases. Evidence supports that plasmids shown in red are 
required for infectivity or persistence in the tick or vertebrate host.  
             
for biosynthesis of lipoproteins were found when sequencing the B. burgdorferi genome (Fraser 
et al., 1997, Haake, 2000). 
                        Lipoproteins are synthesized as precursors in the cytoplasm and then translocated across 
the inner membrane by a preprotein translocase complex, in an energy-dependent cycle. 
Subsequent modifications take place sequentially leading to the formation of mature lipoproteins 
having a lipid-modified cystein at the N-terminus (Hayashi and Wu, 1990, Pugsley, 1993). Thus, 
the characteristic feature of all lipoproteins is a signal sequence in the N-terminal end, followed 
by a cystein (Hayashi and Wu, 1990). Lipoprotein processing is similar to that in E.coli. The first 
of the three enzymes in the pathway is phosphadidyl-glycerol: prolipoprotein diacylglyceryl 
transferase (Lgt). This enzyme transfers a diacylglyceryl group (containing two fatty acids) from 
22 
 
phosphatidylglycerol to the sulfur atom of cystein. The second enzyme in the pathway is 
prolipoprotein signal peptidase (Lsp), which proteolytically removes the signal peptide, making 
cystein the new N-terminal amino acid. The third enzyme is phospholipid:apolipoprotein 
transacylase (Lnt) which transfers a third fatty acid from a membrane phospholipid to the 
nitrogen atom of cystein. After processing, lipoproteins will have three fatty acids attached to the 
cystein residue (Wu, 1996). Figure 1.10 summarizes the biosynthesis of lipoproteins.       
            Among the various lipoproteins of B. burgdorferi described are the outer surface proteins 
OspA, which was the first Osp identified in culture (Barbour et al., 1983, Bergstrom et al., 
1989), OspB (Bergstrom et al., 1989, Howe et al., 1985), OspC (Fuchs et al., 1992, Wilske et al., 
1993), OspD (Norris et al., 1992), OspE (Lam et al., 1994), and OspF (Lam et al., 1994).  
            Coordinated Expression of OspA and OspC. The spirochetes are transmitted to small 
mammals, mainly rodents, through the bite of Ixodes ticks (Burgdorfer et al., 1982). In unfed 
ticks, the spirochetes remain in the tick midgut. During tick feeding, which lasts several days, 
bacteria migrate from the tick midgut to the salivary glands, from which they are transmitted 
through the saliva to the dermis of the mammalian host (Ribeiro, 1987). Studies have shown that 
spirochetes in unfed ticks have OspA, but no OspC; yet, immediately after a blood meal, a 
significant number of spirochetes are stained positive for OspC and negative for OspA (Schwan 
et al., 1995). This switch from OspA to OspC accompanies a change in location of the 
spirochetes within the tick, from the tick midgut to the salivary glands (de Silva et al., 1997, 
Schwan et al., 1995). Figure 1.11 summarizes the changes in the expression of the surface 
lipoproteins, especially OspA and OspC as Borrelia transits between the tick vector and the 
mammalian host. Aspects of the midgut environment that change during tick feeding, such as 
temperature, pH, and nutrients, influence the expression of many genes, including ospA and 
ospC (Carroll et al., 1999, Ojaimi et al., 2003, Revel et al., 2002, Schwan et al., 1995). 
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Figure 1.10. Biosynthesis of lipoproteins. (Juncker et al., 2003). Shown here are the transfer of 
a diacylglyceride to the cystein sulphydryl group of the unmodified prolipoprotein; cleavage of 
the signal peptide by signal peptidase II, forming an apolipoprotein; and finally, acylation of the 
α-amino group of the N-terminal cystein of the apolipoprotein. Lipids are attached to cystein. 
Peptides are shown to the left and to the right of the cystein residue. Catalytic enzymes are 
written beside reaction arrows.  
 
            According to some findings, a tick midgut receptor for OspA which has been identified and has 
an acronym as TROSPA was shown to be required for spirochetal colonization of I. scapularis 
(Pal et al., 2004a). On the other hand, Salp 15 a tick salivary gland ligand was shown to be a  
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ligand for both OspC and the CD4 molecule of CD4+ T cells (Garg et al., 2006, Ramamoorthi et 
al., 2005).   
            OspC Groups and Invasiveness. The ospC gene has a high degree of sequence 
variability (Jauris-Heipke et al., 1995, Theisen et al., 1993, Wilske et al., 1995). On the basis of 
ospC sequence analysis of ospC alleles collected from a single site on Shelter Island, NY, Wang 
et al., (Wang et al., 1999) defined 19 major ospC groups or types (from A to S, with divergence 
of < 2% within a group and > 8% between groups) for B. burgdorferi sensu strictu strain. Two 
new groups (groups T and U) were described by Seinost, et al., 1999 (Seinost et al., 1999). Of 
the 21 major groups, only four (A, B, I and K) contain invasive clones and therefore cause 
infections of the skin (or primary site) and extra-cutaneous sites, also known as secondary sites 
(such as heart, joint, and nervous system), while the others are non-human pathogens, or infect 
the skin only (Seinost et al., 1999). The ospC gene could, therefore, be one of the determinants 
involved in the invasiveness of Borrelia strains leading to disseminated forms of the disease. The 
B. burgdorferi sensu strictu strain B31 belongs to the ospC invasive group A.       
            Regulation of ospC Gene Expression. Borrelia burgdorferi has an enzootic life cycle 
alternating between Ixodes ticks and mammalian hosts (mice or deer) (Lane et al., 1991). 
Therefore, the spirochete must transition between, adapt to and survive in the tick and 
mammalian host, which are two vastly different environments. Similar to many other pathogenic 
bacteria, B. burgdorferi senses and responds to environmental cues by regulating the synthesis of  
various proteins. These cues include changes in temperature, pH, cell density, oxygen and/or 
exposure to host factors (Carroll et al., 1999, Indest and Philipp, 2000, Indest et al., 1997, Ojaimi 
et al., 2002, Ramamoorthy and Philipp, 1998, Schwan and Piesman, 2000, Schwan et al., 1995, 
Seshu et al., 2004, Stevenson et al., 1995). 
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            Figure 1.11. Coordinated expression of OspA and OspC as Borrelia cycles between the tick 
vector and the mammalian host. (Mulay et al., 2007). In the flat tick, Borrelia expresses high 
levels of OspA and does not express OspC (shown in red). A fresh blood meal changes the 
microenvironment in the tick midgut inducing the downregulation of OspA and the upregulation 
of OspC, preparing the bacteria to infect a mammalian host. This switch of OspA to OspC 
coincides with the migration of the bacteria from the tick midgut to the salivary glands. Within 
the host, Borrelia abundantly produces OspC. However, in order to avoid clearance by specific 
antibody response, Borrelia downregulates OspC. Once Borrelia enters a naïve tick, it 
upregulates OspA which remains upregulated in the flat tick. Figure was modified from its 
original version. 
 
                        For example, B. burgdorferi alters its Osps with changes in temperature. During in vitro 
growth, a temperature shift from 24 °C to 37 °C stimulates the spirochetes to synthesize OspC, 
whereas decreasing the temperature back to 24 °C caused OspC to be decreased to below 
detectable levels (Schwan et al., 1995). Also, high spirochete density at least in vitro influences 
the upregulation of OspC (Indest et al., 1997, Ramamoorthy and Philipp, 1998). In vitro, the  
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expression of OspC is thus phase-dependent. Finally, although B. burgdorferi produces OspC at 
pH 6.0 and 7.0, it does not at pH 8.0 (Carroll et al., 1999). 
            Recent advances in genetic manipulation of B. burgdorferi have culminated in the 
discovery of the first genetic regulatory network, the RpoN-RpoS pathway (Caimano et al., 
2004, Yang et al., 2003b). In this pathway, the response regulator, Rrp2, functions as an 
enhancer binding protein (EBP), along with the alternative sigma factor RpoN (σN), to control 
the expression of another alternative sigma factor, RpoS (σS). RpoS, in turn regulates the 
expression of OspC, and other lipoproteins, such as DbpA and Mlp family of lipoproteins (Yang 
et al., 2000, Yang et al., 2003b). In B. burgdorferi, interestingly, the regulation of the ospC gene 
expression involves not only the RpoN-RpoS signaling pathway but also DNA supercoiling 
(Alverson et al., 2003). The discovery of the RpoN-RpoS regulatory network prompts an 
important question concerning how σS induces the expression of ospC.  
                        Mechanisms governing in vitro OspC regulation may be controlled solely by an RpoS-
dependent promoter (Eggers et al., 2004, Yang et al., 2005). In the mammalian host, it would be 
unfeasible for B. burgdorferi to turn off rpoS to achieve selective OspC downregulation. Two 
sets of conserved inverted repeats (IRs) of 20 bp have been proposed to be candidate binding 
sites for a potential transactivator (Fraser et al., 1997).  Xu et al., (Xu et al., 2007) have 
identified the operator region of OspC immediately upstream of the promoter region. To 
negatively regulate its controlled gene, the operator must interact with an as yet unidentified 
regulatory protein(s) called a repressor.  
            Characteristics of OspC. The ospC gene (named as BBB19 on the genome) is located 
on the circular plasmid cp26 which is ubiquitously present in B. burgdorferi isolates (Casjens et 
al., 2000, Tilly et al., 1997). B. burgdorferi exhibits tissue-specific ospC gene expression during 
mammalian infection (Narasimhan et al., 2003). The ospC gene is more abundantly expressed in 
27 
 
both heart and skin than in the joints in the absence of immune pressure (Liang et al., 2004b). 
The expression of ospC gene is also dependent on the present or absence of adaptive immune 
pressure. The spirochete persistently expresses OspC during infection of severe combined 
immunodeficient (SCID) mice (Liang et al., 2002a, Liang et al., 2002b). The development of 
OspC antibody, however, preferentially selects for spirochetes that do not abundantly express 
OspC in wild type mice. It is likely that antibodies against OspC antigens exert an immune 
pressure on spirochetes that express OspC (Liang et al., 2004a). 
            Of all the Outer surface proteins, OspC is one of the well-characterized lipoproteins in B. 
burgdorferi. OspC is a basic protein (with an isoelectric point of ~ 9.0) and has a subunit 
molecular weight of 22 kDa (Fuchs et al., 1992). The full length lipoprotein is 220 amino acids 
long. The signal peptide is 18-AA long, the N-terminal linker is 23-AA long, and the C terminal 
stretch (CTS) is 13-AA long. Compared to the N-terminal linker, the C-terminal stretch is 
conserved among borrelial isolates and highly immunogenic (Mathiesen et al., 1998). The lipid 
moiety of OspC is highly immunogenic; the lipoprotein is a strong innate agonist which interacts  
            with toll-like receptor TLR2 (Aliprantis et al., 1999, Brightbill et al., 1999, Hirschfeld et al., 
1999).            
                     Crystal Structure of OspC. The crystal structure of OspC was resolved in 2001 by two 
different scientific groups (Eicken et al., 2001, Kumaran et al., 2001) (Figure 1.12). Whereas 
Kumaran et al., used the B. burgdorferi strains HB19 (ospC group I) and B31 (ospC group A), 
Eicken et al., used strain N40 (ospC group E) to study OspC structure (Seinost et al., 1999). The 
OspC monomer is predominantly an up and down alpha helical bundle. It is composed of five 
parallel α-helices and two short β-strands. The α-helices consist of α1 (residues 43-74), α2 
(residues 94-112), α3 (residues 119-144), α4 (residues 151-154), and α5 (residues 169-196). The 
two β-strands, β1 (residues 78-82) and β2 (residues 85-89) connect helices α1 and α2. The long 
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helices α1 and α5 are closely packed together such that the N and C termini, which define the 
membrane proximal end of both subunits, are in close proximity to each other. It is suggested 
that the biologically functional OspC molecule may be a dimer with a characteristic central four-
helical bundle formed by the association of the two longest helices of each subunit, namely α 
helix 1 and α helix 5 (Eicken et al., 2001, Kumaran et al., 2001). Both the N- and the C-terminal 
regions of the protein are quite flexible and unable to produce crystals. Neither the N terminal 
linker nor the C terminal stretch contributes to the core structure of OspC. The N- and C-termini 
are on the same side of the molecule and are close to each other, suggesting that the C-terminus 
is also close to the membrane surface on which the lipidated N-terminus is anchored (Kumaran 
et al., 2001). The topology diagram of the OspC monomer is shown in Figure 1.13. 
                        All helices, except for α4 and α5, are anti-parallel. The dimeric interaction is mostly 
between helices α1 and α1' (of each monomer), which are parallel. The interaction in the dimeric 
interface is almost completely hydrophobic (Kumaran et al., 2001). The surface that projects 
away from the membrane has a strong negative electrostatic potential. It also has two 50 Å 
cavities ~8 Å below the exposed surface. Thus the pocket formed by these cavities may bind an 
as yet unknown ligand of OspC. A Dali server (network service for comparing protein structures 
in 3D) search (Holm and Sander, 1996) indicates that OspC has similarity to the periplasmic 
domain of the Salmonella aspartate receptor (AR), which is also a dimer (Yeh et al., 1996). 
            Functions of OspC. The structural similarity between the aspartate receptor (AR) of 
Salmonella and OspC HB19 suggests that OspC may possibly be a binding protein. If OspC is a 
binding-protein, the region that projects away from the membrane may be involved in the 
binding (Kumaran et al., 2001). As an extracellular bacterium, Borrelia has a predilection for 
extracellular matrix (ECM) and connective tissue. Although some lipoproteins are known to bind 
ECM components such as the Decorin binding protein (DbpA) which binds to the proteoglycan 
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decorin (Guo et al., 1995), no such role has been attributed to OspC yet. A better understanding 
of the function of OspC began with a better understanding of the requirements for OspC by 
Borrelia.  
                        In 2003, Schwan T.G., stated that B. burgdorferi probably requires OspC for initial 
infection of mammals but that no definitive proof of this hypothesis existed (Schwan, 2003).  
The analysis of OspC knock-out mutants has demonstrated that the OspC protein is required for 
the spirochete to establish infection in a mammal, following either a tick bite or needle 
inoculation (Grimm et al., 2004, Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006).  
            Concerning the role of OspC in tick colonization, while Grimm et al., March 2004 
(PNAS) of Patricia Rosa group, concluded that OspC is not required for migration in the tick 
(from the I. scapularis tick midgut to the salivary glands), Utpal Pal et al., January 2004 (JCI) of 
Erol Fikrig group, concluded that OspC is required for migration of B. burgdorferi in the tick 
(Pal et al., 2004b). The discrepancy between the two studies may be due to the fact that the two 
groups used different types of OspC knock-out mutants. As proof of principle, the Patricia Rosa 
group (Tilly et al., 2006) constructed a complete deletion of OspC, and was able to confirm that 
OspC is not required for migration of spirochetes from tick midguts to salivary glands. It was 
however, shown to be required for mammalian infection. Furthermore, the study concluded that 
OspC is required only during an early period (first 28 days post-inoculation) in mammalian 
infection.   
            OspC is the only surface lipoprotein to be essential for mammalian infection (Grimm et 
al., 2004, Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006). Rosa and colleagues had 
hypothesized that OspC is required for evasion of innate immunity during initial mammalian 
infection. One pertinent study by Tilly, et al., showed that OspC-knockout mutants were cleared 
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Figure 1.12. Crystal Structure of OspC. (Kumaran et al., 2001). A ribbon representation of the 
OspC dimer is shown. The core structure of OspC is predominantly α-helical. It contains five 
parallel α helices and two short β sheets. The α helices pack closely together such that the N and 
C termini are in close proximity to each other.  These termini are quite flexible and unable to 
produce crystals. The membrane distal end is towards the β sheets whereas the membrane 
proximal end is defined by the N and C termini. The lipoprotein is anchored to the outer surface 
of the outer membrane of B. burgdorferi by the N-terminus. 
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             Figure 1.13. Topology diagram of OspC-HB19 monomer. (Kumaran et al., 2001). Red  
 cylinders represent α-helices and green arrows β-sheets. The N terminus amino acids were  
 added to represent the peptide sequence from the lipidated cystein. The C-terminus aminoacids  
 were added to represent the complete peptide sequence (Figure was modified from its original  
 version).  
             
within 48h from C3H wild type mice (Tilly et al., 2007). However, Xu., et al, 2008 (Xu et al., 
2008) using OspC-deficient B. burgdorferi, which were modified to increase expression of other 
well-defined surface lipoproteins (such as OspA, OspE, VlsE and DbpA), were able to show that 
the essential protective role of OspC against early elimination can be overridden by increasing 
the expression of any of the four lipoproteins. Thus, although during natural infection OspC is 
exclusively required for initial infection of a mammalian host, on a laboratory experimental 
basis, it is not so. Heterologous lipoproteins can substitute for the function of OspC when 
overexpressed, suggesting that an abundance of lipoprotein(s) is needed to stabilize the borrelial 
outer membrane against innate defences. Furthermore, the study showed that OspC is required 
for efficient dissemination and this function can be substituted to varying extents by other outer 
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surface lipoproteins; OspC was also shown not to be required for the efficient colonization of the 
joint or skin, but for the heart tissues of SCID mice. Hence, the following functions for OspC 
have been identified so far: evasion of innate immunity and facilitating dissemination in the 
vertebrate host. 
            Recently, a study by the P. Rosa group (Tilly et al., 2009), has shown that mammalian 
host-adapted spirochetes can infect and disseminate in mice in the absence of OspC. They 
proposed a model in which OspC is one of a succession of functionally equivalent, essential 
proteins that are synthesized at different stages of mammalian infection. 
STATEMENT OF THE PROBLEM 
                        More than three decades have elapsed since the discovery of the tick-borne illness named 
Lyme disease in 1975. Since then, much has been learnt about the life cycle of the tick vector, I. 
scapularis, and the molecular changes that Borrelia, the agent of Lyme disease, undergoes in 
order to survive in two very disparate environments, the tick vector and the mammalian host 
(Burgdorfer et al., 1988a, de Silva and Fikrig, 1997, Lane and Loye, 1991, Schwan et al., 1995). 
Of the molecular changes that Borrelia undergoes, the up- and down-regulation of its many 
lipoproteins, both during its transmission between the tick vector and the mammalian host and 
within the mammalian host itself, are obviously crucial for its survival and maximal virulence 
(de Silva et al., 1997, Schwan et al., 1995).  OspC is a known virulence factor of B. burgdorferi. 
Since the upregulation of OspC within the tick vector is required for initial mammalian infection 
(Schwan et al., 1995, Tilly et al., 2006, Yang et al., 2000) whereas its downregulation is required 
for avoidance of spirochetal clearance (Liang et al., 2002a, Xu et al., 2007, Xu et al., 2006), 
many researchers are focused on the function and regulation of OspC in order to better 
understand the role of OspC in the pathogenesis of B. burgdorferi.    
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            Recent studies have shown that a common role of all surface lipoproteins, including 
OspC, is that of evasion from host innate immune defences (Tilly et al., 2007, Xu et al., 2008) 
and that the unique role of OspC is that of a dissemination-facilitating factor of B. burgdorferi 
(Xu et al., 2008). Since the solution of the three-dimensional structure of OspC (Eicken et al., 
2001, Kumaran et al., 2001), not much is known as to how the various secondary structures that 
make up OspC as a whole lipoprotein relate to its function(s) and/or possible ospC mRNA 
regulation.  
                                   GOAL, SPECIFIC OBJECTIVES AND HYPOTHESES 
            The overall goal of this dissertation research was to make strategic structural deletions of 
OspC and study their phenotypic effects on infectivity, dissemination, pathogenicity and 
colonization of B. burgdorferi and on the regulation of ospC mRNA expression in the murine 
model. The specific objectives were: 
            1. To create beta sheets 1 and 2 (βs1 and βs2) and alpha helix 4 (αH4) deletions of OspC and 
study the effects of such deletions on the infectivity of B. burgdorferi.  
2. To create an N-terminus 5-AA and 10-AA deletion of OspC in order to dissect the role of 
OspC in evasion from innate immunity and in dissemination of B. burgdorferi to distal tissues 
during mammalian infection. 
3. To study the role of the N-terminus 5-AA sequence in regulation of ospC mRNA expression. 
4. To create C-terminus 6-,9-, and 13-AA deletions of OspC and study their contributions to the 
overall function(s) of OspC and to the regulation of ospC mRNA expression. 
                        The hypotheses of the proposed work for the above objectives were the following: 1) that 
there is a correlation between the OspC secondary structure and function of the lipoprotein that 
can be well delineated; and 2) that OspC is involved in self-regulation.  
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            Chapter 2 describes the selective, relatively small, deletions that were made within the 
core of OspC structure of beta sheets 1and 2 and alpha helix 4 (βs1 and βs2 and αH4). Included in 
this work were longer deletions of the N- and C-terminus of OspC (Nt10 and Ct13). All these 
deletions resulted in complete abolishment of the immune evasion role of OspC, indicating that 
these regions of OspC are critical for the survival of the spirochetes during the initial infection of 
the mammalian host.   
            Chapter 3 describes a deletion of 5-AA of the N-terminus of OspC. This deletion did not 
affect the innate immune evasive role of OspC as measured by a 50% infectious dose (ID50) 
study. The tissue spirochetal load measured by qPCR was used as another criterion of the 
evasion of the spirochete from elimination. There was no significant difference in the tissue 
spirochetal burden in the joint and skin; however, there was a significant decrease in the heart 
tissues as compared to controls. Deletion of N-terminus 5-AA of OspC resulted in inefficient 
dissemination of B. burgdorferi to remote tissues in the SCID mice. This dissemination defect 
was even more pronounced in wild type mice. This particular deletion, therefore, led to a 
dissection of the role of OspC in evasion from that of facilitating dissemination of B. 
burgdorferi.  
            Chapter 4 describes the influence of the 5-AA N-terminus deletion of OspC on ospC 
mRNA levels as measured by RT-qPCR in the heart, joints and skin tissues of SCID mice. The 
results show an upregulation in ospC expression in the joint of mutant spirochetes as compared 
to control spirochetes containing a full length OspC copy, indicating that OspC is involved in 
self-regulation. There was no significant difference in ospC mRNA levels the heart and skin 
tissues between the mutant and control spirochetes. The role of OspC in self-regulation was 
further confirmed by OspC monoclonal antibody treatment of SCID mice inoculated with 
Borrelia expressing the truncated OspC. The treatment resulted in clearance of spirochetes from 
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all sites tested, except the joints, indicating that the joint tissue may serve as an immune 
privileged site. 
            Chapter 5 describes the phenotypic effects of sequential deletion of 6-, 9-, and 13-AA of 
the C-terminus of OspC on infectivity and pathogenicity of B. burgdorferi and on ospC 
expression. While spirochetes containing a deletion of 13-AA resulted in a non-infectious 
phenotype, as described earlier, spirochetes containing deletions of 6- and 9-AA retained their 
innate immune evasive roles as measured by ID50 values in both SCID and wild type mice, 
which were similar to those of control spirochetes. However, interestingly, whereas spirochetes 
with 6-AA deletion had lost their arthritis virulence, spirochetes with 9-AA C-terminus deletion 
retained their arthritis virulence. In terms of tissue spirochete burden, the study highlighted the 
tissue-dependent effects of the C-terminus deletion.  Finally, deletion of C-terminus 9-AA 
sequence of OspC led to significant changes in ospC mRNA accumulation in all tissues, whereas 
deletion of C-terminus 6-AA sequence of OspC led to significant changes in ospC expression in 
the joint tissue only. Interestingly, in the joints, the deletion of 6-AA and 9-AA sequence of the 
C-terminus of OspC resulted in a down-regulation of ospC transcripts, indicating that OspC is 
involved in self-regulation.    
            Chapter 6, the last chapter, describes the general conclusions of this study. It summarizes 
the major findings of this dissertation research in a table format. It also provides an overview of 
our current accumulated knowledge in regards to the function(s) of OspC and how this 
dissertation research has contributed to a better understanding of those functions and of the  
regulation of OspC. Ultimately, this work contributes to an appreciation of the role that OspC 
plays in the pathogenesis of B. burgdorferi. 
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CHAPTER 2 
SELECTIVE STRUCTURAL DELETIONS OF OSPC ABOLISH THE 
ROLE OF OSPC IN EVASION OF BORRELIA BURGDORFERI FROM 
HOST INNATE DEFENCES  
 
INTRODUCTION 
            Borrelia burgdorferi, the agent of Lyme disease, requires OspC upon initial infection of a 
mammalian host. OspC-knock out mutants were shown to be cleared from skin after 
intradermal/subcutaneous inoculation of Borrelia burgdorferi (Tilly et al., 2007). The 
requirement for OspC may be exclusive in nature; however, under laboratory setting, this role of 
OspC in evasion from host innate defences can be overridden by other heterologous lipoproteins 
(Xu et al., 2008). OspC has been shown to have dual roles: in protection against (or evasion 
from) host innate immune response and in dissemination during infection of murine hosts (Xu et 
al., 2008). To understand the function of a lipoprotein at a molecular level, it is often necessary 
to determine the three-dimensional structure of that lipoprotein. Based on this premise, the 
crystal structure of OspC was explored for its possible role in infectivity of B. burgdorferi. OspC 
is a predominantly α-helical in structure. A single unit of OspC is composed of five parallel α-
helices and two short β-strands inter-connected by six loops, apart from an amino (N) - and 
carboxy (C)-terminus. The N-terminus linker is 23 AA long, whereas the C-terminal stretch is 
13-AA long (Eicken et al., 2001, Kumaran et al., 2001). Of these, the nucleotides encoding for 
the two β strands (βs1 and βs2), alpha helix 4 (αH4), C-terminus 13-AA (Ct13) and N-terminus 
10-AA (Nt10) sequence of OspC were deleted, and the resulting truncated OspC for each clone 
was tested for infectivity potential in the SCID mouse. All five (βs1, βs2, αH4, Ct13 and Nt10) 
OspC mutations produced non-infectious phenotypes. There was, however, recovery of OspC-
deficient spirochetes containing a mutation in DbpA lipoprotein. The truncated OspC mutants  
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revealed that these corresponding regions of the ospC gene are required for the function of the 
lipoprotein in protection against host innate defences. 
MATERIALS AND METHODS 
             Strains Generated Previously and Used in This Study. The B. burgdorferi strain B31 
clone 13A was generated previously (Xu et al., 2007). Serially diluting the B. burgdorferi B31 
5A13 culture led to the identification of a single clone designated 13A, which lost lp25 and lp56 
but contained the remaining 19 plasmids. This clone is highly transformable because lp25 and 
lp56 may carry restriction enzymes to negatively affect transformation efficiency of B. 
burgdorferi (Kawabata et al., 2004, Lawrenz et al., 2002).  The ospC mutant clone was also 
generated previously by insertion of the aacC1 cassette within the ospC locus and was confirmed 
by PCR (Xu et al., 2007). This clone contained lp28-1 but lost cp9, lp5 and lp21, in addition to 
lp25 and lp56. 
            Construction of Plasmids pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4 and 
pBBE22-ospCNt10. As illustrated in Fig. 2.1 through Fig. 2.4, to efficiently generate constructs 
encoding the two beta strands, alpha helix 4 and N-terminus 10 amino acid deletions, a 1057-bp 
fragment covering the ospC-coding region and up- and down-stream sequences was amplified by 
PCR using primers P1F and P1R (Table 2.1) and cloned into TA cloning vector pNCO1T 
(Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. Four large 
amplicons, βs1, βs2, αH4 and Nt10 were generated by PCR using pNCO1T-ospC as a template 
and each of four forward primers P2F, P3F, P4F, P5F and each of four reverse primers, P2R, 
P3R, P4R and P5R, respectively (Table 2.1).  
            Primers P4F and P4R for αH4 were designed for blunt end ligation; these primers were 
phosphorylated using T4 polynucleotide kinase, ATP and appropriate buffer (New England  
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Figure 2.1. Generation of B. burgdorferi producing OspC with βs1 deletion. A. Construction 
of pBBE22-ospCβs1 coding for OspC with beta sheet 1 deletion. The five codons coding for 
the five amino acid residues (residues 78—82) and their adjacent codons are presented.  The 
amplification starting sites and directions of four primers, P1F, P1R, P2F and P2R, used for 
plasmid construction are also marked.  The long bar represents the 1057-bp fragment, covering 
the entire ospC-coding region and down- (extending to +801 from the transcriptional start site) 
and up-stream sequences (extending to -256).  The detailed construction of the vector was 
described in Materials and Methods section. B. Restoration of OspC production. The parental 
clone 13A and the clones ΔospC/βs1/1 through ΔospC/βs1/3 (of the total of 7 transformants) were 
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC anti-sera. 
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Figure 2.2. Generation of B. burgdorferi producing OspC with βs2 deletion. A. Construction 
of pBBE22-ospCβs2 coding for OspC with beta sheet 2 deletion. The five codons coding for 
the five amino acid residues (residues 85—89) and their adjacent codons are presented.  The 
amplification starting sites and directions of four primers, P1F, P1R, P3F and P3R, used for 
plasmid construction are also marked.  The long bar represents the 1057-bp fragment, covering 
the entire ospC-coding region and down- (extending to +801 from the transcriptional start site) 
and up-stream sequences (extending to -256).  The detailed construction of the vector was 
described in Materials and Methods section. B. Restoration of OspC production. The parental 
clone 13A and the clones ΔospC/βs2/1 through ΔospC/βs2/7 were verified for OspC expression by 
immunoblot probed with a mixture of FlaB and OspC anti-sera. 
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Figure 2.3 Generation of B. burgdorferi producing OspC with αH4 deletion. A. 
Construction of pBBE22-ospCαH4 coding for OspC with alpha helix 4 deletion. The eight 
codons coding for the eight amino acid residues (residues 152—159) and their adjacent codons 
are presented.  The amplification starting sites and directions of four primers, P1F, P1R, P4F and 
P4R, used for plasmid construction are also marked.  The long bar represents the 1057-bp 
fragment, covering the entire ospC-coding region and down- (extending to +801 from the 
transcriptional start site) and up-stream sequences (extending to -256).  The detailed construction 
of the vector was described in Materials and Methods section. B. Restoration of OspC 
production. The parental clone 13A and the clones ΔospC/αH4/1 through ΔospC/αH4/4 were 
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC anti-sera. 
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Figure 2.4. Generation of B. burgdorferi producing OspC with Nt10 deletion. A. 
Construction of pBBE22-ospCNt10 coding for OspC with N-terminus 10 amino acid 
deletion. The ten codons coding for the ten amino acid residues (residues 26—35) and their 
adjacent codons are presented.  The amplification starting sites and directions of four primers, 
P1F, P1R, P5F and P5R, used for plasmid construction are also marked.  Downstream of the 
deletion, the S was changed to a D as marked by an asterisk. The long bar represents the 1057-bp 
fragment, covering the entire ospC-coding region and down- (extending to +801 from the 
transcriptional start site) and up-stream sequences (extending to -256).  The detailed construction 
of the vector was described in Materials and Methods section. B. Restoration of OspC 
production. The parental clone 13A and the clones ΔospC/Nt10/1 through ΔospC/Nt10/6 were 
verified for OspC expression by immunoblot probed with a mixture of FlaB and OspC MAbs. 
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Table 2.1. Primers used to make the pBBE22-ospCβs1, pBBE22-ospCβs2, pBBE22-ospCαH4 
and pBBE22-ospCNt10. 
 
Construct             Primer name             Primer sequence (5’-3’)a 
 
FL         P1F        5’-TAGTTGGCTATATTGGGATCCAA-3’   
              P1R        5’-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3’ 
 
βs1                            P2F        5’-ACGCTCTTCTTCAAAATAATGGTTTGGATACC-3’  
                                 P2R        5’-ATGCTCTTCTTGAATAGCTTTAGCAGCAATTTC-3’ 
βs2                            P3F        5’-ACGCTCTTCTTGAAAATAATCACAATGGATCATTG-3’ 
                                 P3R        5’-ACGCTCTTCTTCATTTTGGTGTATTTTTTTACC-3’ 
 
αH4          P4F        5’-AGTAACACCTTCTTTACCAAG-3’    
                                 P4R        5’-TTAAAAACAAATGGTACTAAAAC-3’ 
Nt10                         P5F         5'-ATGACGTCAAAGGGCCTA-3' 
                                 P5R        5'-CTGACGTCTTCCCCTGAATT-3'   
a
 The underlined sequences are restriction enzyme sites. P1F contains a BamHI site; P1R has an XbaI site; 
P2F, P2R, P3F and P3R have SapI sites; P4F and P4R are blunt end primers, with no restriction sites; P5F 
and P5R contain AatII sites.  
 
Biolabs, Ipswich, MA). After PCR, the termini of the PCR product was polished using T4 DNA 
polymerase (New England Biolabs, Ipswich, MA); digested with DpnI (to cut methylated 
Adenine), purified, and underwent T4 DNA ligation with the vector pNCO1T. 
            To construct the N terminus 10-AA deletion, an AatII restriction enzyme site was chosen 
as the appropriate site to be added to primers P5F and P5R.  In order to introduce the site, the S 
(serine) residue was changed to a D (aspartic acid) residue at position 36 from start codon. 
            After digestion with SapI for βs1 and βs2 and digestion with AatII for Nt10 and 
subsequent purification, the four amplicons were circularized via ligation (blunt-end ligation in 
the case of αH4) and then digested with BamHI and XbaI to release, βs1, βs2, αH4 and Nt10. 
These four fragments, encoding an OspC variant with βs1, βs2 αH4, and Nt10 deletions, were 
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cloned into the recombinant plasmid pBBE22 (a gift from S. Norris) after the vector was 
digested with BamH1 and XbaI. Resulting constructs were designated, pBBE22-ospCβs1, 
pBBE22-ospCβs2, pBBE22-ospCαH4 and pBBE22-ospCNt10 respectively. The inserts and their 
flanking regions within pBBE22 were sequenced to ensure the constructs were as designed. 
            Additional Plasmids Generated Previously and Used in This Study. Construct 
pBBE22-ospCct13 was generated and described further in Chapter 5. OspCct13 is a truncated 
ospC in which the nucleotides corresponding to 13-AA of the carboxy-terminus of OspC were 
deleted. Mouse infectivity studies (included in Chapter 5) had shown that clone ∆ospC/ospCct13 
was non-infectious at one month post-inoculation in SCID mice. Therefore, to test if infectivity 
was lost at an earlier time point, clone ∆ospC/ospCct13 now named as ∆ospC/∆ct13 was 
included in this study. Construct pBBE22-dbpAmt82 was also generated in a previous study 
(unpublished data). The dbpAmt82 has a point mutation at the nucleotide coding for one of the 
three critical lysine residues for the binding of decorin-binding protein A (DbpA) to decorin. 
This was the lysine at amino acid position 82 from the methionine start codon (Brown et al., 
1999, Pikas et al., 2003).  The construct pBBE22-ospC’ which has a flaB-promoter to 
constitutively express a full length copy of OspC was used as a positive control (Xu et al., 2006). 
All three plasmids were electroporated into an OspC mutant. The resulting clones were 
designated ∆ospC/ospCct13, ∆ospC/dbpAmt82 and ∆ospC/ospC’ and were used in the SCID mice 
infection study.  
            Generation of ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4, ∆ospC/∆Nt10 and ∆ospC/∆ct13 
Transformants. Complementation plasmids were electroporated into an ospC mutant, namely, 
∆ospC, which was generated in our previous study (Xu et al., 2007). Briefly, ∆ospC spirochetes 
were grown in 10 ml of BSK-H medium at densities of 5x10
7
 to 1x10
8
 cells/ml (mid to late  
exponential phase), harvested, washed, and transformed with 1.5 µg of plasmid pBBE22-
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ospCαH4, pBBE22-ospCβs , pBBE22-ospCβs2, and pBBE22-ospCNt10 under standard 
electroporation conditions (Lawrenz et al., 2002, Stewart et al., 2001). The plasmid pBBE22 was  
derived from shuttle vector pBSV2 by inserting the gene BBE22 (Purser et al., 2003, Stewart et 
al., 2001). The cells were allowed to recover in 20 ml of BSK-H medium at 33 °C for 18h. After 
adding kanamycin at a concentration of 200 µg/ml and gentamycin at 50 µg/ml, the suspension 
was transferred into 96 PCR tubes (200 µl/tube). The limited dilution assay has been widely used 
in the screening of transformants (Blevins et al., 2004, Caimano et al., 2004, Revel et al., 2005, 
Yang et al., 2004). Aliquots were incubated at 33 °C for 10 days and live spirochetes were 
examined under a dark-field microscope. Viable spirochetes were found in 7, 7, 4, 6 and 5 of the 
96 tubes for ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4, ∆ospC/∆Nt10 and ∆ospC/∆ct13 clones, 
respectively. Approximately 30 µl of the kanamycin/gentamycin resistant culture was transferred 
to 1.3 ml of BSK-H medium in a 1.5 ml microcentrifuge tube and grown to stationary phase at 
33 °C. Spirochetes were harvested from 200 µl of culture by centrifugation at 11,000xg for 5 min 
at room temperature and washed twice with excess volumes of phosphate-buffered saline (pH 
7.3) to remove residual plasmid DNA and resuspended in 200 µl and resuspended in 200 µl of 
deionized H20. One microliter of suspension was used as a DNA template source for 
examination of recombinant plasmid pBBE22 by examining the kanamycin-resistant cassette by 
PCR. The specific kanamycin primers (forward: 5’-ATGAGCCATATTCAACGGGAAACGT-
3’; reverse: 5’-TCAGCGTAATGCTCTGCCAGTGT-3’) were used. The PCR conditions 
included: 94 °C for 1 min; 94 °C for 30 seconds, 54 °C for 30 seconds, 72 °C for 1 min, 35 
cycles; 72 °C for 10 min. PCR products were separated on an ethidium bromide-agarose gel.  
            Immunoblot Analysis. Transformants were grown in BSK-H complete medium to late 
log phase at 33 °C and harvested by centrifugation. Spirochetes were dissolved in sodium 
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dodecyl sulfate-polyacrylamide gel electrophoresis sample buffer, separated by electrophoresis 
(Biorad, Hercules, CA), and electrotransferred onto nitrocellulose membranes (Thermo 
Scientific, Rockford, IL). Restoration of OspC expression was verified using immunoblots 
probed with a mixture of FlaB and OspC monoclonal antibodies (MAbs) for clone ∆ospC/∆Nt10, 
or with the FlaB MAb and mouse anti-OspC sera raised against a recombinant OspC antigen for 
clones ∆ospC/∆βs1, ∆ospC/∆βs2, ∆ospC/∆αH4 and ∆ospC/∆ct13. The flaB and OspC MAbs were 
developed by Barbour et al., (Barbour et al., 1986) and Mbow et al., (Mbow et al., 1999) and 
used at 1:100 and 1:10,000 final dilutions, respectively. The secondary antibody used was goat 
anti-mouse IgG conjugated with horseradish peroxidase (hrp) at a 1:5,000 final dilution (Thermo 
Scientific, Waltham, MA). To develop the nitrocellulose membrane, a colorimetric blotting 
substrate solution (4CN) was used (Kirkegaard and Perry Laboratories, Gaithesburg, MD). The 
clone ∆ospC/FL/1, which was generated in our previous study (Xu et al., 2007) and expressed 
wild-type OspC, was included as a control.  
            SCID Mice Infection Study. BALB/c SCID mice (ages 4-8 weeks, provided by the 
Division of LSU Laboratory Animal Medicine) were given two intradermal/subcutaneous 
injections of 10
5
 spirochetes. The two inoculation sites were at least 2 cm apart. Animals were  
sacrificed at 24 and 48h later; inoculation skin site tissues were harvested for spirochete isolation 
as previously described (Xu et al., 2005). 
            Examination of Plasmid Content by PCR. The presence of lp28-1, lp28-2, lp28-4 and 
cp32-3, that tend to be spontaneously lost, was surveyed by PCR with primer pairs specific for 
each of the four plasmids (Table 2.2). Approximately 1 µl of spirochete culture was used as a 
DNA template source in a PCR volume of 25 µl. Taq polymerase was purchased from Takara 
Mirus Bio Inc (Madison, WI). The PCR conditions included: 94 °C for 1 min; 94 °C for 30  
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seconds, 54 °C for 30 seconds, 72 °C for 1 min, 35 cycles; 72 °C for 10 min. PCR products were 
separated on an ethidium bromide-agarose gel.   
Table 2.2. PCR primers for examination of plasmid content in B. burgdorferi 
                                                                                  Sequence 
 Plasmid 
                                         Forward                                                              Reverse 
 
 lp28-1     5’-TTTCATTATAAGGAGACGATGA-3’   5’-CGTCGTACTACTTATATCGC-3’ 
 
lp28-2      5’-TTCTAGTATCTACTAGACCG-3’         5’-AGCCAAGTATTTCTTCTGCA-3’ 
lp28-4      5’-GTGTCGCTTAATTTTAGAGTTA-3’    5’-ATAGAGATCCTCTATTAGAGA-3’ 
 
cp32-3     5’-CTGTTTAATCCACCACCAGTA-3’      5’-ACTTTCTCAGTACTTTCTCC-3’ 
 
                                                                           RESULTS 
            The Plasmid Contents of The Various Transformants Generated. All of the identified 
transformants had the kanamycin-resistant cassette as tested by PCR, indicating the presence of 
pBBE22. Then, the transformants were surveyed for the presence of lp28-1, a plasmid essential 
for infection of immunocompetent hosts (Labandeira-Rey et al., 2003, Purser and Norris, 2000), 
but not required for infectivity in SCID mice (Labandeira-Rey et al., 2003).  Only clones 
containing lp28-1 were further analyzed for the content of those plasmids that tend to be 
spontaneously lost during in vitro propagation, described in the Materials and Methods section, 
with the exception of αH4 construct for which only one of the four transformants contained lp28-
1. For the majority of clones, two transformants from each clone that had identical plasmid 
contents were chosen for inoculation into SCID mice, except for ∆ospC/∆Nt10 and ∆ospC/∆αH4.  
For ∆ospC/∆Nt10, the plasmid content was identical for lp28-2 but not lp28-4. For ∆ospC/∆αH4,  
the two transformants had lp28-2 and lp28-4, although one clone had lp28-1 and the other did 
not.  
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            Various Truncated OspC Mutants Are Unable to Aid Borrelia Evade Quick 
Clearance.  Groups of four SCID mice each received two intradermal/subcutaneous inoculations 
of the clones ∆ospC/ospC’/1, ∆ospC/ospC’/2, ∆ospC/∆βs1/1, ∆ospC/∆βs1/2, ∆ospC/∆βs2/1, 
∆ospC/∆βs2/2, ∆ospC/∆αH4/1, ∆ospC/∆αH4/2, ∆ospC/∆Nt10/1, ∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1, 
∆ospC/∆Ct13/2, ∆ospC/dbpAmt82/1, or ∆ospC/dbpAmt82/2. The control spirochetes 
∆ospC/ospC’/1 and ∆ospC/ospC’/2 were consistently grown from each of the 16 inoculation 
sites from all the eight inoculated mice (Table 2.3). In contrast, none of the ∆ospC/∆βs1/1, 
∆ospC/∆βs1/2, ∆ospC/∆βs2/1, ∆ospC/∆βs2/2, ∆ospC/∆αH4/1, ∆ospC/∆αH4/2,  ∆ospC/∆Nt10/1, 
∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1, or ∆ospC/∆Ct13/2 were grown from either the 8 inoculation 
sites at 24h time point or the 48h time point.  Like the positive control, the clone 
∆ospC/dbpAmt82/1 and ∆ospC/dbpAmt82/2 were also recovered from all inoculation sites at both 
time points.  These results indicate that strategic deletions of OspC of small number of amino 
acids within the core region or of large number of amino acids in the termini of OspC abolish the 
ability of the lipoprotein to aid B. burgdorferi evade from quick clearance. In contrast, the DbpA 
mutant is able to compensate for the role of OspC in evasion of host innate defenses, although 
one of its decorin binding sites was mutated.  
DISCUSSION 
             B. burgdorferi depends on the expression of OspC for its survival during early 
mammalian infection. The essential role of OspC was demonstrated when OspC knock-out 
spirochetes were cleared from skin inoculation site by 48h (Tilly et al., 2007). In spite of a 
myriad of host innate immune responses devised by neutrophils, macrophages, or by toll-like 
receptors (TLRs), particularly TLR-2 against borrelial lipoproteins (Hartiala et al., 2008, 
Hirschfeld et al., 1999, Linder et al., 2001, Peterson et al., 1984), one of the mechanisms by 
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which Borrelia are able to evade these responses is through the abundance of expression of 
OspC and other lipoproteins on the outer surface of the outer membrane of the spirochete.  
Table 2.3. Various types of truncated OspC mutants are unable to aid Borrelia evade quick  
clearance from murine skin 
a
 
 
Clone                  No. of sites positive/total                                  Clone                 No. of sites positive/total                                                                       
                              no. of sites examined  at                                                              no. of sites examined at 
                               post-inoculation hours                                                                   post-inoculation hours  
                                       24                    48                                                                       24                       48  
 ∆ospC/ospC’/1             4/4                  4/4                             ∆ospC/∆βs1/1                   0/4                      0/4 
 ∆ospC/ospC’/2             4/4                  4/4                             ∆ospC/∆βs1/2                   0/4                      0/4                                                                                                  
 
∆ospC/∆βs2/1                0/4                   0/4                            ∆ospC/∆αH4/1                  0/4                      0/4 
 ∆ospC/∆βs2/2               0/4                   0/4                            ∆ospC/∆αH4/2                  0/4                      0/4 
∆ospC/∆Nt10/1             0/4                   0/4                             ∆ospC/∆Ct13/1       0/4                      0/4 
 ∆ospC/∆Nt10/2            0/4                   0/4                             ∆ospC/∆Ct13/2       0/4                      0/4   
 
 ∆ospC/dbpAmt82/1       4/4                   4/4                                                     
 ∆ospC/dbpAmt82/2       4/4                   4/4                              
a 
 Groups of four BALB/c SCID mice each received two intradermal/subcutaneous injections of the clone  
∆ospC/ospC’/1, ∆ospC/ospC’/2, ∆ospC/∆βs1/1, ∆ospC/∆βs1/2,  ∆ospC/∆βs2/1, ∆ospC/∆βs2/2, 
∆ospC/∆αH4/1, ∆ospC/∆αH4/2, ∆ospC/∆Nt10/1, ∆ospC/∆Nt10/2, ∆ospC/∆Ct13/1, ∆ospC/∆Ct13/2,  
∆ospC/dbpAmt82/1 or  ∆ospC/dbpAmt82/2.  Approximately 10
5
 organisms were administered in each 
inoculation; two inoculations sites were at least 2 cm apart. Two animals from each group were 
euthanized at 24 and 48 h post-inoculation; skin specimen s were harvested from inoculations sites and 
cultured for spirochetes in BSK-H complete medium.                                                                                           
            OspC has been found to have a dual function: that of protection against host innate 
immune responses, which is common to that of other surface lipoproteins and thus can be 
overridden by the same, such as DbpA and OspA; and that of dissemination, which is one of the 
unique roles of OspC, discovered so far, in the pathogenesis of B. burgdorferi (Xu et al., 2008).    
            Since the crystal structure of OspC has been resolved, many labs have focused on 
exploring the structure of OspC for finding epitopes for adaptive immune responses (Earnhart et 
al., 2005, Jobe et al., 2003). To our knowledge, this is the first study that explored the crystal 
structure of OspC for finding its function in protection against innate immune response. Since 
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deleting several regions of OspC within the core structure (the 2 beta sheets and alpha helix 4) 
resulted in non-infectious phenotypes, we decided to test clones with larger deletions of the 
OspC termini. The results showed that larger segments in the flexible, non-crystalizable portion 
of OspC (the N- and C-terminus) are also involved in protection against host innate immune 
responses. Both ∆ospC/∆Nt10 and ∆ospC/∆Ct13 clones were included because studies 
(described in Chapter 3 and 5, respectively) have shown that these clones were non-infectious at  
least at a one month post-inoculation time point and therefore tested in this study to verify that 
the loss of infectivity occurred at an earlier time point.    
            Although numerous studies have attempted to associate infectivity of B. burgdorferi with 
plasmid content (Caimano et al., 2000, Casjens et al., 2000, Labandeira-Rey and Skare, 2001, 
Marconi et al., 1996, Purser and Norris, 2000, Simpson et al., 1990), two of them proved that 
lp25 and lp28-1 may be necessary for full virulence (Labandeira-Rey and Skare, 2001, Purser 
and Norris, 2000). In this study, because the B. burgdorferi strain B31 clone 13A, an ospC 
mutant, had lost lp25, the plasmid that carries the gene bbe22 coding for a nicotinamidase 
essential for survival of B. burgdorferi in the mammalian environment, the recombinant plasmid 
pBBE22, which harbors a copy of bbe22, was used as the shuttle vector (Purser et al., 2003). The 
clone 13A had also lost lp56 but contained the remaining 19 plasmids (Xu et al., 2007). 
However, plasmid lp56 is not associated with loss of infectivity (Purser and Norris, 2000). B. 
burgdorferi B31 clones that lacked lp28-1 were shown to be of either low or intermediate 
infectivity (Purser and Norris, 2000). However, B. burgdorferi strains that have lost lp28-1 are 
still infectious and persist in immunodeficient mice (Labandeira-Rey et al., 2003). The plasmid 
lp28-1 contains the vlsE locus that is required for evasion of humoral immune response 
(Labandeira-Rey et al., 2003, Labandeira-Rey and Skare, 2001, Purser and Norris, 2000, Zhang 
et al., 1997). For that reason, an effort was made in this study to select clones that contained 
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lp28-1 and to verify the content of those plasmids that can be spontaneously lost. Since one of 
the ∆ospC/∆αH4 clones had the plasmid lp28-1 while the other had lost the plasmid, and yet both  
clones were non-infectious, it can be implied that the resulting phenotypes are due to the lack of 
 the alpha helix rather than the lack of the plasmid lp28-1.  
            The small beta strands may be involved in the stabilization of the OspC dimers (Eicken et 
al., 2001). Hence, deletion of their beta strands led to complete loss of infectivity, suggesting that 
the dimer formation may be important in the function of OspC. Interestingly, when the two beta 
sheets βs1 and βs2 of OspC were deleted, the truncated protein expression levels were 
significantly lower than that of the full length OspC controls. The biological significance of this 
observation is not yet known. It could be that the beta sheets are involved in the degradation of 
the lipoprotein.   
            A previous study showed that OspC-deficient spirochetes showing increased DbpA 
expression were able to be recovered from skin inoculation site of SCID mice within 24h (Xu et 
al., 2008). In order to test if mutation of one of the active sites of decorin-binding may 
compromise the protective role of this lipoprotein, a DbpAmt82 was included in the study. The 
results of this study indicate that in spite of the mutation, spirochetes were still able to be 
recovered for at least up to 48h. It also indicates that spirochetes lacking OspC but expressing 
DbpA, although in a mutant form, could protect B. burgdorferi against host innate defenses. 
            This study has shown that a broad range of deletions in the OspC structure can lead to the 
abolishment of OspC function in protection against host innate responses. Since βs1 and βs2 and 
αH4 are part of the core structure of OspC, their deletions might have led to a collapse in the 
structure of the lipoprotein. Deletion of 10-AA of the N-terminus of OspC, on the other hand, 
might have compromised the anchoring of the lipoprotein to the outer surface of the outer 
membrane of the spirochete. Finally, deletion of the C-terminus of OspC might have hindered 
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the interaction of the lipoprotein with the outer environment, since the terminus is not linked to 
the borrelial membrane. A further analysis by circular dichroism, which examines protein 
structures in solution (Kelly et al., 2005), could demonstrate whether these truncated OspC 
proteins cause a collapse of the core structure of OspC. Nevertheless, this study shows that there 
is a correlation between the certain regions of OspC and the role of this surface lipoprotein in 
evasion of B. burgdorferi from host innate defences. 
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CHAPTER 3 
 
OUTER SURFACE PROTEIN C IS A DISSEMINATION-FACILITATING 
FACTOR OF BORRELIA BURGDORFERI DURING MAMMALIAN 
INFECTION 
 
                                                              INTRODUCTION                                                      
            Coordinated production of outer surface proteins (Osp) is crucial for the pathogenic 
strategy of the Lyme disease spirochete, Borrelia burgdorferi (Burgdorfer et al., 1982). In 
engorged and unfed ticks, B. burgdorferi abundantly produces OspA and OspB, but no OspC 
(Ohnishi et al., 2001, Schwan et al., 1995), but dramatically upregulates OspC in response to a 
fresh blood meal and prepares itself for infection of mammals (Grimm et al., 2004b, Pal et al., 
2004, Stewart et al., 2006). B. burgdorferi maintains high OspC synthesis during early 
mammalian infection (Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004b). However, 
OspC is not only a strong immunogen, but also an effective target of protective immunity; its 
production ultimately induces a robust humoral response that imposes tremendous pressure on 
the pathogen (Fung et al., 1994, Liang et al., 2004b) To effectively evade the adaptive immune 
response and establish persistent infection, B. burgdorferi must downregulate ospC after the 
specific humoral response has developed (Xu et al., 2006) , suggesting an early role for OspC in 
mammalian infection. 
Inactivation of the ospC gene completely abolishes infectivity of B. burgdorferi (Grimm 
et al., 2004a); however, the resulting mutant is able to persist in mammalian tissues, once the 
initial requirement for OspC is overcome, via introduction of an unstable ospC copy, which is 
readily lost under the immune selection pressure during infection of immunocompetent mice, 
leading to a conclusion that OspC is required exclusively for initial mammalian infection 
(Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006). In fact, however, this initial 
requirement for OspC can be overridden by either increasing expression of another Osp (Xu et 
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al., 2008), or simply adapting ospC mutants in mammalian hosts (Tilly et al., 2009). The nature 
of adaptation is to alter gene expression, and it has been known for years that B. burgdorferi 
undergoes dramatic changes in its surface lipoprotein expression during mammalian infection 
(Liang et al., 2002a, Liang et al., 2002b). Most notably, the downregulation of OspC in response 
to the development of the anti-OspC humoral response is always coordinated with an 
upregulation of both VlsE and BBF01 (Liang et al., 2004b). Although remaining to be 
investigated, the host adaptation process most likely provides OspC-deficient spirochetes with 
both time and environment that enable the upregulation of other Osps, such as VlsE and BBF01, 
to occur during the course of the disappearance of unstable ospC copies.  The ability of an Osp to 
replace the function of OspC in initial mammalian infection highlights a redundant function of 
the Osps, which is to assist B. burgdorferi evade innate immune defenses (Xu et al., 2008). 
However, increasing expression of an Osp fails to fully restore ospC mutants with expected 
dissemination ability, leading us to hypothesize that the unique function of OspC is to promote 
dissemination (Xu et al., 2008).  
            As described by some investigators, the protective and dissemination-promoting 
functions of OspC are like two sides of the same coin (Radolf and Caimano, 2008), highlighting 
the challenge to dissect the functions of OspC.  Fortunately, the event of borrelial infection can 
be divided into several steps.  After inoculated into the dermis of a mammal, B. burgdorferi must 
first be able to evade innate immune clearance, and then replicate, disseminate and colonize 
distal tissues. The 50% infectious dose (ID50) should be the best indication for the ability of B. 
burgdorferi to evade this initial innate immune elimination. After initial replication, B. 
burgdorferi disseminates and colonizes distal tissues. Examining the presence of spirochetes in 
distal tissues would reveal its dissemination ability. Again, information about tissue bacterial 
loads would be another indication of B. burgdorferi to evade innate immune clearance. If an 
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ospC mutant showing the similar ID50 value and tissue bacterial load as a wild-type control can 
be generated, dissecting the protective from dissemination-facilitating functions would become 
possible. 
The goal of the study was to dissect the dissemination-facilitating from protective 
function of OspC.  Our strategy was to generate OspC mutants that can evade innate immunity 
but are unable to efficiently disseminate via mutagenizing the ospC gene.  Based on X-ray 
analyses, OspC is a largely α-helical protein and may be a dimer with a characteristic central 
four-helical bundle formed by the association of the two longest helices, helices 1 and 5, from 
each subunit (Eicken et al., 2001, Kumaran et al., 2001).  Each subunit consists of five α-helices, 
two β-sheets and six loops, in addition to the amino (N-) terminal 23-AA linker and the carboxyl 
(C-) terminal 14-AA stretch.  Neither the N-terminal linker nor the C-terminal stretch contributes 
to the core three-dimensional structure of OspC; instead, the α-helices 1 and 5 bring the two 
terminal regions in close proximity, where the lipoprotein is anchored to the bacterial outer 
membrane through lipidation of the first cysteine residue of the N-terminal linker.  Within the 
core, several small secondary structures are present, including α-helix 4 (consisting of 8 amino 
acids) β-sheet 1 (5 amino acids) and 2 (5 amino acids).  We first generated B. burgdorferi 
expressing OspC with each of these small units being deleted.  Unfortunately, none of the 
resulting mutants were infectious, suggesting that these sequences are critical for the functions of 
OspC (data shown in Chapter 2). 
Next, we focused on the N-terminal sequence.  One role of this sequence is to carry the 
sorting signal, which determines the surface location of OspC.  In E. coli the so-called “+2” rule 
determines the cellular location of a lipoprotein.  However, the sorting signal of B. burgdorferi 
can extend to the +4 position (Schulze and Zuckert, 2006). To create N-terminal deletions, which 
can be successfully sorted to the outer surface, we intended to generate mutations starting at the 
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+7 position, and tested the mutants for OspC surface exposure, and then analyzed the mutants for 
the protective and dissemination-facilitating roles of OspC.   
In this study, mutants producing OspC with a 5-AA and a 10-AA N-terminus deletion 
were generated.  Although the N-terminus 10-AA deletion did not affect its surface exposure of 
the truncated OspC, the deletion mutant was non-infectious and thus could not be used in a 
dissemination study (data shown in Chapter 2 and here). However, a mutant producing OspC 
with only 5-AA N-terminal deletion was infectious. This mutant registered a similar ID50 value 
and tissue bacterial load as a control but disseminated to remote tissues at a noticeably slower 
pace.  The study allowed us to confirm that OspC is a dissemination-facilitating factor of B. 
burgdorferi.  
MATERIALS AND METHODS 
            Previously Generated Strains and Constructs Used in The Current Study.  The B. 
burgdorferi B31 clone 13A and the ospC mutant were generated previously (Xu et al., 2007). 
The TA cloning vector pNCO1T was constructed in a previous study (Downie et al., 2004). The 
shuttle vector pBBE22 was a gift from S. Norris (Purser et al., 2003). The features of these 
constructs and clones are summarized in Table 3.1. 
            Creation of The Constructs pBBE22-ospCnt5 and pBBE22-ospCnt10.  As illustrated 
in Figure 3.1, to efficiently generate a 5-AA N-terminus deletion, a 1057-bp fragment covering 
the ospC region and the up- and down-stream sequences was amplified from genomic DNA by 
PCR using primers P1F and P1R (Table 3.2) and cloned into the TA cloning vector pNCO1T 
(Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. One large 
amplicon was generated by inverse PCR using pNCO1T-ospC as a template and primers P2F and 
P2R (Table 3.2). After digestion with SapI and subsequent purification, the amplicon was  
circularized via ligation and then digested with BamHI and XbaI to release ospCnt5. This   
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Table 3.1. Constructs and clones used in the study. 
Construct or clone                                          Description                                                  Source 
pNCO1T                     homemade T/A cloning vector                                                 (Downie, et al., 2004) 
pNCO1T-ospC           pNCO1T carrying ospC gene driven by its native promoter                       This study 
pNCO1T-ospCnt5     pNCO1T carrying ospC gene expressing N-terminus 5-AA deletion         This study 
pNCO1T-ospCnt10  pNOC1T carrying ospC gene expressing N-terminus 10-AA deletion        This study 
pBBE22                      pBSV2 carrying a bbe22 copy                                                     (Purser, et al., 2003) 
pBBE22-ospCnt5      pBBE22 carrying ospC gene expressing N-terminus 5-AA deletion           This study 
pBBE22-ospCnt10    pBBE22 carrying ospC gene expressing N-terminus 10-AA deletion         This study 
13A                             B. burgdorferi B31 clone lacking plasmids  lp25 and lp56              (Xu, et al., 2007) 
ΔospC                         ospC mutant                                                                                      (Xu, et al., 2007) 
ΔospC/FL/1        ospC mutant expressing ospC controlled by ospC regulatory elements a (Xu, et al., 2007) 
 ΔospC/FL/2       ospC mutant expressing ospC controlled by ospC regulatory elements   (Xu, et al., 2007) 
ΔospC/Nt5/1       ospC mutant expressing N-terminus 5-AA deletion                                            This study             
ΔospC/Nt5/2       ospC mutant expression N-terminus 5-AA deletion                                            This study 
ΔospC/Nt10/1     ospC mutant expression N-terminus 10-AA deletion                                          This study                        
ΔospC/Nt10/2     ospC mutant expression N-terminus 10-AA deletion                                          This study 
a.
 The ospC regulatory elements include both operator and promoter. 
 
fragment, encoding an OspC variant with N-terminal 5-AA deletion, was cloned into the 
recombinant plasmid pBBE22 after the vector was digested with BamHI and XbaI. The resulting 
construct was designated pBBE22-ospCnt5. The insert and its flanking regions within pBBE22 
were sequenced to ensure the construct was as designed. Sequencing was performed on an ABI 
3130 Genetic Analyzer (Applied Biosystems, Foster city, CA) using a BigDye Terminator kit 
protocol version 3.1, at the Division of Biotechnology and Molecular Medicine (BioMMed), 
LSU-School of Veterinary Medicine (LSU-SVM), Baton Rouge, LA. The same strategy was 
used to generate construct pBBE22-ospCnt10. The details of this construct are found in Chapter 
2. 
            Two constructs, pBBE22-ospCnt5 (shown in Figure 3.1A) and pBBE22-ospCnt10 
(shown in Chapter 2), with a 5 and 10 amino acid sequence deletion, respectively, were 
generated. The two constructs were electroporated into the ospC mutant, ΔospC, which was 
generated and characterized in our previous study (Xu et al., 2007). Because ΔospC lacks lp25, 
the plasmid that carries the gene bbe22 coding for a nicotinamidase essential for survival of B. 
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burgdorferi in the mammalian environment, the recombinant plasmid pBBE22, which harbors a 
copy of bbe22, was used as the shuttle vector (Purser et al., 2003).  Expression of truncated 
OspC resulting from the introduced construct was confirmed by immunoblot analysis (Figure 
3.1B). 
Table 3.2. Primers used in the study. 
 
Clone                     Primer                                             Sequences (5’ to 3’) a                                                                   
 
FL         P1F 5’-TAGTTGGCTATATTGGGATCCAA-3’   
              P1R 5’-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3’ 
 
Nt5                         P2F 5'-GACTGCTCTTCAGACAATTCTGCTGATGAGTCT-3'                
                               P2R 5'-CGTACGCTCTTCAGTCTTTCCCAGAATTATTACAAGA-3' 
 
a
P1F and P1R contain restriction enzyme sites (underlined) BamHI, and XbaI, respectively.   
 P2F and P2R contain SapI restriction sites (underlined). 
 
  
            Transformation of B. burgdorferi and Selection of Transformants.  Constructs were 
electroporated into ∆ospC; resulting transformants were screened and analyzed for plasmid 
content as described previously (Xu et al., 2005). Restoration of OspC production was verified 
using immunoblots probed with a mixture of FlaB and OspC MAbs (Figure 3.1B), as described 
in an earlier study (Xu et al., 2007).  
            Indirect Immunofluorescence Assay.  Spirochetes were grown to stationary phase in 
BSK-H complete medium.  Indirect immunofluorescence was performed on unfixed spirochetes 
only. Briefly, B. burgdorferi was grown to stationary phase (10
8
cells/ml) in BSK-H complete 
medium at 33 °C. To count the cell, cells were diluted and counted by averaging eight fields 
under the microscope. It was assumed that one hundred spirochetes/field was equivalent to 3x10
7
 
spirochetes/ml. For fluorescent labeling, 6x10
7
cells were harvested from 0.6 ml of ∆ospC/FL 
control,  ∆ospC/nt5 or ∆ospC/nt10 mutant spirochetes by centrifugation at 8,000xg for 10 min, 
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Figure 3.1. Generation of B. burgdorferi producing OspC with N-terminal 5-AA deletion.  
A. Construction of pBBE22-ospCnt5 coding for OspC with N-terminal 5-AA deletion.  The 
five codons coding for the five amino acid residues (residues 26—30) and their adjacent codons 
are presented.  The amplification starting sites and directions of four primers, P1F, P1R, P2F and 
P2R, used for plasmid construction are also marked.  The long bar represents the 1057-bp 
fragment, covering the entire ospC-coding region and down- (extending to +801 from the 
transcriptional start site) and up-stream sequences (extending to -256).  The detailed construction 
of the vector was described in Materials and Methods section. B. Restoration of OspC 
production. The parental clone 13A, ΔospC, and the clones ΔospC/FL, ΔospC/Cnt5/1 and 
ΔospC/Cnt5/2 were verified for OspC expression by immunoblot probed with a mixture of FlaB 
and OspC MAbs. 
 
 
Fig. 3.1A 
Fig. 3.1B 
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gently suspended in 100 μl PBS supplemented with 3.6 μl of mouse OspC MAb preparation B5 
(Gilmore and Mbow, 1999), and incubated for 1 hour at 33 °C. After one wash with excess 
volume of PBS by centrifugation at 10,000xg for 10 min, spirochetes were resuspended in 100 μl 
of PBS containing 1 μg of fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG 
(Thermo Fisher Scientific, Rockford, IL), incubated for 1 hour, washed once with PBS by 
centrifugation, resuspended in 30μl PBS, applied to microscopic slides, and analyzed using Axio 
Imager (Carl Zeiss Microimaging, Inc., Thornwood, NY). Differential interference contrast 
(DIC) images were also taken for the same field to identify all the spirochetes present.   
            SCID Mice Infectivity Studies. To test for infectivity, groups of three C3H SCID mice 
were inoculated with 10
4
 spirochetes of the clone ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/ΔNt10/1, 
or ΔospC/ΔNt10/2.  As a control, mice were also inoculated with the clone ΔospC/FL/1 or 
ΔospC/FL/2.  The clones ΔospC/FL/1 and ΔospC/FL/2 were generated via introduction of a full-
length ospC gene including both the operator and promoter carried by the shuttle vector pBBE22 
into the ospC mutant in our previous study (Xu et al., 2007). All mice were sacrificed 1 month 
post-inoculation; heart, tibiotarsal joint and skin specimens were harvested for spirochete culture 
in BSK-H complete medium.  
            Because ΔospC/ΔNt10/1 and ΔospC/ΔNt10/2 spirochetes could remain at inoculation sites 
and not disseminate to other tissues, groups of four SCID mice each received two 
intradermal/subcutaneous inoculations of 10
5
 spirochetes of the clone ΔospC/ΔNt10/1 or 
ΔospC/ΔNt10/2.  As a control, an additional eight animals were inoculated with the clone 
ΔospC/FL/1 or ΔospC/FL/2.  The two inoculation sites were at least 2 cm apart.  Two animals 
from each group were euthanized at 24 or 48 h later; inoculation site skin specimens were 
harvested for spirochete culture. 
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            Determination of ID50 Values. Spirochetes were grown to late-log phase (10
8
 cells/ml) 
in BSK-H complete medium at 33 °C and 10-fold serially diluted with fresh medium. C3H SCID 
mice (ages 4-6 week; provided by the Division of Laboratory Animal Medicine at Louisiana 
State University, Baton Rouge, LA) each received one single intradermal/subcutaneous injection 
of 100 µl of spirochetal suspension (containing 10
1
 to 10
4
 organisms). Mice were euthanized one 
month post-inoculation; heart, tibiotarsal joint, and skin (not from inoculation site) specimens 
were harvested for bacterial isolation. The ID50 value was calculated as described by Reed and 
Muench (Reed and Muench, 1938). Briefly, mice were inoculated with sequential 10-fold 
dilutions of spirochetes ranging from 10
4
 to 10
1
. The ID50 value was based on the calculation of 
an index. The index and a table related to the calculation are shown in Appendix A, along with 
an example. The values were input into an ID50 value calculation tool from 
www.biorubyrails.com website. 
            Dissemination Studies in SCID and Wild Type Mice. C3H SCID mice (ages 4-6 
weeks; provided by the Division of LSU Laboratory Animal Medicine) each were given a single 
intradermal/subcutaneous injection of 10
3
 spirochetes in the chest and were euthanized at 1, 2, 3 
and 4 weeks post-inoculation. Tiobiotarsal joint, inoculation site and remote site skin, ear and 
heart specimens were harvested for spirochete isolation as described previously (Xu et al., 2005). 
Because spirochetes were injected into the dermis of the chest, the skin from the back was 
harvested as a remote site. In a second experiment, BALB/c mice (ages 4-8 weeks; provided by 
the Division of LSU Laboratory Animal Medicine) each received a single 
intradermal/subcutaneous injection of 10
5
 spirochetes and were euthanized at 1, 2, 3 and 4 weeks 
post inoculation. The reminder of the experiment was done as previously described for C3H 
SCID mice. 
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            Quantitation of Tissue Spirochetal Load. C3H SCID mice (4-6 weeks; provided by the 
Division of LSU Laboratory Animal Medicine) each were intradermally/subcutaneously 
inoculated with 10
4
 spirochetes. Animals were sacrificed one month post-inoculation; heart, 
joint, and skin specimens were harvested for DNA isolation. DNA was quantified for the copy 
numbers of flaB and murine actin genes by quantitative PCR (qPCR) as described previously 
(Xu et al., 2005). The tissue spirochete burden was expressed as flaB DNA copies per 10
6
 host 
cells (2×10
6
 actin DNA copies). 
            Preparation of flaB-actin Fusion Standard. To better normalize the flaB and actin 
concentration for quantitative PCR (qPCR), an internal sequence from both actin and flaB genes 
were cloned into TA vector pNCO1T (Downie et al., 2004). A primer pair (forward: 5’-AAGG 
ATCCATGAGACCACTTTCAACT-3’; reverse: 5’-GGACAGTGAGGCCAGAATG GA-3’)   
was designed to amplify a 231-bp internal fragment of the actin gene using murine DNA as a 
template. A second primer pair (forward: 5’-CAGCTGAAGAGCTTGGAATGCA-3’; reverse: 
5’-AAGGATCCGCCTTGAGAAGGTGCT-3’) was used to generate a 260-bp internal fragment  
of flaB with spirochete DNA as a template. The underlined sequences were BamH1 sites.    
            After digestion with restriction enzyme and purification, the two amplicons were ligated 
and then amplified by nested PCR with use of a third primer pair (forward: 5’-
CCTCTAGAGTTCATGTTGGAGCAAAC-3’; reverse: 5’-ATTCTAGAATGGAGCCACCGA 
TCCA-3’). The PCR product was cloned into TA vector pNCO1T as described previously 
(Downie et al., 2004). The flaB-actin insert was confirmed by DNA sequencing using the ABI 
3130 Genetic analyzer (Applied Biosystems, Foster City, CA) performed at BioMMed, LSU-
SVM, Baton Rouge, LA. DNA concentrations were determined by measuring optical density at 
650 nm wavelength and converted to copy numbers.                   
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            DNA Preparation. Frozen heart, joint, and skin samples were transferred into liquid 
nitrogen and ground thoroughly with a mortar and pestle. An appropriate amount of tissue 
powder was transferred into a 1.5 ml microcentrifuge tube for DNA preparation with the use of 
DNeasy Mini kit according to the manufacturer’s instructions (Qiagen, Valencia, CA).  
            Quantitative PCR (qPCR). qPCR analyses were performed using the ABI 7900HT 
Sequence Detection System (Applied Biosystems, Foster City, CA), at BioMMed, LSU-SVM, 
Baton Rouge, LA. The Platinum Taq DNA polymerase High fidelity kit was purchased from 
Invitrogen Life Technologies (Carlsbad, CA). The sequences of primers and internal probes 
were: for flaB (forward: 5’-GCAGCTAATGTTGCAAATCTTTTC-3’; reverse: 5’-
GCAGGTGCTGGC TGTTGA-3’; probe: 5’-AAACTGCTCAGGCTCCACCGGTTC-3’) and 
actin (forward: 5’-CCATGTACCCAG GCATTGC-3’; reverse: 5’-CCAGAC 
TGAGTACTTGCGTTC-3’; probe: 5’- GCAGAAGGA GATCACAGCCCTAGCACC-3’). 
Taqman 6-carboxytetramethylrhodamine (TAMRA) probes were ordered from Applied 
Biosystems (Foster City, CA). Amplification was performed in a final volume of 10 µl in the 
ABI PRISM 384-well clear optical reaction plate (Applied Biosystems, Foster City, CA). Two 
sets of 12 wells were assigned as DNA standards for actin or flaB.  The standard concentrations 
ranged from 10
2
 to 10
7
 copies/well for actin DNA Quantitation, and from 10
0
 to 10
5
 copies for 
flaB. Both standards and samples were amplified in duplicate wells. A PCR program with the 
following parameters was used: 50 °C for 30 seconds; 95 °C for 5 min; 50 cycles of 95 °C for 20 
seconds; and 60 °C for 1 min. The mean DNA copy numbers of flaB and actin of each DNA 
sample were calculated from duplicate wells. Tissue spirochete burdens were converted to flaB 
DNA copy number per 2x10
6
 actin DNA copies (spirochete burden per 10
6
 host cells).              
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            Statistical Analysis. A one-way analysis of variance (ANOVA) was used to analyze 
data, followed by a two-tailed Student t test to calculate a P value for each two groups. A P value 
≤ 0.05 was considered to be significant. 
                                                                     RESULTS 
Generation of B. burgdorferi Producing OspC with Either 5 or 10 Amino Acid 
Deletion.  B. burgdorferi B31 ∆ospC mutants were transformed with recombinant plasmid 
pBBE22-ospCnt5 (shown in Figure 3.1A) and pBBE22-ospCnt10 (shown in Chapter 2, Figure 
2.4). Seven and six transformants, respectively, were obtained receiving each construct; plasmid 
analyses by PCR led to the selection of four clones, ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, 
ΔospC/ΔNt10/1 and ΔospC/ΔNt10/1. These clones shared the same plasmid content as ΔospC, 
which had lost lp25, lp5, lp21, lp56 and cp9 (Xu et al., 2007). Expression of the truncated OspC 
proteins was verified by immunoblot analyses (Figure 3.1B). The in vitro growth rate of both 
clones, ΔospC/ΔNt5 and ΔospC/ΔNt10, was similar to that of ∆ospC/FL controls.  
            Neither The 5- nor The 10-AA Deletion Affects The Surface Location of OspC.  
Because the deletion was generated close to the N-terminus, which may harbor the sorting signal, 
it is important to show that truncated OspC can be successfully sorted to the outer surface of B. 
burgdorferi.  To this end, we used indirect immunofluorescence to locate truncated OspC.  As 
shown in Figure 3.2, both truncated proteins showed similar fluorescence patterns as the wild-
type control protein, indicating that neither deletion influenced the cellular location of OspC.   
            The 10- but Not 5-AA Deletion Abolishes Infectivity.    As shown in Table 3.3, like the 
two control clones, the ΔospC/ΔNt5/1 and ΔospC/ΔNt5/2 spirochetes were grown from each 
sample of all inoculated mice.  In contrast, neither ΔospC/ΔNt10/1 nor ΔospC/ΔNt10/2 bacteria 
were recovered from any specimens, suggesting that the 10-AA deletion may completely abolish 
the functions of OspC. 
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Figure 3.2. Deletion of N-terminus 5-AA or 10-AA does not affect surface exposure of 
OspC. ∆ospC/FL, ∆ospC/Nt5 or ∆ospC/Nt10 spirochetes were grown to late log phase (108/ml) 
in BSK-H medium at 33°C. Spirochetes were incubated with mouse mOspC antibodies, washed 
in PBS, probed with FITC-conjugated goat anti-mouse antibody, washed again before being 
placed onto slides. Differential interference contrast (left panel) and immunofluorescence images 
(right panel) were taken from the same field. Magnification: x400.  
 
The ΔospC/ΔNt10/1 and ΔospC/ΔNt10/2 bacteria might have remained at the inoculation 
sites without dissemination.  To rule out this possibility, C3HS mice were given 
intradermal/subcutaneous inoculations of ΔospC/ΔNt10/1, ΔospC/ΔNt10/2, ΔospC/FL/1 or 
ΔospC/FL/2 at a total of four sites for each clone and the inoculation sites were harvested at 24h 
and 48h post-inoculation. Control bacteria were consistently grown from each of the 16 
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inoculation sites from all eight inoculated mice.  In contrast, neither ΔospC/ΔNt10/1 nor 
ΔospC/ΔNt10/2 spirochetes were recovered from any of the 8 sites harvested at each time point, 
confirming that the 10-AA deletion completely destroys the functions of OspC and leads to quick 
clearance of spirochetes (results shown in Chapter 2, Table 2.3).  
             The 5-AA Deletion Does Not Affect The ID50 Value in SCID Mice.  Because the ID50 
value reflects the smallest number of organisms to sufficiently initiate an infection in 50% 
inoculated individuals, it is the best measurable criterion to assess how a pathogen can evade 
innate immune elimination, especially when this is measured in SCID mice.  To examine 
whether the 5-AA deletion reduced the ability of OspC to assist B. burgdorferi avoid innate 
immunity, groups of three C3H SCID mice each received one single inoculation of 10
1
 to 10
4
 
spirochetes of the clone ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/FL/1, or ΔospC/FL/2.  All animals 
were euthanized 1 mo post-inoculation; heart, joint and skin specimens were cultured for 
spirochetes.  The ID50 values of the clones ΔospC/Nt5/1 and ΔospC/Nt5/2 were 18 and 32 
organisms, compared to 18 and 32 organisms determined for the clones ΔospC/FL/1 and 
ΔospC/FL/2, respectively (Table 3.4), indicating that the truncated OspC retains the innate 
immunity evasive function. 
            The 5-AA Deletion Does Not Reduce Spirochete Burdens in Joint or Skin of SCID 
Mice.  The tissue bacterial load reflects the balance between the replication and death rates so 
that it is another measurable criterion to assess how well a pathogen is protected from 
elimination by innate immunity (Figure 3.3). To examine the influence of the 5-AA deletion on 
the tissue bacterial load, subgroups of five SCID mice each received a single 
intradermal/subcutaneous inoculation of 10
4
 spirochetes of the clone ΔospC/Nt5/1, ΔospC/Nt5/2, 
ΔospC/FL/1, or ΔospC/FL/2.  In 10 mice that were inoculated with the ΔospC/FL/1 or  
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ΔospC/FL/2, joint swelling evolved around 10 d post-inoculation and developed into severe  
month post-inoculation; DNA was extracted from heart, joint and skin specimens and quantified 
Table 3.3. The 10-AA deletion abolishes infectivity of B. burgdorferi 
a
 
No. of cultures positive/total            No. of mice infected/total 
specimen examined                     mice inoculated       
 Clone    Heart     Joint    Skin   All sites 
 
ΔospC/FL/1     3/3       3/3       3/3       9/9                           3/3 
ΔospC/FL/2      3/3       3/3       3/3       9/9                           3/3                             
 
ΔospC/ΔNt5/1     3/3       3/3       3/3       9/9                           3/3                             
ΔospC/ΔNt5/2     3/3       3/3       3/3       9/9                           3/3 
 
ΔospC/ΔNt10/1    0/3       0/3       0/3       0/9                           0/3                             
ΔospC/ΔNt10/2    0/3       0/3       0/3       0/9                           0/3 
  
a
 Groups of three C3H SCID mice were inoculated with 10
4
 spirochetes of the clone 
ΔospC/FL/1, ΔospC/FL/2, ΔospC/ΔNt5/1, ΔospC/ΔNt5/2, ΔospC/ΔNt10/1, or ΔospC/ΔNt10/2.  
Mice were sacrificed 1 mo post-inoculation; heart, tibiotarsal joint and skin specimens were 
harvested for spirochete culture in BSK-H complete medium. 
 
for bacterial burden.  Although the ΔospC/Nt5 spirochete burden was 6.7-fold lower than that of 
the ΔospC/FL (P = 2.83 × 10‾10) in the heart tissue, there was no significant difference detected 
either in joint (P = 0.52) or skin tissue (P =0.13). The study indicated that the 5-AA deletion 
does not reduce the ability of OspC to protect B. burgdorferi against innate immunity. 
            The 5-AA Deletion Leads to Slowed Dissemination During Infection of SCID Mice.   
Groups of 20 SCID mice each received a single intradermal/subcutaneous inoculation of 10
4
 
spirochetes of the clone ΔospC/FL/1 or ΔospC/ΔNt5/1.  Five animals from each group were 
euthanized at 1-wk intervals; inoculation site and remote site skin, ear, heart, and joint specimens 
were harvested for spirochete isolation.  Bacteria were injected into the dermis of the chest so the 
skin from the back was harvested as remote sites.  As a positive control, the ΔospC/FL/1 bacteria 
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were grown from all of the skin, joint and heart specimens but from none of the ear samples at 
first week; all sites became culture positive at 2 wk after initial inoculation (Table 3.5).   
Table 3.4.  Deletion of the N terminus 5-AA sequence of OspC does not significantly affect 
the ID50 value in immunodeficient mice 
a 
 
Clone                        No. of cultures positive/total         No. of mice infected/total   ID50 
 and dose   no. of specimens examined          no. of mice inoculated          (No. of  
(no. of organisms) Heart    Joint    Skin   All sites          organisms)  
 
ΔospC/FL/1                                                                                                                          18 
     10
4                                       
3/3      3/3       3/3       9/9  3/3 
     10
3
                          3/3      3/3       3/3       9/9        3/3  
     10
2                                       
3/3      3/3       3/3       9/9  3/3  
     10
1                                       
1/3       1/3       1/3       3/9  1/3 
    
ΔospC/FL/2                                                                                                                          32  
     10
4
                          3/3       3/3      3/3        9/9  3/3                        
                       
 
     10
3
                          3/3       3/3      3/3        9/9  3/3  
     10
2
                          3/3       3/3      3/3        9/9  3/3  
     10
1
                          0/3       0/3      0/3        0/9  0/3 
 
ΔospC/ΔNt5/1                                                                                                                       18 
     10
4
                          3/3       3/3      3/3        9/9  3/3  
 
 
     10
3
                          3/3       3/3      3/3        9/9  3/3  
     10
2
                          3/3       3/3      3/3        9/9  3/3  
     10
1
                          1/3       1/3      1/3        3/9  1/3 
  
ΔospC/ΔNt5/2                                                                                                                       32                                                                                                       
     10
4           
                   3/3       3/3      3/3        9/9  3/3       
     10
3
                          3/3       3/3      3/3        9/9   3/3  
     10
2
                          2/3       2/3      2/3        6/9  2/3  
     10
1
                          1/3       1/3      1/3        3/9  1/3  
 
 
a 
The ΔospC/FL/1, ΔospC/FL/2, ΔospC/ΔNt5/1and  ΔospC/ΔNt5/2 spirochetes were grown to 
late-log phase (10
8
 cells/ml) and 10-fold serially diluted with BSK-H medium.  Approximately 
100 µl of bacterial suspension was intradermally/subcutaneously inoculated into each C3HS 
mouse. Animals were sacrificed 1 month later; heart, tibiotarsal joint and skin specimens were 
harvested for bacterial isolation. The ID50 values were calculated by the method of Reed and 
Muench (Reed and Muench, 1938). 
 
In contrast, the ΔospC/ΔNt5/1 spirochetes were grown only from inoculation sites at a week 
post-inoculation.  Although the mutant disseminated to most of the joint, remote skin and heart 
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specimens at 2 wk, the majority of ear tissues were not colonized until 3 wk.  These data 
indicated that OspC is important for efficient dissemination.  
 
Figure 3.3.  The N-terminal 5-AA deletion does not reduce the ability of B. burgdorferi to 
colonize joint or skin but heart tissues of SCID mice.  Subgroups of five SCID mice were 
inoculated with 10
5
 spirochetes of the clone ΔospC/FL/1, ΔospC/FL2, ΔospC/ΔNt5/1, or 
ΔospC/ΔNt5/2, and euthanized a month later.  DNA was prepared from heart, joint and skin 
specimens and analyzed for spirochete flaB and murine actin DNA copies by qPCR.  Data are 
expressed as spirochete numbers per 10
6
 host cells and presented in four groups by combining 
the subgroups ΔospC/FL/1 and ΔospC/FL/2, ΔospC/ΔNt5/1 and ΔospC/ΔNt5/2 and named as FL 
and Cnt5 respectively.*, P < 0.05 between FL and Cnt5. 
 
The 5-AA Deletion Causes Severely Impaired Dissemination During Infection of 
Immunocompetent Mice.  More severely impaired dissemination was noted during infection of 
immunocompetent mice.  Groups of 24 BALB/c mice each received a single 
intradermal/subcutaneous inoculation of 10
5
 spirochetes of the clone ΔospC/FL/1 or 
ΔospC/ΔNt5/1.  Six animals from each group were euthanized at 1-wk intervals; inoculation site 
and remote site skin, ear, heart, and joint specimens were harvested for spirochete isolation.  
Bacteria were injected into the dermis of the chest so the skin from the back was harvested as 
remote sites.  As a positive control, the ΔospC/FL/1 bacteria were grown from all of the remote 
tissues but the ear at first week; all sites became culture positive at 2 wk after initial inoculation 
(Table 3.6).  In contrast, the ΔospC/ΔNt5/1 spirochetes were not grown from joint tissues until 4 
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weeks after inoculation, and no heart, remote skin or ear tissues became culture positive during 
the period.  These data further highlights that OspC is required for efficient dissemination.  
                                                                  DISCUSSION 
            Like typical Gram-negative bacteria, B. burgdorferi possesses inner and outer 
membranes, between which is a periplasmic space (Cullen et al., 2004, Steere, 2001). Gram-
negative pathogens typically make a thick lipopolysaccharide (LPS) coat to provide a broad 
array of crucial protection (Raetz and Whitfield, 2002). However, B. burgdorferi does not 
 
produce any LPS but instead abundantly expresses lipoproteins and anchors them to the outer 
 
membranous surface through lipidation (Cullen et al., 2004, Radolf et al., 1994, Takayama et al., 
1987). This unique surface antigenic architecture makes the host-pathogen interactions more 
complicated and may contribute to the pathogenic strategy of B. burgdorferi.  As protein is a 
direct product of gene expression, regulation of surface antigen expression can quickly result in 
modification of the surface antigenic architecture. B. burgdorferi indeed takes this advantage and 
vigorously modifies its surface lipoprotein expression to constantly reformulate its overall 
surface antigenic architecture during the enzootic life cycle traveling between the tick vector and 
a mammal, and during the course of mammalian infection (Yang et al., 2004). The pathogen 
abundantly expresses outer surface proteins (Osps) A and B in the unfed tick (Schwan and 
Piesman, 2000, Schwan et al., 1995), suggesting a critical role for these surface antigens while 
residing in the tick vector, which has been confirmed by series of subsequent studies (Fikrig et 
al., 2004, Neelakanta et al., 2007, Ohnishi et al., 2001, Yang et al., 2004). A fresh blood meal 
induces the down-regulation of OspA/B and the up-regulation of OspC and other lipoproteins, a 
process that prepares B. burgdorferi for infection of mammals (Fingerle et al., 2007, Grimm et 
al., 2004b, Pal et al., 2004, Stewart et al., 2006). Abundant OspC expression ultimately induces a 
robust early humoral response that imposes tremendous pressure on the pathogen (Fung et al., 
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1994, Xu et al., 2006). To evade the specific humoral response and cause persistent infection, B. 
burgdorferi down-regulates OspC and dramatically upregulates other surface lipoproteins, 
including VlsE and BBF01 (Crother et al., 2004, Liang et al., 2004a, Liang et al., 2002a, Liang 
et al., 2002b). This demonstrated ospC expression pattern strongly suggested its early role in 
mammalian infection.  This initial requirement has been confirmed as genetic manipulation of B. 
burgdorferi became possible (Stewart et al., 2006, Tilly et al., 2007, Tilly et al., 2006). 
Recent studies showed that this initial requirement for OspC can be overridden by either 
increasing expression of another Osp (Xu et al., 2008), or simply adapting ospC mutants in 
mammalian hosts (Tilly et al., 2009) .  The adaptation process apparently is to increase 
expression of other Osps, which replace lost OspC functions.  Apparently, increasing expression 
of Osps, either via genetic modification or adaptation in mammalian host, can at least partially 
replace OspC.  This raises a question about OspC functions.  These studies led us to hypothesize 
that the borrelial lipoproteins may have a common function, which is to protect B. burgdorferi 
against innate immunity, while the unique function of OspC is to facilitate dissemination, which 
can be only partially replaced by other Osps.  In the current study, we successfully separated 
protective function and dissemination-facilitating function.  We successfully generated a 
truncated OspC, which can effectively protect B. burgdorferi against innate elimination but fails 
to make spirochetes able to disseminate as efficiently as the wild-type control.  
            Our previous study showed that increasing production of one of four randomly chosen 
but well-investigated surface lipoproteins can effectively replace OspC to protect B. burgdorferi 
 against innate immunity, clearly suggesting that any surface lipoprotein apparently can 
substitute OspC for this function. What strikes us is that not all truncated OspC mutants are able 
to protect B. burgdorferi against innate immunity while any other wild-type surface lipoprotein 
can replace OspC for this specific function.  Although the 5-AA deletion retains the full
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Table 3.5. N-terminal 5-AA deletion of OspC impairs the ability of B. burgdorferi to disseminate to remote tissues in 
immunodeficient mice. 
a
 
 
Clone                                     No. of specimens positive/total specimens examined at post-inoculation weeks              
                                                         1 wk                                   2 wks                                             3 wks  
   
                                     I.S.   R.S.   Ear  Heart  Joint               I.S.   R.S.   Ear  Heart  Joint                       I.S.   R.S.   Ear  Heart  Joint       
 
ΔospC/ospC                 5/5    5/5     0/5   5/5     5/5                 5/5    5/5     5/5    5/5     5/5                         NDb  ND   ND    ND    ND   
ΔospC/ΔNt5              5/5    0/5     0/5   0/5     0/5                 5/5    4/5     1/5    4/5     5/5                         5/5    5/5    5/5    5/5     5/5        
 
a.
 Groups of 10 to 15 C3HS SCID mice each received a single intradermal/subcutaneous injection of 10
3
 organisms of the clone 
ΔospC/ospC or ΔospC/ΔNt5. Five animals from each group were euthanized at 1, 2, or 3 wk post-inoculation; inoculation site (I.S.) 
and remote site (R.S.) skin, ear, heart, and joint specimens were harvested for spirochete isolation.  The I.S. site was at the chest; 
therefore the R.S. site was at the back of mice. b. ND, not determined. 
93 
 
Table 3.6. N-terminal 5-AA deletion of OspC severely impairs the ability of B. burgdorferi to disseminate to remote tissues in 
immunocompetent BALB/c mice. 
a
 
 
Clone     No. of specimens positive/Total specimens examined at post-inoculation weeks              
                  1 wk          2 wks          3 wks           4 wks                         
I.S.  R.S.  Ear  Heart  Joint     I.S.  R.S.  Ear  Heart  Joint      I.S.  R.S.  Ear  Heart  Joint     I.S.   R.S.  Ear  Heart  Joint 
 
ΔospC/ospC   6/6   6/6    0/6   6/6     6/6   6/6   6/6    6/6    6/6    6/6   6/6   6/6    6/6    6/6    6/6    6/6    6/6    6/6   6/6    6/6 
ΔospC/ΔNt5  6/6   0/6    ND   0/6    1/6   1/6   0/6    0/6    0/6    0/6   2/6   0/6    0/6    0/6    6/6        6/6    0/6    0/6   0/6    6/6   
 
a.
 Groups of 24 BALB/c mice each received a single intradermal/subcutaneous injection of 10
5
 organisms of the clone ΔospC/ospC or 
ΔospC/ΔNt5. Six animals from each group were euthanized at 1, 2, 3 or 4 wk post-inoculation; inoculation site (I.S.) and remote site 
(R.S.) skin, ear, heart, and joint specimens were harvested for spirochete isolation.  The I.S. site was at the chest; therefore the R.S. 
site was at the back of mice.  
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capacity of OspC to protect B. burgdorferi against innate elimination, the 10-AA deletion 
completely destroys its functions.  Interestingly, a previous study showed that any of the four 
Osps tested can replace OspC to protect B. burgdorferi from innate elimination.  However, OspC 
itself, after 10-AA deletion, failed to protect B. burgdorferi.  This suggests that each Osp may 
protect B. burgdorferi against innate immunity in a unique method. 
After inoculated into murine skin, B. burgdorferi must first be able to evade initial innate 
immune elimination and gain a foothold.  This ability is best represented by the ID50 value 
because this criterion measures the smallest number of organisms that is sufficient to escape 
initial innate elimination.  Regardless of how large the inoculum is, OspC-deficient spirochetes 
are quickly cleared after inoculation into murine skin (Tilly et al., 2007, Xu et al., 2008) .  
Production of OspC with 5-AA deletion conferred OspC deficient B. burgdorferi with ID50 
values similar to the control, indicating that the truncated molecule has the full protective 
function of OspC. 
            Although tissue colonization is an extremely complicated event carried out by an  
extracellular bacterial pathogen during infection and can be affected by many factors, one can 
predict that the ability of the pathogen to evade immune clearance should be one of the major 
determinants.  B. burgdorferi producing OspC with 5-AA deletion was able to generate similar 
bacterial loads in both joint and skin tissues of SCID mice as the control, indicating that the 
truncated OspC can effectively assist the pathogen evade innate immune clearance at least in 
these tissues.  Because many other determinants, such as the interactions of host cells and 
extracellular matrices with the pathogen mediated with its surface antigens, may significantly 
influence tissue colonization, the lower ΔospC/ΔNt5 spirochete load in the heart does not 
necessarily suggest that the truncated OspC cannot effectively provide evasion from host innate 
immune defenses.  Alternatively, OspC may be an important factor contributing to the ability of 
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B. burgdorferi to colonize the heart tissue.  This explanation is also supported by previous 
studies showing that treatment with OspC antibody induces the downregulation of ospC and 
more effectively reduces the bacterial load in the heart more than other tissues (Liang et al., 
2004a, Liang et al., 2004b). 
            Both ID50 and tissue bacterial load data demonstrated that the 5-AA deletion does not 
 affect the innate immune evasive function of OspC, allowing us to dissect the evasive from 
dissemination-facilitating functions.  OspC-deficient B. burgdorferi producing OspC with 5-AA 
deletion disseminated to remote tissues, especially to the heart and ear at a significantly slower 
pace in immunodeficient mice.  In immunocompetent mice, the defect caused by deletion was 
much more severe.  Four weeks after inoculation, the mutant was not able to colonize heart or 
ear tissues, while the control disseminated to all tissues examined within 2 weeks.  Given the  
difference between immunodeficient and immunocompetent mice, infection in the latter induces  
an anti-OspC humoral response, which in turn may further slow dissemination.  The observation  
highlights the importance of quick dissemination of B. burgdorferi during infection of  
immunocompetent animals.  Infection induces immune responses that slow dissemination.  If B.  
burgdorferi fails to colonize remote tissues and establish a systemic infection before effective  
immune responses have developed, its dissemination would be dramatically slowed. 
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CHAPTER 4 
 OUTER SURFACE PROTEIN C IS INVOLVED IN SELF-REGULATION 
IN BORRELIA BURGDORFERI DURING MURINE INFECTION 
 
INTRODUCTION 
Outer surface protein C (OspC) is a critical virulence factor of the Lyme disease 
spirochete Borrelia burgdorferi. Timely expression of OspC is essential for the survival of the 
spirochete as it transits between a tick vector and a mammalian host (Burgdorfer et al., 1982). 
The pathogen abundantly produces OspC during initial infection (Liang et al., 2002a, Liang et 
al., 2002b), when the antigen is required for efficient dissemination (Xu et al., 2008b) (and, as 
shown in Chapter 3), but represses its production to a baseline level after specific humoral 
responses have developed and distal tissues have been colonized (Liang et al., 2004b, Xu et al., 
2006).  The downregulation of OspC allows B. burgdorferi to not only effectively evade the 
immune system but also preserve the integrity of the crucial gene for the subsequent enzootic 
cycle, because a failure to downregulate ospC would lead to either clearance of infection or 
selection of ospC mutants (Xu et al., 2006). OspC production is driven by an RpoS-dependent 
promoter (Yang et al., 2005) and its repression appears to be achieved through the interaction of 
the operator with an unknown repressor (Xu et al., 2007). Here we show that deletion of an N-
terminal 5-amino acid sequence of OspC diminishes the ability of B. burgdorferi to repress ospC 
expression during murine infection and, as a result, dramatically reduces its ability to evade the 
immune system.  Further investigation may lead to disclosure of how OspC can be involved in 
self regulation. 
Coordinated production of OspC is crucial for the pathogenic strategy of the Lyme 
disease spirochete, B. burgdorferi (Burgdorfer et al., 1982). In unfed ticks, B. burgdorferi does 
not express OspC (Ohnishi et al., 2003, Schwan et al., 1995); a fresh blood meal upregulates 
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OspC, a process that prepares the pathogen for infection of a mammal (Grimm et al., 2004b, Pal 
et al., 2004, Stewart et al., 2006).  B. burgdorferi abundantly expresses OspC during early 
infection when the antigen is required for efficient dissemination as shown in Chapter 3 of this 
dissertation and in Liang, et al., 2004, Tilly, et al., 2006, and Xu et al., 2008 (Liang et al., 2004a, 
Tilly et al., 2006, Xu et al., 2008a).  However, OspC is not only a strong immunogen, but also an 
effective target of protective immunity; its production ultimately induces a robust humoral 
response that imposes tremendous pressure on the pathogen (Fung et al., 1994, Liang et al., 
2004a).  If B. burgdorferi fails to repress ospC expression or undergo escape mutations on the 
ospC gene, infection would be cleared (Xu et al., 2006).  While mutation is an effective way to 
evade the immune system, it may cause the functional loss of affected genes.  Although the 
spirochetes with lost OspC function may persist during chronic infection (Tilly et al., 2006), they 
are unable to initiate an infection (Stewart et al., 2006), thus leading to a discontinuation of the 
enzootic cycle.  Therefore, the downregulation of OspC allows the pathogen to not only 
effectively evade the specific immune response but also to preserve the integrity of the ospC 
gene for subsequent need during its life cycle (Liang et al., 2004a, Liang et al., 2002a).  It is also 
critical for B. burgdorferi to maintain an OspC downregulation status after acquired by the tick 
vector as specific antibodies in bloodmeal can efficiently kills spirochetes (Gilmore and 
Piesman, 2000).  Overall, when OspC is required, B. burgdorferi up-regulates it; when its 
presence confers disadvantage to the bacteria, the pathogen down-regulates it.   
While many gaps remain to be filled, recent advances in borrelial genetic study provide a 
relatively clear picture of how ospC is regulated during the course of the enzootic cycle.  ospC 
expression uses a well-defined RpoS-dependent promoter (Eggers et al., 2004, Yang et al., 
2005).  In response to a fresh bloodmeal, B. burgdorferi upregulates the alternative σ factor, 
which in turn initiates expression of many genes important for mammalian infection, including 
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ospC (Caimano et al., 2007).  Because RpoS controls the expression of multiple crucial virulence 
determinants, B. burgdorferi cannot afford to shut off rpoS in order to realize ospC 
downregulation during mammalian infection.  Instead, the pathogen is most likely to induce 
expression of an unknown repressor, which specifically interacts with the ospC operator and 
shuts the gene off without affecting expression of other RpoS-dependent genes in response to the 
development of specific humoral responses (Xu et al., 2007).  Once acquired by the tick vector, 
B. burgdorferi turns rpoS off, and consequently ospC and other RpoS-dependent genes (Caimano 
et al., 2007), regardless of whether the ospC operator-repressor system is involved. 
Either down- or up-regulation of RpoS is initiated in the tick vector (Caimano et al., 
2007), while the ospC operator-repressor system is needed only in the response to the specific 
humoral response during mammalian infection (Xu et al., 2007).  A series of seminal studies by 
Norgard and colleagues showed that rpoS expression is dependent on the response regulator 
protein, Rrp2, which along with RpoN regulates expression of RpoS (Hubner et al., 2001, Smith 
et al., 2007, Yang et al., 2003).  However, nothing is known about how the environmental cues 
are converted into regulatory events.  In our previous study, we noticed that the ospC regulatory 
element did not function well when it controlled ospA expression in an ospC knockout mutant, 
leading us to hypothesize that OspC may be involved in self-regulation.  The current study 
focused on this issue. 
Structurally, OspC is predominantly alpha-helical and forms a dimer in solution. The 
lipoprotein is made up of five alpha-helices, two beta sheets, six loops and a carboxy (C-) 
terminus and an amino (N)-terminus (Eicken et al., 2001, Kumaran et al., 2001). The amino-
terminus anchors the lipoprotein to the outer surface of the outer membrane of Borrelia by a 
lipidated cystein (Hayashi and Wu, 1990, Pugsley and Possot, 1993). Since the N-terminus is the 
only portion of the crystal structure of OspC that connects the rest of the lipoprotein to the outer 
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membrane, this region was chosen for a minor amino acid deletion mutation and then tested for 
resulting changes in ospC regulation. 
MATERIALS AND METHODS 
            Strains and Constructs Generated Previously and Used in This Study. The B. 
burgdorferi B31 clone 13A and the ospC mutant were generated previously (Xu et al., 2007). 
The shuttle vector pBBE22 was a gift from S. Norris (Purser et al., 2003). The features of the 
constructs and clones used in this study are summarized in Table 4.1 
Table 4.1. Constructs and clones used in the study. 
Construct or clone                                          Description                                                  Source 
pNCO1T                    homemade T/A cloning vector                                                            (Downie, et al., 2004) 
pNCO1T-ospC          pNCO1T carrying ospC gene driven by its native promoter                        This study 
pNCO1T-ospCnt5    pNCO1T carrying ospC gene expressing N-terminus 5-AA deletion          This study 
pBBE22                     pBSV2 carrying a bbe22 copy                                                               (Purser et al., 2003) 
pBBE22-ospCnt5     pBBE22 carrying ospC gene expressing N-terminus 5-AA deletion           This study 
13A                            B. burgdorferi B31 clone lacking plasmids  lp25 and lp56                       (Xu et al., 2007) 
ΔospC                        ospC mutant                                                                                               (Xu et al., 2007) 
ΔospC/FL/1               ospC mutant expressing ospC controlled by ospC regulatory elementsa   (Xu et al., 2007)  
ΔospC/FL/2               ospC mutant expressing ospC controlled by ospC regulatory elements    (Xu et al., 2007) 
ΔospC/Nt5/1              ospC mutant expressing N-terminus 5-AA deletion                                     This study             
ΔospC/Nt5/2              ospC mutant expression N-terminus 5-AA deletion                                     This study 
a.
 The ospC regulatory elements include both operator and promoter. 
 
            Generation of B. burgdorferi Producing OspC with N-terminus 5-AA Deletion. As 
illustrated in Figure 4.1A, to efficiently generate an N-terminus deletion, a 1057-bp fragment 
covering the ospC region and the up- and down-stream sequences was amplified on genomic 
DNA by PCR using primers P1F and P1R (Table 4.2) and cloned into the TA cloning vector 
pNCO1T (Downie et al., 2004), creating an intermediate vector designated pNCO1T-ospC. One 
linear and large amplicon was generated by inverse PCR using pNCO1T-ospC as a template and 
primers P2F and P2R (Table 4.2). After digestion with SapI and subsequent purification, the 
amplicon was circularized via ligation and then digested with BamH1 and XbaI to release 
ospCnt5. This fragment, encoding an OspC variant with N-terminal 5-AA deletion, was cloned 
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into the recombinant plasmid pBBE22 after the vector was digested with BamH1 and XbaI. The 
resulting construct was designated pBBE22-ospCnt5. The insert and its flanking regions within 
pBBE22 were sequenced to ensure the construct was as designed. 
The complementation plasmid was then electroporated into an ospC mutant (∆ospC), 
which was generated in our previous study (Xu et al., 2007); the seven resulting transformants 
were first screened for the presence of lp28-1, a plasmid essential for persistent infection in 
immunocompetent hosts (Grimm et al., 2004a, Xu et al., 2005). Two of the transformants that 
contained lp28-1 were further analyzed for the content of those plasmids that tend to be 
spontaneously lost during in vitro propagation, as described previously (Xu et al., 2005). The 
plasmid contents for both these clones were identical with the presence of lp28-2, lp28-4 and 
cp32-3. Efficient production of OspC protein by the clones was verified by immunoblots probed 
with a mixture of FlaB and OspC monoclonal antibodies (MAbs) (Figure 4.1B) as previously 
described (Xu et al., 2006). The clone 13A, which was generated in our previous study was 
included as a control (Xu et al., 2007).   
Indirect Immunofluorescene Assay (I-IFA): Indirect immunofluorescence was 
performed on unfixed and fixed spirochetes. Briefly, B. burgdorferi was grown to late log phase 
(10
8
 cells/ml) in BSK-H complete medium at 33 °C. For fluorescent labeling of unfixed 
spirochetes, 6x10
7
cells were harvested from 0.6 ml of ∆ospC/FL or ∆ospC/Nt5 mutant  
spirochetes by centrifugation at 8,000xg for 10 min, gently suspended in 100 μl PBS 
supplemented with 3.6 μl of mouse OspC or FlaB MAb preparation, and incubated for 1 hour at 
33 °C. After one wash with excess volume of PBS by centrifugation at 10,000xg for 10 min, 
spirochetes were resuspended in 100 μl of PBS containing 1 μg of fluorescein isothiocyanate 
(FITC)-conjugated goat anti-mouse IgG (Thermo Fisher Scientific, Rockford, IL), incubated for 
1 hour, washed once with PBS by centrifugation, resuspended in 30μl PBS, applied to 
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Figure 4.1. Generation of B. burgdorferi producing OspC with N-terminal 5-AA deletion.  
A. Construction of pBBE22-ospCNt5 coding for OspC with N-terminal 5-AA deletion.  The 
five codons coding for the five amino acid residues (residues 26—30) and their adjacent codons 
are presented.  The amplification starting sites and directions of four primers, P1F, P1R, P2F and 
P2R, used for plasmid construction are also marked.  The long bar represents the 1057-bp 
fragment, covering the entire ospC-coding region and down- (extending to +801 from the 
transcriptional start site) and up-stream sequences (extending to -256).  The detailed construction 
of the vector was described in Materials and Methods section. B. Restoration of OspC 
production. The parental clone 13A, ΔospC, and the clones ΔospC/FL, ΔospC/Nt5/1 and 
ΔospC/Nt5/2 were verified for OspC expression by immunoblot probed with a mixture of FlaB  
and OspC MAbs. 
 
 
Fig. 4.1A 
Fig. 4.1B 
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Table 4.2 Primers used in this study: 
_____________________________________________________________________________________________ 
Construct:       Primer name                Primer sequence (5’-3’)a          
______________________________________________________________________________ 
 
    FL                         P1F       5'-TAGTTGGCTATATTGGGATCCAA-3'   
                                  P1R      5'-TTCCTCTAGAGAAGAGCTTAAAGTTAA-3'    
                                     
   ΔNt5                       P2F       5'-GACTGCTCTTCAGACAATTCTGCTGATGAGTCT-3'                                   
                                  P2R       5'-CGTACGCTCTTCAGTCTTTCCCAGAATTATTACAAG-3’             
_____________________________________________________________________________________________ 
 a 
The underlined sequences are restriction enzyme sites. P1F contains a BamHI site; P1R has an XbaI site; P2F   
and P2R have a SapI site.  
 
microscopic slides, and analyzed using Axio Imager (Carl Zeiss Microimaging, Inc., Thornwood, 
NY).  
            For fluorescent labeling of fixed spirochetes, organisms were harvested from 0.6 ml 
culture by centrifugation, suspended in 50 µl of PBS, followed by addition of 700 µl acetone 
(Mallincrodt Baker, Phillipsburg, NJ), incubated at room temperature for 10 min, and then 
centrifuged at 10,000xg for 10 min. After being washed once with excess volume of PBS, fixed 
spirochetes were processed as described above for fluorescent labeling of unfixed bacteria.  
            Quantitation of ospC Gene Expression. C3H SCID mice (ages 4-6 weeks; provided by 
the Division of LSU Laboratory Animal Medicine) each were intradermally/subcutaneously 
inoculated with 10
4
 spirochetes. Animals were sacrificed one month post-inoculation; heart, 
joint, and skin specimens were harvested for RNA extraction. RNA was quantified for flaB and 
ospC mRNA copy numbers by reverse transcription qPCR (RT-qPCR) as described below. Data 
are presented as ospC transcripts per 1,000 flaB mRNA copies. 
            RNA Preparation. Frozen heart, joint, and skin samples were transferred in liquid 
nitrogen and ground thoroughly with a mortar and pestle. RNA was isolated with the use of 
Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA). Briefly, 1ml of Trizol was added to 
the sample when the mortar became wet. The solution containing the powder was gently mixed 
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and transferred to a microcentrifuge tube by pipetting, and the sample was incubated for 5 
minutes at room temperature. 0.2 ml of chloroform:isoamyl alchohol (24:1) was added to the 
tube and mixed vigorously and incubated again for 3 minutes. Samples were spun at 12400 rpm 
for 15 minutes at 4 °C.  The upper colorless aqueous phase was transferred to a fresh microfuge 
tube. 0.5 ml of Isopropanol was added, incubated at room temperature for 10 minutes and 
centrifuged for 10 minutes at 12400xg at 4 °C. The supernatant was removed by pipetting.  The 
RNA pellet was washed with 1 ml of fresh 75% cold Ethanol, vortexed and centrifuged at 10,000 
rpm for 5 minutes at 4 °C. Ethanol was removed as much as possible. Samples were stored at -20 
°C for a short period.  
            cDNA Preparation. The DNA-free RNA preparation was first annealed with reverse 
oligonucleotide mixture of flaB (5’-ATTCCAAGCTCTTCAGCTG-3’) and ospC (5’-
CAGCCATCAGTAACACCTTC-3’) genes at 65, 60, 55, 50, and 45 °C each for 1 min, in the 
presence of reverse transcription (RT) buffer (Invitrogen). Deoxynucleoside triphosphates and 
SuperScript II RNase H
-
 reverse transcriptase (Invitrogen) were added, RT was conducted at 42 
̊ C for 1 h, and then reaction mixture was inactivated at 70 °C for 15 min. 
            Quantitative RT-PCR (qRT-PCR).  qRT-PCR analyses were performed by using the 
ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA). The Platinum 
Taq DNA polymerase high fidelity kit was purchased from Invitrogen Life Technologies 
(Carlsbad, CA). The sequences of primers and internal probes were: for flaB (forward: 5’-
GAGTTTCTGGTAA GATTAATGCTC-3’; reverse: 5’-CATTTAAATTCCCTTCTGTTG 
TCTGA-3’; probe: 5’-AGAGGTTTGTCACAAGCTTCTAGAAATACTTCAAAGGC-3’) and 
for ospC (forward: 5’-TACGGATTCTAATGCGGTTTTAC-3’; reverse: 5’-GTGATTATT 
TTCGGTATCCA AACCA-3’; probe: 5’-TGAAGCGTTGCTGTCATCTATAGATGAAATTG 
CTGCT-3’). 
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            Passive Immunization of SCID Mice with Anti-OspC Monoclonal Antibody. C3HS 
SCID mice (ages 4-6 weeks; provided by the Division of LSU Laboratory Animal Medicine) 
each were given a single intradermal/subcutaneous injection of 10
5
 ∆ospC/FL or ∆ospC/Nt5 
spirochetes. At one month post-inoculation, OspC monoclonal antibody B5 (Mbow et al., 1999) 
or purified normal mouse IgG2a isotype (Sigma Aldrich) as a control was given at 100 µg. Three 
days later, mice were killed and heart, joint, skin (remote), and ear specimens were collected for 
bacterial culture.  
            Evaluation of Anti-Borrelia Specific Immune Response in Wild Type Mice. BALB/c 
mice (ages 4-8 weeks; provided by the Division of LSU Laboratory Animal Medicine) each 
received a single intradermal/subcutaneous injection of 10
5
 ∆ospC/FL or ∆ospC/Nt5 spirochetes 
and were euthanized at 1, 2, 3 and 4 weeks post inoculation. Tiobiotarsal joint, inoculation site 
and remote site skin, ear and heart specimens were harvested for spirochete isolation as 
described previously (Xu et al., 2005). Spirochetes were injected into the dermis of the chest, so 
the skin from the back was harvested as remote site. 
            Statistical Analysis. A one-way analysis of variance (ANOVA) was used to analyze 
data, followed by a two-tailed Student t test to calculate a P value for each two groups. P ≤ 0.05 
was considered to be significant. 
RESULTS 
            Generation of B. burgdorferi Producing OspC with N-terminal 5-AA Deletion.            
One construct, namely pBBE22-ospCnt5, was electroporated into the ospC mutant ΔospC, which 
was generated and characterized in our previous study (Xu et al., 2007).  pBBE22-ospCnt5 was 
constructed as illustrated in Figure 4.1A. Because ΔospC had lost lp25, the plasmid that carries 
the gene bbe22 coding for a nicotinamidase essential for survival of B. burgdorferi in the 
mammalian environment, the recombinant plasmid pBBE22, which harbors a copy of  bbe22, 
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was used as the shuttle vector (Purser et al., 2003).  Thirteen transformants were obtained; 
plasmid analyses led to selection of two clones, namely ΔospC/CNt5/1 and ΔospC/CNt5/2.  Both 
clones shared the same plasmid content as ΔospC, which had lost lp25, lp5, lp21, lp56 and cp9 
(Xu et al., 2007).  Expression of truncated OspC resulting from the introduced construct was 
confirmed by immunoblot analysis (Figure 4.1B).  
            The N-terminal Truncation Does Not Affect The Surface Location of OspC. The 
cellular location of borrelial lipoprotein is primarily determined by the first few residues 
following the signal peptide (Schulze and Zuckert, 2006).  To investigate whether removal of the 
N-terminal 5 residues affects the surface location of OspC, indirect immunofluorescence was 
performed using mOspC (Figure 4.2A).  Since flagellin is a periplasmic protein, FlaB MAb was 
used as an internal control (Figure 4.2B). Both ∆ospC/FL and ∆ospC/∆Nt5 spirochetes 
fluoresced after incubation with anti-OspC antibodies (Figure 4.2A), indicating that the 
truncation does not affect the cellular location of the lipoprotein. FlaB MAb could not bind its 
antigen in ∆ospC/FL unfixed spirochetes but resulted in strong fluorescence on all fixed bacteria 
(Figure 4.2B), indicating that our indirect immunofluoresence procedure did not expose internal 
antigens of unfixed spirochetes.  
            Deletion of The N-terminal 5-AA Sequence Severely Affects The Ability of B. 
burgdorferi to Downregulate ospC During Infection of SCID Mice.  Aimed at investigating 
whether deletion of N-terminal truncation affects ospC regulation, ospC mRNA accumulation 
was analyzed.  RNA samples were prepared from the heart, joint, and skin specimens of the 10 
infected mice used for the determination of spirochetal loads, and quantified for flaB and ospC 
expression by RT-qPCR. The results are shown in Figure 4.3.  
            There was no significant difference in the ospC mRNA accumulation between ΔospC/Nt5 
and ΔospC/FL spirochetes in the heart tissue (P =0.3145). In the joint tissue, ospC mRNA levels 
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were significantly higher in the ΔospC/Nt5 spirochetes when compared to ΔospC/FL spirochetes 
(P <.0001). In the skin, there was no significant difference in the levels of ospC mRNA when 
ΔospC/Nt5 spirochetes were compared to ΔospC/FL spirochetes (P = 0.1064). 
            The results indicate that, in the joint, operator of the spirochetes expressing truncated 
ospC was unable to repress ospC mRNA expression, when compared to wild type controls. 
Taken together, these data indicated that deletion of the N-terminal 5-AA sequence led to 
significant changes in ospC mRNA accumulation in the joints by B. burgdorferi during murine 
infection. 
            OspC Monoclonal Antibodies Clear Borrelia Expressing N-terminus 5-AA Deleted 
OspC. The ospC promoter is RpoS-dependent (Eggers et al., 2004, Yang et al., 2000, Yang et 
al., 2005).  Because RpoS is constitutively expressed during mammalian infection, the 
downregulation of ospC is realized through the interaction of the ospC operator with its specific,  
but as-yet unidentified, repressor (Xu et al., 2007).  If the coding region of OspC is involved in 
self-regulation, spirochetes containing a deletion of the N-terminus 5-AA sequence of OspC 
would be affected adversely by anti-OspC borreliacidal antibodies. 
            To examine whether specific anti-OspC antibodies in the absence of T and B cells are 
able to kill ∆ospC/Nt5 Borrelia for their inability to downregulate ospC, a passive immunization 
study was conducted (Table 4.3). C3H SCID mice were infected with ∆ospC/FL and ∆ospC/Nt5 
B. burgdorferi for one month, a time point at which Borrelia would still express OspC, and then 
passively immunized either mouse IgG2a as a control or OspC monoclonal antibody B5. This 
monoclonal antibody was shown to passively protect mice from a tick-transmitted challenge 
infection (Mbow et al., 1999). Previous studies have shown that B. burgdorferi persistently 
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Figure 4.2. The N-terminal 5-AA deletion does not affect the surface exposure of OspC.  The clones ΔospC/FL and ΔospC/Nt5 
were grown to late-log phase and analyzed by indirect immunofluorescence.  Each pair of images (top and bottom) was taken from the 
same field under differential interference contrast (DIC-top) and immunofluorescence (IFA-bottom) microscopy. (A) Unfixed 
ΔospC/FL and ΔospC/Nt5 spirochetes were probed with OspC MAb. (B) Unfixed and fixed ΔospC/FL spirochetes were probed with 
FlaB MAb. Images were obtained at x400 magnification. 
Fig. 4.2A Fig. 4.2B 
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Figure 4.3. Deletion of N-terminus 5-AA residues leads to significant changes in ospC 
mRNA accumulation in the joint tissues. RNA samples were prepared from heart, joint, and 
skin specimens and quantified for flaB and ospC expression by RT-qPCR.  The data are 
presented as ospC transcripts per 1,000 flaB mRNA copy numbers. *, P < 0.05 between FL and  
Nt5.             
expresses ospC during infection of immunodeficient mice (Liang et al., 2002a, Liang et al., 
2002b). However, the pathogen downregulates ospC expression when placed under immune 
selection pressure (Liang et al., 2002b). 
            Whereas both ∆ospC/FL and ∆ospC/Nt5 spirochetes were able to be recovered from all 
sites examined upon control IgG2a treatment, ∆ospC/FL spirochetes were able to be recovered 
from the skin (remote), joint, ear, and most of the heart tissues upon OspC MAb treatment. 
However, ∆ospC/Nt5 spirochetes were cleared from all sites examined, except for the joint 
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tissues, upon OspC MAb treatment. These results indicate that ∆ospC/Nt5 spirochetes are cleared 
due to the borreliacidal nature of the anti-ospC antibodies.  
            Anti-Borrelia Specific Immune Responses Clear ∆ospC/Nt5 Spirochetes in  
Immunocompetent Mice. B. burgdorferi abundantly expresses OspC during initial mammalian 
infection, when the antigen is required. Its continued presence, however, poses a threat to the 
pathogen since anti-ospC antibodies are borreliacidal (Fung et al., 1994, Liang et al., 2004b). To 
evade the specific immune response B. burgdorferi reduces ospC expression through the 
interaction of an as yet unidentified repressor to the ospC operator (Xu et al., 2007).  
            We used immunocompetent mice to investigate if the deletion of the N-terminus 5-AA of 
OspC affects the regulation of ospC expression under broader immune pressure. The results are 
shown in Table 4.4. Control ∆ospC/FL spirochetes were grown from the inoculation site (I.S.) 
and remote site (R.S.) skin, joint, and heart specimen but from none of the ear samples at first 
 
 
Table 4.3. Monoclonal antibodies clear spirochetes expressing N terminus 5-AA deleted 
OspC in SCID mice. 
a
 
 
No. of cultures positive/no. examined 
                                                                      1 month  
 
Clone               Antibody treatment               Skin    Joint      Heart    Ear                  All sites     
 
∆ospC/FL                  mAb     5/5 5/5 3/5 5/5  18/20             
 
                                  IgG2a   5/5 5/5 5/5 5/5  20/20   
 
∆ospC/Nt5                 mAb     0/6 6/6 0/6 0/6  6/24 
                  
                                  IgG2a   6/6 6/6 6/6 6/6  24/24 
 
a.
 Groups of 5 or 6 C3H SCID mice were inoculated with either ∆ospC/FL or ∆ospC/Nt5 at 
10
5
/100 µl. At one month post inoculation, OspC monoclonal antibody or purified normal mouse 
IgG2a as a control was given at 100 µg. Three days later, mice were killed and heart, joint, skin 
and ear specimens were collected for bacterial culture. 
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week; the ∆ospC/Nt5 bacteria were grown only from all of the skin inoculation sites and one of 
six joint samples at a week post-inoculation.  Whereas all sites became culture positive with 
control ∆ospC/FL spirochetes by 2 weeks after initial inoculation, the ∆ospC/Nt5 bacteria were 
cleared from all sites, except from one inoculation site skin. At 3 and 4 weeks post infection, the 
∆ospC/Nt5 spirochetes were cleared from all sites examined except inoculation site (I.S.) and 
joint tissues. These data demonstrate that ∆ospC/Nt5 spirochetes were initially (at 1 week post-
inoculation) unable to disseminate to remote tissues. Furthermore, upon development of specific 
humoral responses at 2 weeks post-inoculation, the ∆ospC/Nt5 spirochetes began to be cleared 
from all remote sites except the joint by 3 to 4 weeks, which might serve as an immune-
privileged site. This is an indirect indication that the ∆ospC/Nt5 spirochetes were unable to  
downregulate ospC in response to the development of specific anti-OspC borrelicidal antibodies  
in an immunocompetent environment.  
                                                                  DISCUSSION 
            B. burgdorferi upregulates the alternative sigma factor rpoS in response to a fresh blood 
meal, which in turn upregulates OspC, a lipoprotein required for initial mammalian infectivity 
(Caimano et al., 2007). The pathogen then selectively reduces the expression of this antibody-
targeted antigen in response to immune pressure through an unknown trans-acting repressor 
(Crother et al., 2003, Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004b, Xu et al., 
2007). Constitutive expression of OspC leads to clearance of infection, if not survival of 
spirochetes expressing OspC escape mutants (Xu et al., 2006). Interestingly, when ospC 
regulatory elements were placed upstream of OspA coding region in an ospC mutant 
background, OspA was unable to be downregulated under immune pressure (data not shown). 
This led us to investigate whether OspC is involved in self-regulation.
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Table 4.4. Spirochetes expressing the N-terminus 5-AA deleted OspC are unable to evade specific immune response in wild 
type mice.
a
 
 
 
  Clone        No. of specimens positive/no. of specimens examined at post-inoculation week 
 
                                       1                                              2                                                 3                                               4 
 
                      I.S.  R.S.  Ear  Heart  Joint         I.S.  R.S.  Ear  Heart  Joint            I.S.  R.S.  Ear  Heart  Joint          I.S.  R.S.  Ear  Heart  Joint 
 
∆ospC/FL     6/6   6/6   0/6    6/6    6/6         6/6   6/6   6/6   6/6   6/6              ND  ND   ND  ND  ND           ND  ND   ND   ND   ND   
 
∆ospC/Nt5     6/6  0/6   ND   0/6    1/6          1/6   0/6   0/6   0/6   0/6              2/6   0/6   0/6   0/6   6/6           6/6   0/6   0/6   0/6   6/6     
 
a.
 Groups of 12 to 24 BALB/c Wt mice each received a single intradermal/subcutaneous injection of 10
5
 organisms of the clone 
∆ospC/FL and ∆ospC/Nt5. Six animals from each group were euthanized at 1, 2, 3 and 4 wk post-inoculation; inoculation site (I.S.) 
and remote site (R.S) skin, ear, heart, and joint specimens were harvested for spirochete isolation. The I.S. site was at the chest; 
therefore the R.S. site was at the back of the mice. b. ND, not determined. 
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            Structurally, OspC is a predominantly alpha-helical lipoprotein; in its dimer 
conformation, the C- and N-terminus of OspC come close together and while the C-terminus of 
OspC is exposed to the outer environment, the N-terminus anchors the lipoprotein to the outer 
membrane of B. burgdorferi by a lipidated cystein (Eicken et al., 2001, Kumaran et al., 2001). 
This study addressed the role of the N-terminus of OspC in ospC mRNA regulation when a small 
5-AA region of OspC downstream of the lipidated cystein was deleted. Deletion of N-terminal 5-
AA did not affect the surface exposure of OspC as observed by indirect immunofluorescence 
assay. Sorting of major lipoproteins in the E.coli Lol pathway is based on properties of the amino 
acid following the N-terminal, acylated cystein, i.e., the so-called ‘+2’ rule (Yamaguchi et al., 
1988). Although Borrelia spirochetes have Lol homologues (Masuda et al., 2002), sorting signal 
in these pathogens are different from those found in other diderm bacteria. Hence, the ‘+2’ rule 
established for E.coli inner membrane (IM) and outer membrane (OM) lipoproteins does not 
apply to borrelial lipoproteins. It also known that for the outer surface lipoprotein OspA, the first 
five aminoacids from the N-terminus cystein are required for surface localization (Schulze and 
Zuckert, 2006). In this study, the 5-AA deletion was made seven amino acids downstream of the  
lipidated cystein, allowing for the translocation of the lipoprotein to the outer surface of the outer 
membrane of B. burgdorferi. 
            The infectivity and innate immunity evasive roles of OspC were preserved in spite of the 
N-terminal 5-AA deletion as reflected in the 50% infectious dose values at one month post-
infection in SCID mice.  Measurements of spirochete burdens showed that the deletion did not 
reduce the spirochete burden in joint or skin, but did reduce in the heart, compared to control 
spirochetes. A recent study has shown that OspC-deficient spirochetes over expressing 
heterologous lipoproteins generated significantly lower bacterial loads when compared to 
controls, indicating that OspC is required for the colonization of the heart (Xu et al., 2008b). In 
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addition, OspC may serve as an adhesion molecule and was shown to colonize the heart in high 
frequency (Antonara et al., 2007).  Nevertheless, the deletion did not decrease spirochete burden 
in the skin and, on the contrary, recorded an increase in the joint tissue when compared to FL 
control spirochetes. The phenotype that resulted from these initial studies (explained in detail in 
Chapter 3) allowed us to use this strain to further investigate the effect of such deletion on the 
regulation of ospC.  
            Studies have shown that in the absence of adaptive immune pressure, the tissue 
microenvironment influences the spirochetal mRNA expression. In the joint, ospC is usually 
expressed at low levels (Liang et al., 2004b). Our data related to upregulation of ospC expression 
in the joints in 5-AA deleted spirochetes is consistent with previous studies that also showed an 
upregulation of ospC mRNA in spirochetes lacking the ospC operator region comprising the two 
inverted repeats (Xu et al., 2007) indicating that both the ospC operator and the coding region of 
OspC may be involved in the repression of ospC mRNA by spirochetes in this tissue and 
therefore, that OspC may be involved in self-regulation.  
            Wild type B. burgdorferi downregulates OspC under immune pressure (Liang et al., 
2004b). In this study, the specific monoclonal OspC antibody treatment was probably unable to 
downregulate OspC, hence leading to clearance of the bacteria from all the sites tested, except 
joint. These results are in agreement with previous data that shows monoclonal antibody 
treatment led to clearance of spirochetes expressing OspC lacking the operator region from the 
sites tested, including joint tissue, whereas ear was not tested in their study (Xu et al., 2007). In 
wild type mice, the data indicate that spirochetes expressing N-terminus 5-AA deleted ospC were 
cleared from most sites except the inoculation site and the joint tissues. It could be that the 
deletion led to an initial dissemination defect (in the first week, as also shown in Chapter 3) that 
could be a confounding factor to the study of self-regulation of OspC. OspC has been shown to 
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be a dissemination-facilitating factor of B. burgdorferi (Xu et al., 2008b). In addition, the fact 
that the spirochetes could not be cleared from the joint tissues either under monoclonal antibody 
treatment or under an anti-Borrelia immunocompetent environment denotes that the joint is an 
immune-privileged site and that although ospC levels are high this tissue, it is able to harbor the 
spirochetes and avoid host adaptive immune pressure. The persistent finding of spirochetes at the 
site of inoculation may signify a high density of spirochetes in this particular location, and thus 
the inability of OspC monoclonal antibodies to clear the spirochetes from this area. On the other 
hand, it may signify a dissemination defect due to the N-terminus sequence deletion. 
           Researchers have shown previously that the majority of IgM and IgG OspC antibodies 
produced after infection with B. burgdorferi were complement-dependent borreliacidal 
antibodies that killed the spirochetes without the necessity of scavenging by phagocytic cells 
(Callister et al., 1996, Jobe et al., 2003, Rousselle et al., 1998). The OspC MAb B5 is located at 
the C-terminus of OspC and has a conformational-dependent epitope (Gilmore and Mbow, 1999, 
Mbow et al., 1999). Therefore, since overall fold of OspC monomer brings the adjacent location 
of the N- and C-terminal residues in the membrane proximal region of OspC, this explains how 
the N-termini can be recognized by this B5 OspC monoclonal antibody (Eicken et al., 2001).  
            The current study highlighted the involvement of the coding sequence of OspC in the 
regulation of the gene. The fact that a gene expressing the coding region of a heterologous 
lipoprotein (OspA) was unable to be regulated by the ospC operator led us to analyze the coding 
region of OspC itself for self-regulation. This study showed that there was a clear defect in the 
regulation of OspC when a segment of the N-terminus of OspC was deleted. This may be a 
partial defect, since some tissues still harbored the variant spirochetes. The mechanistic details of 
the self-regulation of OspC are also yet to be deciphered.  A long-term study may allow us to 
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make stronger conclusions. Further studies with deletion of more amino acids from the N-
terminus of OspC or studies of ospC expression levels in double knock-out spirochetes in which  
both the ospC operator and the N-terminus 5-AA sequence are deleted can provide additional  
insights into the regulation of this lipoprotein that is crucial in the enzootic life cycle of B. 
burgdorferi. 
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CHAPTER 5 
 
THE C-TERMINAL 9-AA STRETCH OF OSPC IS NOT IMPORTANT 
FOR VIRULENCE OF BORRELIA BURGDORFERI BUT FOR 
BALANCING OSPC EXPRESSION DURING MURINE INFECTION 
 
INTRODUCTION 
The Lyme disease spirochete, Borrelia burgdorferi, is one of the most invasive bacterial 
pathogens, causing persistent infection despite the development of vigorous immune responses 
(Schwan et al., 1995, Seiler and Weis, 1996, Steere, 2001).  Both timely up- and down-
regulations of the outer surface protein C (OspC) are crucial for its pathogenic strategy.  In unfed 
ticks, B. burgdorferi does not express OspC (Ohnishi et al., 2001, Schwan et al., 1995); a fresh 
blood meal upregulates OspC and prepares the pathogen for infection of a mammal (Grimm et 
al., 2004, Pal et al., 2004, Stewart et al., 2006).  B. burgdorferi abundantly expresses OspC 
during early infection when the antigen is required (Liang et al., 2004, Tilly et al., 2006) and its 
expression ultimately induces a robust humoral response that imposes tremendous pressure on 
the pathogen (Fung et al., 1994, Liang et al., 2004).  If B. burgdorferi fails to repress OspC 
expression or undergo escape mutations, infection is cleared (Xu et al., 2007, Xu et al., 2006).  
Although mutation is an effective way to evade the immune system, it may cause the functional 
loss of affected genes.  B. burgdorferi with lost OspC function may eventually persist during 
chronic infection (Tilly et al., 2006); however, it would lose the ability to initiate an infection 
(Stewart et al., 2006), leading to discontinuation of the enzootic cycle.  B. burgdorferi is able to 
down-regulate OspC, thus allowing the pathogen to effectively evade specific humoral immunity 
and preserve the integrity of the ospC gene for subsequent need during its life cycle (Liang et al., 
2002a, Liang et al., 2004). 
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            In terms of regulation, ospC is probably has been the most investigated among all 
borrelial genes.  Its expression is driven by an RpoS-dependent promoter (Eggers et al., 2004, 
Gilbert et al., 2007, Yang et al., 2005).  The alternative δ factor, RpoS, not only positively 
regulates several other important borrelial genes, such as decorin-binding protein A (dbpA) and 
ospF (Eggers et al., 2004, Fisher et al., 2005, Hubner et al., 2001), but may also indirectly 
repress other lipoprotein genes, including ospA and lp6.6 (Caimano et al., 2005, Caimano et al., 
2007), making it unfeasible for B. burgdorferi to turn off rpoS to achieve ospC down-regulation.  
To selectively repress ospC in response to specific immune pressure during mammalian 
infection, B. burgdorferi may express a repressor to interact with the newly identified operator, a 
large palindromic sequence consisting mainly of two 20 bp inverted repeats located immediately 
upstream of the ospC promoter (Xu et al., 2007).  
The ospC gene, like other microbial lipoprotein genes, encodes a leader peptide of 18-AA 
residues, which is cleaved off during post-translational modification, and protein portion (Figure 
5.1A).  The mature OspC, a largely α-helical protein, may be a dimer with a characteristic central 
four-helical bundle formed by the association of the two longest helices from each subunit 
(Eicken et al., 2001, Kumaran et al., 2001).  Neither the N-terminal 23-AA linker nor the C-
terminal 14-AA stretch contributes to the core three-dimensional structure of OspC; instead, the 
α-helices 1 and 5 bring the two terminal regions in close proximity, where the lipoprotein is 
anchored to the bacterial outer membrane through lipidation of the first cystein residue of the N-
terminal linker (Figure 5.1B).  Compared to the N-terminal linker, the C-terminal stretch is 
highly conserved among borrelial isolates (Figure 5.1C) and highly immunogenic (Mathiesen et 
al., 1998).  
            One essential role of the N-terminal linker is to position the lipoprotein on the bacterial 
outer membrane, with the essential role of the C-terminal stretch remaining elusive in its 
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Figure 5.1. The tertiary structure and possible cellular location of OspC. A. Fragmentation 
of the secondary structure of OspC (Eicken et al., 2001, Kumaran et al., 2001). The ospC gene 
of B. burgdorferi B31 codes for a total of 210 amino acids.  The first 18-AA sequence is a leader 
peptide (LP) that is cleaved off before a mature OspC molecule is translocated to the spirochete 
outer surface, followed by the N-terminal linker (NTL) that includes the residues 19 – 41.  The 
residues 42 – 73, 94 – 112, 121 – 145, 152-159, and 170 – 196 form the α-helices 1, 2, 3, 4, and 
5, respectively; 78 – 82 and 85 – 89 make up the β-strands 1 and 2, respectively.  The residues 
197 – 210 form the C-terminal stretch (CTS). B. The tertiary structure and possible cellular 
location of OspC.  B. burgdorferi possesses inner and outer membranes that are separated by a 
periplasmic space.  As a surface lipoprotein, OspC is anchored to the outer membrane through 
lipidation of the cystein residue 19.  Neither the N-terminal 23-AA linker nor the C-terminal 14-
AA stretch contributes to the OspC core structure, which consists mainly of five α-helices.  The 
helices 1 and 5 bring the two terminal sequences in close proximity, where the NTL anchors the 
protein to the bacterial outer membrane, thus positioning the CTS to the membrane. C. Sequence 
comparison of the C-terminal 14-AA stretch among borrelial isolates.  The sequences (top) 
are from the three most investigated B. burgdorferi sensu stricto strains, followed by 15 
sequences randomly selected from B. burgdorferi sensu stricto, Borrelia garinii, and Borrelia 
afzelii isolates.  The highlighted letters indicate amino acid substitutions. 
 
contribution to the overall function of OspC.  In this study, B. burgdorferi expressing OspC with 
different C-terminal truncations was generated and investigated for infectivity, tissue 
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colonization, pathogenicity, and gene expression in a murine model.  The study allowed us to 
conclude that the C-terminal stretch of OspC is not required for virulence of B. burgdorferi, but 
may be involved in a yet unidentified event that either directly or indirectly regulates ospC 
expression in the murine host. Interestingly, the N-terminal linker was also shown to be involved 
in the regulation of ospC expression (Chapter 4). 
MATERIALS AND METHODS 
Generation of B. burgdorferi Expressing OspC with Different C-terminal Deletions.  
As illustrated in Figure 5.2A, to efficiently generate constructs containing various versions of C-
terminal deletions, a 1057-bp fragment covering the ospC-coding region and up- and down-
stream sequences was amplified by PCR using the primers P1F and P1R (Table 5.1) and cloned 
into the TA cloning vector pNCO1T (Shi et al., 2006), creating an intermediate vector, 
designated pNCO1T-ospC.  Three large amplicons, namely, ct6, ct9 and ct13, were generated by 
PCR using pNCO1T-ospC as a template and one common forward primer, P2F, and each of the 
three reverse primers, P2R, P3R, and P4R (Table 5.1).  After digestion with AflII and subsequent 
purification, the amplicons were circularized via ligation and then digested with BamHI and XbaI 
to release ospCct6, ospCct9, and ospCct13.  These three fragments, encoding an OspC variant 
with the C-terminal 6-, 9- or 13-AA deletion, were cloned into the recombinant plasmid pBBE22 
(a gift from S. Norris) after the vector was digested with BamHI and XbaI.  Resulting 
complementation plasmids were designated pBBE22-ospCct6, pBBE22-ospCct9 and pBBE22-
ospCct13, respectively.  The inserts and their flanking regions within pBBE22 were sequenced to 
ensure the constructs were as designed.   
            Complementation plasmids were electroporated into an ospC mutant, namely, ospCΔ, 
which was generated in our previous study (Xu et al., 2007); resulting transformants were 
screened as described previously (Xu et al., 2005).  Identified transformants were first surveyed 
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for the presence of lp28-1, a plasmid essential for infection of immunocompetent hosts 
(Labandeira-Rey et al., 2003, Purser and Norris, 2000).  Only clones containing lp28-1 were 
further analyzed for plasmid content as described previously (Xu et al., 2005).  Restoration of 
OspC expression was verified using immunoblots probed with a mixture of FlaB and OspC 
monoclonal antibodies (MAbs), or of the FlaB MAb and mouse anti-OspC sera (Figure 5.2B), as 
described previously (Xu et al., 2006).  The clone ospCΔ/FL/1, which was generated in our 
previous study (Xu et al., 2007) and expressed wild-type OspC, was included as a control.  
Table 5.1. Primers used in the study 
Primer                                             Sequences (5’ to 3’) a                                                                   
 
P1F                          TTGGGATCCAAAATCTAATACAAGT 
P1R                          TTCCTCTAGAGAAGAGCTTAAAGTTAA  
P2F                          GCGCTTAAGATCAAATTAATATTATAAGA 
P2R                              ATCTTAAGCCACAACAGGGC 
P3R                              AGCTTAAGGGCTTGTAAGCTCTTTAAC 
P4R                              ACATCTTAAGTTACTCTTTAACTGAATTAGCA 
 
a
 The underlined sequences are the restriction enzyme site BamHI (P1F),  XbaI (P1R), or AflII 
(P2F, P2R, P3R, and P4R).  
 
            Infection Study in SCID Mice.  SCID mice on a C3H background, ages 4 – 8 weeks, 
(provided by the Division of Laboratory Animal Medicine at Louisiana State University, Baton 
Rouge, LA) were given one single intradermal/subcutaneous injection of 10
4
 spirochetes.  
Animals were examined for the development of arthritis at 2-day intervals, starting at day 7, and 
sacrificed one month post-inoculation.  Joint, heart, and skin specimens were collected for 
spirochete isolation and histopathological examination as described previously (Xu et al., 2005).  
The harvested samples were also used for DNA and RNA preparation as described below. 
            Determination of ID50 Values.  Spirochetes were grown to late-log phase (10
8
 cells/ml) 
at 33
o
C and 10-fold serially diluted with Barbour-Stoenner-Kelly H (BSK-H) complete medium 
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Figure 5.2. Generation of B. burgdorferi expressing OspC with C-terminal deletions.  
A. Construction of complementation plasmids coding for OspC with C-terminal 
truncations.  The last 15 codons, including the stop one (marked with an asterisk), and their 
encoded 14-AA sequence of OspC are presented (on top).  The amplification starting sites and 
directions of four primers, P2F, P2R, P3R, and P4R, used for plasmid construction are also 
marked.  The long bar represents the 1057-bp fragment, covering the entire ospC-coding region 
and down- (extending to +801 from the transcriptional start site) and up-stream sequences 
(extending to -256). B. Restoration of OspC expression. The parental clone 13A, ospCΔ, and 
the ospCΔ/FL, ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, 
ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2 spirochetes were verified for OspC expression by 
immunoblots probed with a mixture of FlaB and OspC MAbs (top panel), or of the FlaB MAb 
and mouse antisera raised against recombinant OspC (bottom panel). 
 
 
 (Sigma Chemical Co., St. Louis, MO).  C3H SCID mice or BALB/c mice, ages 4 to 6 weeks, 
(provided by the Division of Laboratory Animal Medicine at Louisiana State University, Baton 
Rouge, LA) each received one single intradermal/subcutaneous injection of 100 l of spirochetal 
Fig.5.2A 
Fig.5.2B 
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suspension.  SCID mice, but not wild-type, were examined for the development of arthritis as 
described above.  Mice were euthanized one month post-inoculation; heart, tibiotarsal joint, and 
skin (not from inoculation site) specimens were harvested for bacterial culture as described 
above (Xu et al., 2005).  The ID50 value was calculated as described by Reed and Muench (Reed 
and Muench, 1938).  SCID mouse specimens were also used for DNA and RNA preparation as 
described below.  
Quantification of Tissue Spirochetal Load and ospC Gene Expression Level.  DNA 
was extracted for heart, joint, and skin specimens of infected SCID mice and quantified for the 
copy numbers of flaB and murine actin genes by quantitative PCR (qPCR) as described 
previously (Xu et al., 2005).  The tissue spirochete burden was expressed as flaB DNA copies 
per 10
6
 host cells (2  106 actin DNA copies).  RNA was prepared from heart, joint, and skin 
tissues, then quantified for the mRNA copy numbers of flaB and ospC by reverse transcription 
qPCR (RT-qPCR) as described previously (Xu et al., 2006).  The data are presented as ospC 
transcripts per 1,000 flaB mRNA copy numbers. 
Statistical Analysis.  A two-tailed Student t test was used to compare each two groups 
and calculate P values.  A P value ≤ 0.05 was considered to be significant. 
RESULTS 
Generation of B. burgdorferi Expressing OspC with Different C-terminal 
Truncations.  Three trans-complementation plasmids, pBBE22-ospCct6, pBBE22-ospCct9 and 
pBBE22-ospCct13, were constructed as diagrammed in Figure 5.2A.  These constructs encoded 
OspC with C-terminal 6-, 9- or 13-AA deletion, respectively.  Because the ospC mutant, ospCΔ, 
had lost lp25, the plasmid that carries the gene bbe22 coding for a nicotinamidase essential for 
survival of B. burgdorferi in the mammalian environment, all the complementation plasmids 
were derived from the recombinant plasmid pBBE22, which harbors a copy of  bbe22 (Purser et 
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al., 2003).  Between six and fourteen transformants were obtained from transformation of the 
mutant ospCΔ with each construct.  Plasmid analyses identified two clones receiving each 
complementation plasmid, namely, ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, 
ospCΔ/ospCct9/2, ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2.  These clones shared the same 
plasmid content as the mutant ospCΔ (Xu et al., 2007): they all lost cp9, lp5, lp21, lp25 and lp56.   
Restoration of OspC expression was confirmed by immunoblot analysis (Figure 5.2B), in 
which the clone ospCΔ/FL/1 was included as a control.  This clone was generated from 
transformation of the mutant ospCΔ with a complementation plasmid, pBBE22-FL, which was 
constructed by cloning a 1057-bp fragment covering the ospC-coding region and up- and down- 
stream sequences into pBBE22, as described in our previous study (Xu et al., 2007).  Similar to 
the parental clone 13A, the ospCΔ/FL/1 spirochetes expressed full-length OspC (Figure 5.2B).  
In contrast, the ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, 
ospCΔ/ospCct13/1, and ospCΔ/ospCct13/2 bacteria expressed shorter versions of OspC 
respective to their C-terminal deletions.  The truncated OspC expressed by the clones 
ospCΔ/ospCct13/1 and ospCΔ/ospCct13/2 was no longer recognized by OspC MAb (Figure 
5.2B, top panel) but reacted well with antisera raised against recombinant OspC (Figure 5.2B, 
bottom panel).   
Deletion of the C-terminal 6- but Not 9-AA Sequence Abrogates Arthritis Virulence 
in SCID Mice.  Groups of three C3H SCID mice were inoculated with the clone 
ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, 
or ospCΔ/ospCct6/2.  Additionally, six animals received the clone ospCΔ/FL/1 as a control, 
which had been extensively examined for infectivity and ospC expression in our previous study 
(Xu et al., 2007).  In these six mice, joint swelling evolved 10 to12 days post-inoculation and 
developed into severe arthritis within a week (Figure 5.3A).  In the six mice that received either 
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clone ospCΔ/ospCct9/1 or ospCΔ/ospCct9/2, joint swelling developed following the same course 
as described above, indicating that deletion of the C-terminal 9-AA stretch does not reduce 
infectivity and arthritis virulence in immunodeficient mice.  However, none of the 12 animals 
inoculated with the ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct6/1, or 
ospCΔ/ospCct6/2 bacteria showed joint swelling during the course of 1 month, indicating that 
truncation of either the C-terminal 6- or 13-AA sequence completely diminished arthritis 
virulence, and probably infectivity as well.  Histopathological examination confirmed that 
intensive inflammatory responses appeared in and around the joint space of mice receiving the 
ospCΔ/FL/1, ospCΔ/ospCct9/1 or ospCΔ/ospCct9/2 spirochetes but not in those inoculated with 
the clone ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2 (Figure 
5.3B).   
To rule out the possibility that the loss of infectivity disabled the four clones from 
inducing arthritis, the heart, joint, and skin samples were cultured for spirochetes.  Similar to the 
clones ospCΔ/FL/1, ospCΔ/ospCct9/1, and ospCΔ/ospCct9/2, ospCΔ/ospCct6/1 and 
ospCΔ/ospCct6/2 bacteria were recovered from each specimen of all 12 inoculated mice (Table 
5.2), indicating that deletion of the C-terminal 6-AA stretch does not abrogate infectivity.  
Neither ospCΔ/ospCct13/1 nor ospCΔ/ospCct13/2 spirochetes could be grown from any of the 
six inoculated mice, indicating that deletion of the C-terminal 13-AA sequence abrogates the  
infectivity of B. burgdorferi. The loss of infectivity in this clone occurs as early as 24h post-
inoculation as shown in Chapter 2. 
            Deletion of the C-terminal 6- or 9-AA Sequence Does Not Lead to an Increase in 
The ID50  Values in SCID or Immunocompetent Mice.  Groups of two or three C3H SCID 
mice each received one single inoculation of 10
1
 to 10
4
 spirochetes of the clone ospCΔ/FL/1, 
ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2.  Animals were 
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Figure 5.3. Deletion of the C-terminal 6- but not 9-AA sequence diminishes arthritis 
virulence in SCID mice. A. SCID mice were inoculated with the ospCΔ/FL/1, 
ospCΔ/ospCct13/1, ospCΔ/ospCct9/1 or ospCΔ/ospCct6/1 spirochetes, and sacrificed one 
month later.  Severe joint swelling was noted only in mice challenged with ospCΔ/FL or 
ospCΔ/ospCct9/1, but not with ospCΔ/ospCct13/1or ospCΔ/ospCct6/1. B. Intensive 
inflammatory responses (pointed with black arrows) were noted in and around the joint 
space of mice inoculated with ospCΔ/FL or ospCΔ/ospCct9/1, but not with 
ospCΔ/ospCct13/1or ospCΔ/ospCct6/1.  Tissue sections were stained with hematoxylin and 
eosin.  js: joint space; sm: synovial membrane; tb: tibial bone; tr: tarsal bone.   
 
euthanized one month later; heart, joint and skin specimens were cultured for spirochetes for 
ID50 determination.  The ID50 values were 18 and 32 organisms for the clone ospCΔ/FL/1 (in two 
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Table 5.2. Deletion of the C-terminal 13- but not 6- or 9-AA sequence abrogates infectivity 
in SCID mice
a
 
                                          No. of cultures positive/total            No. of mice infected/total no. 
                                            no of specimens examined                       of mice inoculated       
 Inoculum                        Heart     Joint    Skin   All sites 
 
ospCΔ/FL/1                       6/6         6/6      6/6      18/18                              6/6 
 
ospCΔ/ospCct13/1             0/3         0/3      0/3       0/9                                 0/3 
ospCΔ/ospCct13/2             0/3         0/3      0/3       0/9                                 0/3 
 
ospCΔ/ospCct9/1               3/3         3/3      3/3       9/9                                 3/3 
ospCΔ/ospCct9/2               3/3         3/3      3/3       9/9                                 3/3 
 
ospCΔ/ospCct6/1               3/3         3/3      3/3       9/9                                 3/3 
ospCΔ/ospCct6/2               3/3         3/3      3/3       9/9                                 3/3 
 
a
 Groups of three or six C3H SCID mice were inoculated with the clone ospCΔ/FL/1, 
ospCΔ/ospCct13/1, ospCΔ/ospCct13/2, ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, 
or ospCΔ/ospCct6/2, and sacrificed one month later.  Heart, tibiotarsal joint, and skin specimens 
were harvested and cultured for spirochetes in BSK-H complete medium. 
 
 
separate experiments), 56 and 178 for the clones ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2, and 32 
and 32 for the clones ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2, respectively (Table 5.3).   
The ID50 values were also determined in immunocompetent mice.  The values were 32 
and 32 organisms for the clone ospCΔ/FL/1 (in two separate experiments), 32 and 56 for the 
clones ospCΔ/ospCct6/1 and ospCΔ/ospCct6/2, and 316 and 56 for the clones ospCΔ/ospCct9/1 
and ospCΔ/ospCct9/2, respectively (Table 5.4).  Taken together, the study indicated that either 
C-terminal deletion leads to a decrease in infectivity in both immunodeficient and 
immunocompetent mice. 
            Deletion of The C-terminal 9-AA Sequence Does Not Affect Tissue Colonization in 
Heart or Joint Tissue but Increases Colonization in The Skin of SCID Mice.  The spirochetal 
burden was analyzed to further assess whether truncations affected tissue colonization.  Heart, 
joint and skin specimens were harvested from SCID mice that were infected with ospCΔ/FL/1, 
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Table 5.3. Deletion of neither C-terminal 6- nor 9-AA sequence significantly affects the ID50  
value in SCID mice
a 
                                     No. of cultures positive/total       No. of mice infected/total          ID50 
 Inoculum &                  no. of specimens examined           no. of mice inoculated             (No. of  
  dose                          Heart    Joint    Skin   All sites                                                      organisms) 
ospCΔ/FL/1                                                                                                                            18                   
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   1/3 1/3 1/3 3/9   1/3 
ospCΔ/FL/2                                                                                                                            32                   
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
 
ospCΔ/ospCct6/1                                                                                                                   56 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    2/3 1/3 2/3 5/9   2/3 
     10
1   
0/3 0/3 0/3 0/9   0/3 
ospCΔ/ospCct6/2                                                                                                                  178 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    1/3 0/3 1/3 2/9   1/3 
     10
1
   0/3 0/3 0/3 0/9   0/3 
 
ospCΔ/ospCct9/1                                                                                                                   32 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
ospCΔ/ospCct9/2                                                                                                                   32 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
 
a
 The ospCΔ/FL/1, ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2 
spirochetes were grown to late-log phase (10
8
 cells/ml) and 10-fold serially diluted with BSK-H 
medium.  Approximately 100 µl of bacterial suspension with cell densities at 10
2
 – 105 ml-1 was 
intradermally/subcutaneously inoculated into each C3H SCID mouse.  Animals were sacrificed 
one month later; heart, tibiotarsal joint, and skin specimens were harvested for bacterial isolation.  
The ID50 values were calculated by the method of Reed and Muench. 
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Table 5.4. Deletion of neither C-terminal 6- nor 9-AA sequence significantly affects the ID50  
value in immunocompetent mice
a 
                                     No. of cultures positive/total       No. of mice infected/total          ID50 
 Inoculum &                  no. of specimens examined           no. of mice inoculated             (No. of  
  dose                          Heart    Joint    Skin   All sites                                                      organisms) 
ospCΔ/FL/1                                                                                                                           32                 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
  2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
ospCΔ/FL/2                                                                                                                           32                 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
 
ospCΔ/ospCct6/1                                                                                                                   32 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    3/3 3/3 3/3 9/9   3/3 
     10
1   
0/3 0/3 0/3 0/9   0/3 
ospCΔ/ospCct6/2                                                                                                                   56 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    2/3 2/3 2/3 6/9   2/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
 
ospCΔ/ospCct9/1                                                                                                                  316 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    0/3 0/3 0/3 0/9   0/3 
     10
1 
   0/3 0/3 0/3 0/9                               0/3 
ospCΔ/ospCct9/2                                                                                                                   56 
     10
4
    2/2 2/2 2/2 6/6   2/2 
     10
3 
   2/2 2/2 2/2 6/6   2/2 
     10
2
    1/3 2/3 2/3 5/9   2/3 
     10
1 
   0/3 0/3 0/3 0/9   0/3 
 
a
 The ospCΔ/FL/1, ospCΔ/ospCct6/1, ospCΔ/ospCct6/2, ospCΔ/ospCct9/1 and ospCΔ/ospCct9/2 
spirochetes were grown to late-log phase (10
8
 cells/ml) and 10-fold serially diluted with BSK-H 
medium.  Approximately 100 µl of bacterial suspension with cell densities at 10
2
 - 10
5
 ml
-1
 was 
intradermally/subcutaneously inoculated into each BALB/c mouse.  Animals were sacrificed one 
month later; heart, tibiotarsal joint, and skin specimens were harvested for bacterial isolation.  
The ID50 values were calculated by the method of Reed and Muench. 
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ospCΔ/ospCct9/1, ospCΔ/ospCct9/2, ospCΔ/ospCct6/1, or ospCΔ/ospCct6/2.  A total of 30 mice, 
which had been used for Table 5.2 or 5.3, were used, including 10 mice infected with the 
ospCΔ/FL/1, 10 mice with either clone ospCΔ/ospCct6/1 (n = 5) or ospCΔ/ospCct6/2 (n = 5), 
and 10 mice with clone ospCΔ/ospCct9/1 (n =5) or ospCΔ/ospCct9/2 (n = 5).  DNA samples 
were extracted and quantified for tissue spirochete loads.  The ospCΔ/FL/1 and ospCΔ/ospCct9 
spirochetes generated similar bacterial loads in the heart (P = 0.26) and joint tissues (P = 0.57) 
(Figure 5.4A). In contrast, the ospCΔ/ospCct6 load was 3.6-, and 1.8-fold lower than that of the 
ospCΔ/FL/1 spirochetes in the heart (P = 1.8 × 10-7) and joint tissues (P = 4.8 × 10-4), 
respectively, but both bacteria generated similar burdens in skin (P = 0.14).  The ospCΔ/ospCct6 
load was also 3.0-, and 2.1-fold lower than that of the ospCΔ/ospCct9 bacteria in the heart (P = 
6.0 × 10
-4
) and joint tissues (P < 0.03), respectively, but they registered similar burdens in skin 
(P = 0.17).  Interestingly, deletion of the C-terminal 9-AA sequence led to a two-fold increase in  
the bacterial load in the skin over the control (P < 0.05). Taken together, deletion of the C-
terminal 9-AA stretch did not affect tissue colonization in either heart or joint but led to a 
significant increase in the bacterial load in the skin of SCID mice. 
            Deletion of the C-terminal 9-AA Sequence Leads to Significant Changes in ospC  
mRNA Accumulation in All Tissues of SCID Mice.  Aimed at explaining how truncations  
affected tissue colonization, ospC mRNA accumulation was analyzed.  Heart, joint, and skin 
specimens were randomly selected from 15 mice that were infected with the ospCΔ/FL/1 (n = 5), 
ospCΔ/ospCct6/1 (n = 4), ospCΔ/ospCct6/2 (n = 1), ospCΔ/ospCct9/1 (n = 1), or 
ospCΔ/ospCct9/2 (n = 4) spirochetes.  These 15 mice had been used either for Table 5.3 or 5.4.  
RNA samples were prepared and quantified for flaB and ospC expression by RT-qPCR.  No 
significant differences in ospC mRNA accumulation were noted between the ospCΔ/FL and 
ospCΔ/ospCct6 bacteria in either heart (P = 0.25) or skin tissue (P = 0.81), but deletion of the 6-
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AA sequence led to a seven-fold decrease in ospC mRNA density in the joint (P = 0.0002) 
(Figure 5.4B).  The ospCΔ/ospCct9 spirochetes accumulated ospC transcripts 61% and 84% 
more than the clone ospCΔ/FL/1 in the heart (P = 0.001) and skin tissues (P = 0.002), 
respectively, but 3.4-fold less in the joint (P = 0.0007).  B. burgdorferi expressing OspC with the 
9-AA deletion accumulated ospC mRNA 37%, 109%, and 92% more than the ospCΔ/ospCct6 
spirochetes in the heart (P = 0.03), joint (P = 0.04), and skin tissues (P = 0.0003), respectively.  
Taken together, these data indicated that deletion of the C-terminal residues led to significant 
changes in ospC mRNA accumulation by B. burgdorferi during murine infection.    
DISCUSSION 
OspC is a well-defined virulence factor of B. burgdorferi in mammalian hosts (Grimm et 
al., 2004, Stewart et al., 2006, Tilly et al., 2006).  In immunocompetent mice, OspC is  
abundantly expressed only during early infection when it is required (Liang et al., 2004, Tilly et 
al., 2006), and its expression ultimately induces a robust, protective humoral response (Fung et 
al., 1994, Liang et al., 2004).  To evade the specific immune response, B. burgdorferi must  
repress OspC expression (Liang et al., 2002a, Liang et al., 2002b, Liang et al., 2004, Xu et al., 
2006).  To investigate how the C-terminal sequence contributes to the overall function of OspC, 
B. burgdorferi expressing OspC with different deletions were generated.  The study showed that 
deletion of the C-terminal 13- but not the 6- or 9-AA sequence completely abolishes infectivity 
as tested at one month post-inoculation. This loss in protection occurs as early as 24h post-
inoculation (as shown in Chapter 2). Although truncation of the 6-AA region did not 
significantly increase the ID50 values in SCID or immunocompetent mice, B. burgdorferi 
expressing OspC lacking the six residues generated lower bacterial loads in both heart and joint 
tissues and was unable to induce arthritis in SCID mice.  However, removal of the C-terminal 9- 
AA sequence did not increase the ID50 value in SCID or immunocompetent mice, or reduce the 
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Figure 5.4. Influence of deletion of the C-terminal 6- and 9-AA sequences on the tissue 
bacterial burden and ospC expression. A. Deletion of the C-terminal 6- but not 9-AA 
sequence reduces bacterial burdens in both heart and joint tissues but not skin.  Heart, joint 
and skin specimens were harvested from 10 mice infected with the clone ospCΔ/FL/1, 10 mice 
with either clone ospCΔ/ospCct6/1 (n = 5) or ospCΔ/ospCct6/2 (n = 5), and 10 mice with clone 
ospCΔ/ospCct9/1 (n = 5) or ospCΔ/ospCct9/2 (n = 5); the three groups are labeled as FL, ct6 and 
ct9, respectively.  These 30 mice had been used in Tables 5.2 and 5.3. B. Deletion of the  
C-terminal residues leads to significant changes in ospC mRNA accumulation. RNA 
samples were prepared from heart, joint, and skin specimens and quantified for flaB and ospC 
expression by RT-qPCR.  The data are presented as ospC transcripts per 1,000 flaB mRNA copy 
numbers.  Because of a smaller variation in ospC expression compared with the tissue bacterial 
load, the size of five samples was large enough to generate sufficient statistical power to show a 
significant difference. *, P < 0.05 (Ct6 or Ct9 compared with FL controls) *, P < 0.05 (Ct6 
compared with Ct9). 
 
tissue bacterial load either in heart or joint tissue, but did significantly increase the burden in skin 
while retaining arthritis virulence in immunodeficient mice.  Deletion of the 6-AA region led to a 
decrease in ospC mRNA accumulation only in the joint.  Likewise, the removal of additional 
three residues significantly reduced mRNA accumulation in the joints, as it increased in both 
heart and skin tissues of SCID mice.  
As a lipoprotein, OspC repeatedly has been shown to be essential for initial mammalian 
infection (Grimm et al., 2004, Stewart et al., 2006, Tilly et al., 2006).  It likely contributes to the 
virulence of B. burgdorferi by interacting with host components and protecting the pathogen 
Fig. 5.4B Fig. 5.4A 
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against hostile mammalian environments.  Portions of some of its five helices are exposed to the 
environment (Buckles et al., 2006, Eicken et al., 2001, Kumaran et al., 2001), so they potentially 
may play such a protective role.  In contrast, neither the N-terminal 23-AA linker nor the C-
terminal 14-AA stretch composes the core structure of OspC; instead, these terminal sequences 
are brought together by the α-helices 1 and 5, therefore allowing the terminal regions to directly 
interact with the components of the spirochetal outer membrane.  Although the last 14-AA 
sequence of the C-terminus does not contribute to the core structure, some of the residues, 
especially those that are close to the fifth helix, may play a critical role in stabilizing the core 
structure.  The removal of the last 13 residues indeed abolished the reactivity with the MAb. It is 
unknown whether deletion of these residues causes a collapse of the core structure and, as a 
result, abolishes infectivity.  Alternatively, the residues, especially those that are close to the 
helix, may mediate crucial interactions of OspC with the bacterial outer membrane, essential for 
the function of OspC during mammalian infection.   
Deletion of the C-terminal 6-AA region did not significantly reduce infectivity, in terms 
of ID50, in either immunodeficient or immunocompetent mice, but impaired the ability of B. 
burgdorferi to colonize both heart and joint tissues and diminished arthritis virulence in SCID 
mice.  In the heart tissue, the C-terminal truncation did not affect ospC expression, but 
significantly reduced the bacterial load, providing evidence that the integrity of OspC is crucial 
for its full function and that the lipoprotein is important for maintaining a high bacterial load in 
this specific tissue.  In joints, removal of the six residues significantly reduced ospC mRNA 
accumulation and the bacterial load, while diminishing arthritis virulence.  The reduced ospC 
expression level could be the primary reason for this chain of defects, as the OspC density on the 
spirochetal surface may be crucial for maintaining the bacterial load, which, in turn, may be 
important for the induction of arthritis.  Alternatively, the OspC expression level may be less 
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important than the integrity of OspC for these capacities.  In skin, the lack of the 6-AA sequence 
affected neither ospC mRNA accumulation nor tissue colonization, indicating that the integrity 
of OspC is not important for its full function; or alternatively, the lipoprotein has no significant 
contribution to borrelial virulence in this tissue.  In addition, these data indicate that the effect 
resulting from the deletion of the C-terminal 6-AA sequence is tissue-dependent, in both ospC 
mRNA accumulation and bacterial load.     
No significant defects were noted, in terms of ID50, tissue colonization and arthritis 
virulence, due to deletion of the C-terminal 9-AA sequence; instead, the truncation elevated the 
tissue bacterial load in skin.  An analysis of ospC expression revealed that the deletion 
significantly increased ospC mRNA accumulation in both heart and skin tissues.  As discussed 
above, the integrity of OspC may be critical for OspC function in the heart tissue. The increased 
OspC expression resulting from the removal of the 9-AA sequence apparently compensated for 
the structural defects caused by the truncation, therefore allowing the mutant to maintain a 
bacterial burden at the control level.  In the joint, the lack of the 9-AA sequence led to a decrease 
in ospC expression but maintained the bacterial load and retained arthritis virulence, indicating 
that neither OspC expression level nor structural integrity is crucial for the virulence of B. 
burgdorferi in this tissue.  However, a threshold level of OspC expression may be required for 
these two capacities, as the removal of the 6-AA sequence led to a reduced ospC mRNA 
accumulation, a lower bacterial load, and diminished arthritis virulence.  In skin, the integrity of 
OspC may not be important for tissue colonization as evidenced by the dramatically elevated 
tissue bacterial load resulting from the 9-AA deletion.  It also provides evidence that OspC is an 
important virulence factor in colonization of the skin tissue, although its integrity is not critical in 
this specific tissue.  Again, the study highlights tissue-dependent effects resulting from deletion 
of the C-terminal sequence. 
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Rosa and colleagues repeatedly showed that OspC is not required for the enzootic cycle 
of B. burgdorferi in the tick vector (Grimm et al., 2004, Stewart et al., 2006); in contrast, neither 
Pal et al. nor Fingerle et al. could make OspC mutants cross the salivary gland barrier to a 
murine host (Fingerle et al., 2007, Pal et al., 2004). The first group used fully competent ospC 
mutants in their studies, while the ospC mutants generated by the latter two groups could not be 
restored to infectivity.  Remaining reasons for the disparity could be techniques used by different 
groups.  A fresh blood meal leads to the upregulation of OspC and other antigens, a process that 
prepares B. burgdorferi for mammalian infection.  The requirement for OspC is temporal; once 
B. burgdorferi has adapted to the mammalian environment, the lipoprotein becomes unessential 
(Tilly et al., 2006).  If OspC plays a role in the tick, it remains to be addressed whether the C-
terminal stretch is negligible for B. burgdorferi during the life cycle in the vector.  
            The presence of the C-terminal stretch influences ospC mRNA accumulation, which is 
determined by both transcriptional initiation and RNA turnover.  Deletion of the 6-codons 
affected ospC mRNA accumulation only in the joint, while removal of three more influenced all 
tissues.  The 6-codon deletion unlikely affected mRNA turnover; nevertheless, removal of an 
additional three codons increased ospC mRNA accumulation in both heart and skin tissues, 
arguing against faster mRNA turnover.  For these reasons, the reduced mRNA accumulation 
originated most likely from lowered transcriptional initiation.  The ospC expression is driven by 
an RpoS-dependent promoter (Eggers et al., 2004, Yang et al., 2005) and repressed through the 
interaction of the newly identified operator with a unknown repressor (Xu et al., 2007).  
Reducing RpoS expression and/or inducing the repressor would lead to the down-regulation of 
OspC, unless other unidentified regulatory layers exist.  It is well known that B. burgdorferi 
adapts to diverse environments, in part, by selective gene expression.  How environmental cues, 
such as temperature (Brooks et al., 2003, Ojaimi et al., 2003, Ramamoorthy and Scholl-Meeker, 
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2001, Stevenson et al., 1995), pH (Carroll et al., 1999, Yang et al., 2000), nutrients or chemicals 
(Yang et al., 2001), and mammalian environments and specific immune responses (Caimano et 
al., 2007, Liang et al., 2002a, Liang et al., 2004), are decoded to specific signals, which 
ultimately influence gene expression in B. burgdorferi, remains unknown.  The C-terminal 9-AA 
stretch does not contribute to the core structure of OspC (Eicken et al., 2001, Kumaran et al., 
2001) and is not required for virulence of B. burgdorferi; given its special membranous location, 
future research should address how the C-terminal deletion affects ospC expression during 
murine infection. It is interesting to find that while deletion of N-terminus 5-AA of OspC led to 
an upregulation of ospC (Chapter 4), deletion of C-terminus of up to 9-AA of OspC led to a 
down-regulation of ospC, further suggesting a role for the termini of OspC in self-regulation of 
this enigmatic lipoprotein of B. burgdorferi. 
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CHAPTER 6 
 
GENERAL CONCLUSIONS 
            Lyme disease is included in the current list of emerging and re-emerging infectious 
diseases posted online by the National Institute of Allergy and Infectious disease (NIAID) 
(http://www3.niaid.nih.gov/topics/emerging). The disease is caused by at least three species of 
bacteria belonging to the genus Borrelia (Johnson et al., 1984). Borrelia burgdorferi sensu lato 
is the major cause of Lyme disease in the United States (Baranton et al., 1992). Borrelia is 
transmitted to humans by the bite of an infected tick of the genus Ixodes (the so-called hard 
ticks) (Cooley and  Kohls, 1945). The pathogen accomplishes some remarkable feats during its 
enzootic life cycle. Not only does it adjust physiologically to two markedly different host 
environments, the arthropod vector and the mammalian reservoir, but on a molecular level the 
pathogen changes its surface lipoprotein expression in order to maintain its enzootic life cycle. 
            The outer surface protein C (OspC) is a major lipoprotein of B.burgdorferi that is induced 
within the tick during blood-feeding and is maintained in mammals only during the early stages 
of infection (Grimm et al., 2004). Using improved genetic and molecular methodologies, 
investigators have begun to slowly decipher the various functions of OspC. Some of these 
functions are specific while others are non-specific to OspC. Table 6.1 summarizes these 
functions of OspC within the tick and the mammalian host (with their respective references), 
some of which are already well characterized, while others remain controversial.  
            Within the tick vector, OspC was shown not to be required for either tick colonization or 
transmission from the tick vector to a mammal at least in B. burgdorferi (Grimm et al., 2004, 
Tilly et al., 2006) . However, OspC was shown to be crucial for the dissemination of the 
European species B. afzelii, transmitted by the European vector Ixodes ricinus (Fingerle et al., 
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2007). OspC also serves as a ligand for tick salivary gland protein Salp15, and thus facilitates the 
survival of the spirochete after inoculation into the mammal (Ramamoorthi et al., 2005).  
Table 6.1: Functions of OspC within the tick vector and the mammalian host. 
 
Tick vector                                                                                                References:   
 
Crucial for dissemination of B.afzelii  in I. ricinus                                    (Fingerle et al., 2007)    
Not required for migration to salivary glands or 
transmission to the mammal of B. burgdorferi in I. scapularis                  (Grimm et al., 2004) 
                                                                                                                         (Tilly et al., 2006)                           
Interacts with Salp15 tick salivary gland protein                            (Ramamoorthi et al., 2005) 
 
Mammalian host  
Protection against host innate defenses (non-specific)                                 (Tilly et al., 2006)          
                                                                                                                          (Xu et al., 2008)                                          
 
Dissemination-facilitating factor of B. burgdorferi  (specific)                        (Xu et al., 2008)  
                                                                                                                  This research project      
 
Not required for dissemination of host-adapted B.burgdorferi                    (Tilly et al., 2009)       
Adhesion for heart colonization                                                            (Antonara et al., 2007) 
Plasminogen-binding protein                                                                      (Lagal et al., 2006) 
Self-regulation                                                                                         This research project 
______________________________________________________________________________ 
            Within the mammalian host, OspC is absolutely required in the early stages of infections 
initiated by tick bite or needle inoculation. OspC deletion mutants were shown to be cleared 
within 48h. Eight days are required for the wild type spirochetes to disseminate. OspC then 
becomes dispensable as infection proceeds (Tilly et al., 2007), because a product produced 
during persistent infection can perform the early essential function normally performed by OspC 
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(Tilly et al., 2009). The requirement for OspC ends by 28 days post-inoculation (Tilly et al., 
2006). The essential function of OspC in evasion from host innate defences can be replaced by 
other lipoproteins, if properly regulated (Xu et al., 2008).  
            One function that is uniquely attributed to OspC is that of facilitating the dissemination of 
B. burgdorferi. OspC-deficient spirochetes over-expressing heterologous lipoproteins were 
shown not to be as efficient in disseminating to distal tissues as those over-expressing OspC 
itself (Xu et al., 2008). Although OspC as a whole was shown to be involved in assisting the 
dissemination of B. burgdorferi to remote tissues, this research work was the first of its kind 
being able to delineate this particular function of OspC to at least 5-AA of the N-terminus of 
OspC. This was also the first study to dissect the dissemination-facilitating function from the 
protection-promoting role of OspC. A study by the Tilly, K. et al., however, reports 
contradictory findings (Tilly et al., 2009). Their study suggests that OspC plays no role in 
dissemination since spirochetes lacking OspC could disseminate and efficiently colonize distal 
tissues within 3 weeks of infection. However, the spirochetes used in their study were host-
adapted, and thus, it is not possible to discriminate between the role that OspC performs from the 
role that a presumptive OspC surrogate (produced by the transferred host-adapted bacteria) 
performs in facilitating dissemination of B. burgdorferi. Further experiments directed towards 
solving this controversy are required.  
            Yet another function for OspC in the mammalian host is that of an adhesion to 
endothelial cells for the colonization of the heart (Antonara et al., 2007). ospC transcripts were 
shown to be more abundant in the heart than in any other tissues (Hodzic et al., 2003). Finally, 
the role of OspC as a plasminogen receptor was confirmed by using ELISA and surface plasmon 
resonance  (Lagal et al., 2006). The results of this study suggest that the correlation between  
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OspC polymorphism and Borrelia invasiveness is attributed in part to differences in OspC 
affinity for plasminogen.       
            In spite of recent advances in borrelial genetics that led to the development of selectable 
markers and shuttle vectors ((Bono et al., 2000, Eggers et al., 2002, Elias et al., 2003, Stewart et 
al., 2001), targeted gene inactivation (Rosa et al., 2005), and identification of virulence factors 
such as OspC, OspA/B and PncA (Grimm et al., 2004, Purser et al., 2003, Yang et al., 2004), the 
use of these methodologies alone cannot help investigators elucidate the functions of these 
virulence factors. The analysis of secondary structures and three-dimensional crystal structures 
of solved proteins may lead to a more thorough understanding of the functions of these virulence 
factors. However, the resolution of OspC in 2001 did not help much in elucidating the function 
of this lipoprotein.  Although a similarity between OspC and the aspartate receptor of Salmonella 
was found (Kumaran et al., 2001), it did not have further implications. One reason for this gap in 
knowledge being that research groups have so far been focusing on the OspC structure as it 
relates to epitopes for the purposes of vaccine production and characterization of monoclonal 
antibodies (Earnhart et al., 2007, Earnhart and  Marconi, 2007, Yang et al., 2006). 
            The overall goal of this research project was to investigate how the secondary structure of 
OspC relates to its functions and/or regulation of the ospC mRNA expression. This goal was 
accomplished by deleting certain amino acid sequences of OspC and studying their effects on 
infectivity, dissemination, spirochete burden, pathogenicity and ospC mRNA expression. A  
summary of how the diverse amino acid sequences affect the function of the OspC protein, its 
regulation of the ospC transcript, and other parameters are shown in Table 6.2. 
            The studies in this dissertation have shown that deletion of AA sequences within the core 
structure of OspC led to complete loss of infectivity of B. burgdorferi, whereas deletions towards 
the N-terminus or the C-terminus of the lipoprotein had different effects: from loss of infectivity, 
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depending on the number of amino acids deleted, to inefficient dissemination of the spirochetes 
to distal tissues, or changes in pathogenicity, to changes in ospC mRNA accumulation. Thus, our 
hypothesis that phenotypic changes related to the function(s) of OspC in B. burgdorferi can be 
attributed to certain structures of OspC was proven to be true. 
            It is interesting that the roles that OspC plays in innate immune evasion and in 
dissemination of B.burgdorferi have significance in the light of its regulation. While OspC aids 
B. burgdorferi to evade early innate host defences at the site of the tick bite, its role in facilitating 
dissemination  aids the spirochetes to spread to distal tissues within two weeks, at which crucial 
period anti-OspC borreliacidal antibodies have been developed. However, since the pathogen has 
already disseminated to and colonized the remote tissues, it can then afford to downregulate 
ospC expression. Although other lipoproteins can substitute the role of OspC in dissemination to 
various extents, they are not as efficient and as fast in facilitating the dissemination as OspC (Xu 
et al., 2008). One study has shown that OspC is not needed for persistence in the mammalian 
host. It is hypothesized that other lipoproteins may to be able to substitute for the role of OspC 
after a certain period (Tilly et al., 2009). VlsE, a lipoprotein that is required for persistence of B. 
burgdorferi, may take over the function of OspC, which only remains a possibility. 
            It is interesting that the roles that OspC plays in innate protection and in dissemination of 
B.burgdorferi have significance in the light of its regulation. While OspC assists B. burgdorferi   
in evasion of host innate defences at the site of the tick bite, its role in facilitating dissemination 
aids the spirochete to spread to distal tissues within two weeks, at which crucial period anti-
OspC borreliacidal antibodies have been developed. However, since the pathogen has already 
disseminated to and colonized the remote tissues, it can then afford to downregulate ospC 
expression. Although other lipoproteins can substitute the role of OspC in dissemination to 
various extents, they are not as efficient and as fast in facilitating the dissemination as OspC 
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Table 6.2. The effect of OspC amino-acid sequence deletions on OspC function, regulation 
of ospC transcript, and other parameters.
a
 
 
OspC AA-sequence deleted           Function related to OspC 
 
                αH4                                         Loss of protection against host innate defenses 
                βs1 
                βs2 
               Nt10 
               Ct13 
 
                Nt5                                          No loss of protection against host innate defenses 
                                                                Inefficient dissemination of spirochetes 
                                                     Regulation of ospC transcript (SCID mice) 
                                                                          Heart     Joint      Skin 
                                                                                                                 
                Nt5                             
 
                Ct6                                                             
                                                         
                Ct9                                                              
                                                             
                                                            Spirochete burden (SCID mice) 
                                                                           Heart    Joint      Skin 
   
                Nt5 
                Ct6                 
 
                Ct9 
 
                                                           Arthritis virulence (SCID mice)                    
            Nt5 and Ct6                                                      Loss  
                 Ct9                                                               Preserved 
 
 
a.
 Symbols:        : no change         : Significantly increased       : Significantly decreased  
 
(Xu et al., 2008). One study has shown that OspC is not needed for persistence in the 
mammalian host. It is hypothesized that other lipoproteins may to be able to substitute for the 
role of OspC after a certain period (Tilly et al., 2009). VlsE, a lipoprotein that is required for 
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persistence of B. burgdorferi, may take over the function of OspC, which only remains a 
possibility. 
            OspC is among the major lipoproteins regulated by the RpoN-RpoS pathway (Hubner et 
al., 2001). The two-component response regulator Rrp2, along with RpoN, plays a role in 
activating the transcription of rpoS (Yang et al., 2003). An operator region containing two 
inverted repeats has been identified upstream of the RpoS-dependent promoter of ospC (Xu et 
al., 2007). This operator is critical for the immune evasion of B. burgdorferi. A repressor for 
ospC has not yet been identified. A recent study has shown that spirochetes lacking lp281 exhibit 
a sustained and higher production of OspC, suggesting that ospC gene expression is 
downregulated during murine infection by a repressor encoded on lp28-1 and that the absence of 
the repressor in spirochetes lacking lp28-1 plasmid led to constitutive OspC production (Embers 
et al., 2008). 
            OspC protein, on the other hand, is involved in self-regulation. This hypothesis was 
confirmed by the results of this research project have shown that there was an either down- or 
up-regulation of ospC mRNA transcripts in spirochetes expressing truncated OspC. When the C-
terminus 6-AA and 9-AA sequence of OspC was deleted, there was a down-regulation of ospC 
transcript, whereas when the N-terminus 5-AA sequence of OspC was deleted, there was an up-
regulation of ospC transcript compared to the transcripts of control spirochetes. However, we 
cannot exclude the possibility that another molecule could be binding to these C-terminus or N-
terminus sites and thus causing the effect in regulation of ospC transcript. 
            In conclusion, OspC is a virulence factor of B.burgdorferi that has multiple functions. In 
deciphering the functions of this lipoprotein one can appreciate the pathogenicity of Borrelia 
within the mammalian host. This research project was able to relate the structure of OspC to its 
function and transcript regulation among other phenotypic changes. Since in biological solutions, 
154 
 
OspC forms dimers, further studies of mutagenesis and crystal structure of truncated versions of 
OspC will be helpful. Further studies are also needed to better understand the regulation of ospC.  
Since OspC is involved in facilitating the dissemination of Borrelia in the mammalian host, 
prevention of disease progression from an early stage to a disseminated stage can be possible. In 
terms of regulation, molecular control over ospC regulation while the spirochetes remain in the 
mammalian host could mean a discontinuation of the enzootic life cycle of the Lyme disease 
spirochete, B. burgdorferi.  
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APPENDIX A 
 
CALCULATION OF ID50 VALUE BASED ON REED AND MUENCH MATHEMATICAL TECHNIQUE 
Doses No. of infected No. of uninfected 
Accumulated Number 
Percentage of infected 
Infected (A) Not infected (B) Total No. of tested(A+B) 
10
5
 10 0 31 0 31 31/31=100% 
10
4
 10 0 21 0 21 21/21=100% 
10
3
 8 2 11 2 13 11/13=85% 
10
2
 3 7 3 9 12 3/12=25% 
10
1
 0 10 0 19 19 0/19=0% 
Calculation of the index 
                   (% infected at dilution immediately above 50%) – 50%                
Index = _______________________________________________________________________________  
             (% infected immediately above 50%) – (% infected immediately below 50%)   
This is the application for calculating ID50, please prepare your data as shown above, then fill out the form below 
Please input your number of dilution factor (it is 10 in the table above)  
 
Please input the series of dilution from low to high (e.g. 1, 2, 3, 4, 5 in the table above)  
 
Please input numbers of positive treatments (infected in the above table) in the series of dilution from low to high (0, 3, 8, 10, 10 in the 
table above) 
 
Please input numbers of negative treatments (uninfected in the above table) in the series of dilution from low to high (10, 7, 2, 0, 0 in 
the table above) 
 
Submit query  
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APPENDIX B 
 
COMPARISION OF ARTHRITIS VIRULENCE BETWEEN MICE 
INOCULATED WITH CONTROL SPIROCHETES AND MICE 
INOCULATED WITH SPIROCHETES EXPRESSING THE N-TERMINUS 
5-AA DELETED OSPC 
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